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The aim of this dissertation was to compare two magnetic resonance spectroscopy (MRS) 
localization techniques: Fourier based region-of-interest (ROI) averaging, and the non-Fourier 
based spectral localization by imaging (SLIM).  Unlike ROI-averaging, SLIM provides a 
technique for calculating the metabolite spectra of a compartmental region without the need for 
averaging voxels of spectral data to estimate that region.  Because of this, SLIM has the potential 
to greatly reduce the acquisition time needed to acquire compartmental spectra. 
SLIM was processed over multiple k-space sizes and over an assortment of brain regions 
and then these results were compared to their equivalent ROI-averaged regions.  The assorted k-
space sizes were used to demonstrate SLIM operating with different amounts of available data, 
which was used to compare the process to ROI-averaging.  The results of this study validate 
SLIM as a valuable localization tool that will shorten scan times and improve accuracy in 
spectral localization. 
The dissertation is divided into five main chapters: (1) Introduction, which addresses 
magnetic resonance background concepts and applications of MRS techniques; (2) Methods, 
which describes the processes involved in developing a programming pipeline designed to 
produce metabolite data for the localization techniques; (3) Results, which provides statistical 
measures of the localization methods; (4) Discussion, where comparisons were drawn from the 
datasets based on the results section; (5) Conclusions, which evaluates the thesis work and 
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B0: The main (static) magnetic field (in T).  For atoms that possess spin angular momentum, 
B0 is used to produce the magnetization moment in the direction of B0. 
B1: The magnetic field oscillating at the Larmor radio frequency produced by the transmitter 
(in T).  The direction of the B1 magnetic field is perpendicular to that of the B0 field. 
Cho: Choline / choline containing compounds.  A vitamin-like essential nutrient that provides 
structural integrity and signaling roles in cell membranes and plays a role in cholinergic 
neurotransmission. 
Cr: Creatine.  A nitrogenous organic acid that serves a role in facilitating the recycling of 
adenosine triphosphate (ATP) in muscle and brain tissue. 
CRLB: Cramér–Rao Lower Bound.  The lower bound on the variance of any unbiased 
estimator.  CRLB is used in LCModel to estimate the confidence that the model is correct and is 
expressed as the standard deviation value of the metabolite fit being estimated. 
CSF: Cerebral spinal fluid.  A clear, colorless fluid in the brain and spinal cord that provides 
mechanical and immunological protection to the brain inside the skull. 
CSI: Chemical Shift Imaging.  See also MRSI. 
Echo: A signal produced by creating a phase coherence of the spins. 
EMF: Electromotive force.  Electric pressure that causes a current to flow in a circuit and is the 
source of the signal detected on receiver coils. 
FID: Free induction decay.  A damped oscillation of the observable NMR signal excited by a 
RF pulse.  The object’s FID can be detected by creating a change in the electromagnetic field, 
thereby inducing a current in receiver coils that are placed perpendicular to the primary magnetic 
field.  The transverse magnetization is a function of time, which are given by: 
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where 𝜙 is the phase at t = 0, and Mx(t) and My(t) are the real and imaginary FID 
components respectively. 
FOV: Field of view.  The distance (in mm) over which an MR image is acquired or displayed. 
FT: Fourier transformation.  A mathematical function for converting a signal in the time 
domain s(t) to a complex number in the frequency domain s(ω) using the equation: 




while the inverse Fourier transformation for converting a signal in the frequency domain to a 








FWHM: Full width at half maximum.  The width of a line shape at half of its maximum 
amplitude.  Used for quantifying the spectral linewidth.  Spectral peaks with a small FWHM are 
easy to resolve and reduce the chance of overlapping with other peaks. 
GABA: gamma-Aminobutyric acid.  The primary inhibitory neurotransmitter in the 
central nervous system. 
GRE: Gradient echo.  A signal generated at echo time by applying de-phasing and re-phasing 
gradients following a RF pulse.  The gradient echo is a T2
*-weighed signal. 
IR: Inversion recovery.  A pulse sequence utilizing a 180° excitation pulse.  Inversion 




LCModel: Linear Combination of Model Spectra.  A metabolite quantification program that 
estimates the individual contributions of metabolites in a spectra by using a basis set library of 
individual spectra and estimating the individual contributions of each metabolite to the overall 
spectra.  Additionally, the program also applies a baseline correction to the spectra to account for 
signal drift. 
mI: Myo-Inositol.  A carbocyclic sugar that serves as the structural basis for several 
secondary messengers including gene expression, cytoskeleton assembly, and cell membrane 
potential maintenance. 
MIDAS: Metabolite Imaging and Data Analysis System.  A package of software programs 
for processing MRI and MRSI datasets.  Included in this software package is MRSI Data 
reconstruction, B0 / Eddy Current Correction, lipid removal, spatial registration and ROI-
averaged signal reconstruction. 
MINT: Map INTegrated spectrum.  A MIDAS program that estimates compartmental 
spectra by using ROI-averaging for the region(s).  In this paper, MINT also refers to the ROI-
averaged dataset that was produced by MIDAS in the results section. 
MPRAGE: Magnetization Prepared Rapid Acquisition Gradient Echo.  A fast 3D gradient 
echo pulse sequence with a T1 weighted dominance.  MPRAGE is used to obtain an MRI with a 
high signal intensity by acquiring the echo during T1 relaxation. 
MRI: Magnetic resonance imaging.  A medical imaging technique that uses principles of 
nuclear magnetic resonance to generate an image whose signal reflects bulk properties of tissue.  
By applying a gradient of the magnetic field, spatial information about the object can be encoded 
as phase and frequency data, which can be used to reconstruct an image of the object. 
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MRS: Magnetic resonance spectroscopy.  A technique for acquiring metabolic information in 
tissues.  Magnetic resonance spectroscopy is acquired in the same way as MRI, except that 
spatial frequency gradients are not played during signal readout because frequency changes 
cannot be used for spatial encoding.  Spectroscopic techniques can be either single voxel or 
multi-voxel. 
MRSI:  MR spectroscopic imaging, which is also known as chemical shift imaging (CSI).  
A multi-voxel MRS acquisition method utilizes phase encoding gradients applied in 1, 2, or 3 
dimensions to segment larger stimulated volumes into multiple smaller voxels. 
NAA: N-Acetyl aspartate.  A derivative of aspartic acid found predominantly in neuronal cell 
bodies.  NAA is commonly used as a marker for detecting neuronal damage. 
NMR: Nuclear magnetic resonance.  The process of recording the stimulated absorption and 
emission of RF energy from nuclei placed within a magnetic field.  NMR typically refers to the 
physical phenomenon of nuclear resonance. 
OVS: Outer volume saturation.  A technique that uses spatially localized saturation bands to 
remove unwanted signal (e.g., Lipids). 
PCr: Phosphocreatine.  A phosphorylated creatine that recycles adenosine trisphosphate in the 
brain and muscles. 
PRESS: Point resolved spectroscopy.  A pulse sequence that utilizes three slice-selective 
RF-pulses (90° - 180° - 180°) and three orthogonal gradients (x, y, and z) to produce a spin echo 
at the region where the three planes intersect. 
PSF: Point spread function.  The point spread function describes the response of an imaging 
system to a point source or a point object. 
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RF Pulse: Radiofrequency pulse.  A short burst of an electromagnetic wave oscillating at the 
radio frequency used to excite protons in a B0 magnetic field. 
ROI: Region of interest. 
ROIS: ROI-averaged dataset produced by programs that were developed in-house.  This dataset 
was developed using the same processes utilized by the in-house SLIM program to compare the 
two processes in a more direct manner. 
SE: Spin echo.  A signal generated at echo time by applying a RF pulse in addition to those 
used in GRE to eliminate phase shifts resulting from magnetic field inhomogeneities.  The spin 
echo is a T2-weighted signal. 
SLIM:  Spectral Localization by Imaging.  A spectral reconstruction technique for 
acquiring spectral data from arbitrary shapes by utilizing a non-Fourier over-determined system 
to solve for the reconstructed spectra.  The arbitrary shaped compartments are obtained from an 
MRI using segmentation software and are customizable to obtain spectral reconstructions of any 
region of interest in the brain. 
SNR: Signal-to-Noise Ratio.  The ratio of the signal intensity to the baseline / residual noise 
level of the signal. 
Spectroscopy: The study of the interactions between matter and electromagnetic 
radiation. 
STEAM: Stimulated echo acquisition mode.  A pulse sequence that utilizes three slice-
selective RF-pulses (90° - 90° - 90°) concurrently with three orthogonal gradients (x, y, and z) to 
produce a spin echo at the region where the three planes intersect to produce a stimulated echo. 
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SVS: Single voxel spectroscopy.  A spectroscopy acquisition method for acquiring the spectra 
from a single voxel using applied RF-pulses coupled with gradients in three orthogonal planes.  
The most common method of acquiring SVS is PRESS. 
T1: Longitudinal relaxation time constant (in seconds).  Describes the return of longitudinal 
magnetization after a perturbation. 
T2: Transverse relaxation time constant (in seconds) for the decay/dephasing of transverse 
magnetization.  T2 describes the rate of attenuation for the transverse magnetization signal. 
T2*: Apparent transverse relaxation time constant (in seconds) for the decay/dephasing of 
transverse magnetization.  T2* accounts for inhomogeneities of the main magnetic field, and is 











where 1/T2i = γΔBi, and is the relaxation rate contribution caused by magnetic field 
inhomogeneities across a voxel. 
TE: Echo time (in seconds).  The time from the center of the excitation pulse to the center of 
the echo in seconds. 
TI: Inversion time (in seconds).  In inversion recovery pulse sequences, the TI is the time in 
seconds between the first 180° pulse and excitation pulse of the main sequence. 
TR: Repetition time (in seconds).  The length of time between corresponding consecutive 
points on a series of pulses and echoes.  TR signifies the total amount of time a pulse cycle takes. 
δ: Chemical shift (in ppm).  A measure of the differences in resonance frequency of nuclei.  
Chemical shift is caused by differences in electron cloud distribution due to differences in their 






× 106 (6) 
where v and vref are the frequencies of the compound under investigation and of a reference 
compound, respectively. 
γ: Gyromagnetic ratio (in rad T-1 s-1).  The ratio of a particle’s magnetic moment to its 
angular momentum. 
𝜙: Phase (in rad).  The position of a point in time on a waveform cycle. 
ω: Larmor frequency (in rad s-1).  The rate of precession of a particle possessing a magnetic 
moment in the presence of a magnetic field.
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Chapter 1: Introduction 
This report evaluates and characterizes an emerging advanced magnetic resonance 
spectroscopy (MRS) localization method: spectral localization by imaging (SLIM) based MRS.  
The SLIM localization method is evaluated in comparison with conventional Fourier 
transformation-based localization methods, with the report having a focus on data reconstruction 
and analysis strategies. 
MRS imaging (MRSI) is a clinical and research imaging tool that can map the absolute 
concentrations of metabolites in living organs, including the brain.  MRSI when combined with 
anatomical magnetic resonance imaging (MRI) can offer valuable information about the brain in 
an assortment of physiological states and for diseases in general.  MRSI can be used to evaluate 
the effectiveness of a cancer treatment by examining the concentration of metabolites before and 
after treatment.  It can be used to study how metabolic concentrations change over time or over 
the progression of a disease.  The technique can enhance information gleaned from MRI by 
showing metabolic concentration differences in regions that would otherwise appear identical in 
anatomical MRI. 
While MRSI has many valuable uses in medical and research fields, the technique has 
limitations that impede its widespread utilization.  The prolonged scan time required for MRSI 
data acquisition can be quite long due to the relatively low concentration of endogenous brain 
chemicals.  These concentrations, which can be 1/104 the strength of the water signal in the 
brain, can result in significantly lower signal-to-noise ratios (SNR) and restricted spatial 
resolution.  A low spatial resolution in MRSI obscures important spatial anatomical information 
by the point spread function effect, resulting from the truncated Fourier series representation 
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obtained by phase encoding.  Similarly, a large voxel size is prone to substantial partial volume 
effects, requiring careful and difficult corrections for accurate quantification. 
SLIM provides a solution that addresses some of limitations of MRSI techniques.  SLIM 
takes advantage of structural information from MRI as a means of reducing the required phase-
encoding steps needed to acquire MR spectra from homogeneous tissue compartments.  Unlike 
MRSI, which utilizes a Fourier transformation, SLIM utilizes a non-Fourier, overdetermined 
linear system to reconstruct compartment-based spectra.  Thus, the metabolic imaging team at 
KUMC has developed SLIM-based techniques and new data analysis strategies for acquiring 
localized spectra (Adany, Choi, & Lee, 2016; Lee, Adany, & Choi, 2017).  Because SLIM 
reconstructs spectra through localization instead of voxel averaging, the technique resolves the 
partial volume effect and point spread function artifacts, requiring fewer signal acquisitions to 
derive spectra that represent the same region. 
In this report, two region-of-interest (ROI) averaging methods were utilized: ROI 
averaging using the Metabolite Imaging and Data Analysis System (MIDAS) software suite and 
an in-house ROI-averaging program developed at KUMC.  Although MIDAS is a well-
established software suite that produces quality spectra outputs with ROI averaging, the in-house 
software that was utilized offered multiple advantages to the MIDAS software for this study.  
Using the in-house suite, spectral scale of the ROI averaged regions would be identical to the 
SLIM counterparts, allowing metabolic concentrations to be compared without the need of 
transforming them to ratios of creatine.  In addition, most processing steps would be handled 
between SLIM and ROI averaging in an identical manner, including co-registration, lipid 
handling, and B0-correction, enabling a more accurate representation of the differences between 
the two processing techniques. 
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The aim for this MS thesis is to evaluate SLIM over multiple k-space sizes and over an 
assortment of brain regions and then have these results compared to equivalent ROI-averaged 
regions.  This study aims to validate SLIM as a valuable localization method that will shorten 
scan times and improve accuracy in spectral localization.  To clarify the techniques that were 
used in the methods and results section later in the thesis, the following relevant concepts are 
described in the section below: Nuclear Magnetic Resonance (NMR), Magnetic Resonance 
Image (MRI), Magnetic Resonance Spectroscopic Imaging (MRSI), Quantification of MRS 




Nuclear Magnetic Resonance 
Nuclear magnetic resonance (NMR) is a physical phenomenon where nuclei in a 
magnetic field emit an electromagnetic signal after being perturbed by a weak oscillating 
magnetic field.  Nuclei have an intrinsic form of angular momentum known as nuclear spin, 
which produces a spin magnetic moment for the particle.  Nuclei with an imbalance of protons 
and/or neutrons will have a non-zero dipole moment and will reside in discrete energy states 
determined by their spin angular momentum.  These nuclei can transition between states by 
absorbing or emitting electromagnetic radiation in the 10-800 MHz energy range.  While NMR 
is used to analyze compounds containing nitrogen, carbon, or phosphorus (Andrade et al., 2014; 
Lambert, Binsch, & Roberts, 1964; Park et al., 2014), studies performed on 1H have been the 
most valuable due to the abundance of 1H in water and organic tissue. 
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Due to the random alignment of protons in the absence of a magnetic field, the net dipole 
moment of 1H protons is zero.  In presence of a static magnetic field (B0), a torque is exerted on 
the magnetic moment by the larger magnetic B0 field, where the direction of the B0 field by 
convention is chosen as the z-axis.  The angular momentum L of all elementary particles is 
limited to discrete values, whose amplitude is given by: 
 𝐿 = (
ℎ
2𝜋
) √𝐼(𝐼 + 1) J·s (7) 
In this formula, I is the spin quantum number of the nucleus, and h is Planck’s constant 
(6.626×10−34 J·s).  The precession angle between µ and B0 for elementary particles is given by: 




where m = +1/2 or -1/2 and θ yielding an angle of = 54.74° relative to the +z or -z axis.  
Nuclei of spin I = 1/2 are distributed on the surface of two cones and rotate about B0 at the 
Larmor frequency.  The small energy difference between the spin states will cause a small 
difference in the population of the two spin states.  This creates a net magnetic moment vector in 
parallel with the B0 field.  This net magnetization is very weak, but this difference in population 
of these spin states of parallel to antiparallel nuclei can be increased by using a stronger B0 field 
which increases the difference in energy between the two energy states and thus creates a larger 
signal.  The nuclei’s resonating frequency (ω0) can be calculated using the Larmor equation: 
 𝜔0 = 𝛾𝐵0          𝑜𝑟          𝑣0 = (
𝛾
2𝜋
) 𝐵0 Mhz (9) 
where γ is the gyromagnetic ratio of a particle’s magnetic moment to its angular 
momentum, and B0 is the strength of the magnetic field.  By applying a radiofrequency pulse at 
the right resonating frequency, the nuclei will emit a signal that can be captured on receiver coils 




Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) is a medical imaging technique that uses NMR 
techniques to form images of the organs in the body.  This technique has been used in the field of 
medicine to identify white matter lesions in patients with multiple sclerosis, to locate brain 
tumors, and for visualizing other brain abnormalities.  A typical MRI takes 5 minutes to acquire 
and is a regular component of a MR scanning session. 
MRI acquires spatial information about the object of interest by using frequency and 
phase encoding to store spatial information into the signal.  Since there is a direct relationship 
between magnetic field strength and the resonating frequency of nuclei, the expected resonance 
frequency can be changed by adjusting the static B0 magnetic field.  A small readout gradient of 
frequencies is applied to the B0 field over a spatial area, which allows a single dimension of 
resonance data to be acquired instantaneously in a single RF pulse.  Phase information can be 
acquired as a 2nd dimension by applying short magnetic field gradients between the readout 
gradients.  This causes a small shift in phase by temporarily increasing the resonating frequency 
of the nuclei while the gradient is applied. 
 
Figure 1: Phase encoding using a phase gradient pulse. 
During the application of a phase gradient, the precession frequency is increased for the duration of the pulse.  After 
removing the phase gradient, the precession frequency is restored to its original rate, but a change in phase has 
occurred which can be used to encode information into the signal. 
6 
 
MRI image contrast comes in the form of signal intensity that is caused by a couple of 
factors.  The first factor is the concentration of the nuclei being excited in the first place.  Both 
water and lipids have high concentrations of 1H and will form most of the signal in a typical 
MRI.  The second factor involves relaxation times that are affected by tissue properties.  For 
example, nuclei in a liquid have long relaxation times compared to nuclei in lipids.  Different 
tissue signals can be selectively suppressed or emphasized by adjusting pulse sequence timing, 
using spin echo refocusing pulses or using a gradient pulse echo. 
 
Magnetic Resonance Spectroscopy 
Magnetic resonance spectroscopy (MRS) is a spectroscopic technique used for observing 
local magnetic fields around nuclei.  Given a strong magnetic field, the same nuclei on different 
compounds are observed to resonate at different frequencies, even between nuclei on the same 
molecule.  These slight resonance deviations can be used to describe structural characteristics of 
chemicals and is a useful property for identifying compounds from chemical reactions.  Water 
suppression is usually performed when acquiring metabolic spectra as the metabolite signal is as 
low as 1/104 times that of the water signal.  Strong lipid signals can either be suppressed during 
MRS acquisition through outer volume saturation techniques, or through lipid removal 
algorithms during post processing. 
Using linear recombination and a database of individual spectra that were obtained 
previously in vitro, it is possible to fit a lineshape to raw spectra and estimate the metabolite 
concentrations of the original spectra.  Because of this, MRS is used as a non-invasive 
assessment of the metabolic activity of the region of interest.  For example, an MRS could be 
used to determine if a brain tumor is benign or malignant through its observed metabolic activity 
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by observing the differences in spectra (Bruhn et al., 1989).  Metabolites could be observed over 
the course of a disease progression, or to monitor changes during disease treatment to determine 
how effective a treatment is.  MRS has already been used to study the metabolic processes that 
occur after strokes, brain tumors, multiple sclerosis lesions, and has also been used to study an 
assortment of neural abnormalities such as depression and seizures (Brandao & Castillo, 2013; 
Fazekas, Ropele, Enzinger, Seifert, & Strasser-Fuchs, 2002; Rincon et al., 2016; S. Y. Wang et 
al., 2017; Zhang & Sui, 2017). 
Signal deviations at the molecular environment depend on small changes to the larger 
magnetic B0 field.  The major source of this signal deviation comes from electrons, whose 
negative electric charge produces a tiny local magnetic field that is oriented antiparallel to the 
much larger B0 magnetic field.  The small opposing magnetic field reduces the net strength of the 
total magnetic field at that location.  The effect that electrons have on the perceived magnetic 
field can be calculated by this formula: 
 𝐵𝑒𝑓𝑓 = 𝐵0(1 − 𝜎) (10) 
where Beff is the magnetic field experienced by the nuclei and σ is the shielding constant.  The 
new NMR resonance frequency could be calculated then as: 
 𝑣 = 𝛾𝐵0(1 − 𝜎) = 𝑣𝑜(1 − 𝜎) (11) 
In quantum mechanics, electrons are modeled as an electron cloud.  The position of the 
electron cannot be known at any given time, but instead is estimated as a cloud-like region 
surrounding the nuclei that represents the probability of where the electron lies.  On most 
molecules, the electron cloud will not be evenly distributed, but will distribute near nuclei with a 
high electron affinity like fluorine, oxygen and nitrogen instead.  To standardize values across 
MR scanners and other studies, a highly shielded reference molecule such as tetramethylsilane 
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(TMS) is chosen as the reference for 1H-MRS.  Any chemical shift away from that resonance 
peak is recorded in parts per million (ppm) to that peak: 
 𝛿 = (𝑣0 − 𝑣) ∙ 10
6/𝑣𝑜 (12) 
Nuclei that possess a low electron density will experience a greater percentage of the total 
B0 field, compared to nuclei with a greater electron density, and experience a strong downshift in 
resonance frequency, known as a chemical shift (CS).  By using a reference molecule, this 
process is standardized across MR scanners.  In vivo scans lack TMS, so N-acetyl aspartate 
(NAA) is commonly used to determine chemical shift positioning because of its well-defined 
peak. 
In addition to electron shielding, another localized effect that can be observed is the 
indirect (scalar) spin-spin coupling between neighboring nuclei.  This effect is responsible for 
splitting spectroscopic lines into multiplets.  Nuclei attached to a carbon backbone are affected 
by nuclei attached to neighboring carbons.  The multiplet split is the result of different 
combinations of nuclei oriented in parallel and antiparallel orientations to the B0 field.  Nuclei 
with antiparallel orientations behave similarly to electrons as they reduce the effective influence 
of the B0 field; an effect that is felt on their neighboring nuclei.  The signal is split into n + 1 
peaks, where n is the number of nuclei on neighboring carbons. 
Combining these two effects, all compounds can be identified solely on their local spin-
spin coupling effects and their electron shielding properties.  There have been libraries of 
compounds catalogued by their NMR spectra.  Programs like “Linear Combination of Model 
Spectra” (LCModel) use NMR spectral libraries for automating the metabolic quantification 




Quantification of MRS signals 
 In vivo MR spectral signals represent the concentration and the variety of the metabolites 
within the region being observed.  The chemicals vary both in their spectral fingerprint and the 
total quantity of the chemical itself but can be estimated using a metabolite quantification 
program.  These programs will estimate the individual contributions of each metabolite by using 
a library of individual spectra called a “basis set” and will then estimate the individual 
contributions of each spectra.  One widely used program is LCModel, which estimates 
metabolite concentrations using maximum-likelihood estimates of the metabolite concentrations 
and their uncertainties using Cramér–Rao lower bounds on the metabolite spectra.  The Cramér–
Rao lower bound (CRLB) represents the lowest possible standard deviation of all unbiased 
model estimates that were obtained from the spectra (Cavassila, Deval, Huegen, van Ormondt, & 
Graveron-Demilly, 2000).  It is generally accepted that CRLB values < 10% indicate that 
metabolite concentrations are measured with enough precession that they are considered reliable, 
while values greater than 30% are not considered reliable.  These values show up in LCModel as 
the standard deviations of the metabolites fitted in the spectra. 
 
Spectral Localization 
 Much of the technical challenge for acquiring in vivo MRS involves localization of the 
signal to the ROI.  The simplest MRS localization method is single voxel spectroscopy (SVS), 
which uses three orthogonal slice-selective pulses to acquire a single metabolic signal from the 
region/voxel at the intersection with no further localization steps involved.  Signals outside the 
voxel are destroyed using crusher field gradient pulses or outer-volume saturation pulses 
(Felmlee & Ehman, 1987).  High SNR is achieved by selecting a large voxel area, usually in the 
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4 - 8 cm3 range, which is necessary due to the lower strength of metabolic signals in the brain 
compared to the strength of the water and lipid signals.  There are two widely-used methods for 
localizing the signal using a Fourier-based approach: Point REsolved SpectroScopy (PRESS) 
(Bottomley, 1987) and Stimulated Echo Acquisition Mode (STEAM) (Haase et al., 1986).  
PRESS uses a 90° excitation pulse combined with two refocusing pulses, while STEAM uses 3 
slice-selective RF pulses with 90° flip angles. 
 Magnetic Resonance Spectroscopic Imaging (MRSI) is a multi-voxel acquisition of in 
vivo spectral data.  MRSI datasets are often acquired using a PRESS or STEAM localization 
process but require a much larger volume to acquire signals across a 2D or 3D ROI.  Row and 
column localization of the signal within the PRESS or STEAM localization pulse is done using 
phase-encoding only, since frequency encoding cannot be used to store spectral frequency 
information.  Phase-encoding applied by incrementally adjusting the strength of the applied 
magnetic gradient field for each datapoint in the grid to create a spectral image that spatially 
spans the excited region. 
Due to the large ROI, MRSI can suffer from magnetic field inhomogeneity problems and 
is prone to spectral degradation from intervoxel contamination.  The low resolution of MRSI 
datasets cause voxel size deviations from the expected size, which is a byproduct of Fourier 
encoding processes.  This deviation in expected values is caused by point spread function (PSF) 
effects, which describes the response of an imaging system to a point source.  The low number of 
phase-encoding steps causes the reconstructed signal to have strong side lobes from finite 
discrete sampling, which results in signal contamination between neighboring voxels.  Because 
frequency encoding cannot be used, acquisition times can be quite long.  While a 2D MRSI with 
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16 x 16 matrix dataset can take 5-6 minutes to acquire the ROI, each slice takes that amount of 
time, meaning a 16 x 16 x 8 3D dataset will take 8 times the scan time of the 2D dataset. 
 
Echo Planar Spectroscopic Imaging 
There have been several attempts to reduce the acquisition times of MRSI.  One of the 
best currently available pulse sequences is an MRSI sequence known as Echo Planar 
Spectroscopic imaging (EPSI).  This sequence is currently used to reduce the scan time it takes 
to acquire MRSI datasets.  EPSI uses an oscillating readout gradient that is applied during the 
data acquisition to collect spatial and spectral information simultaneously (Posse, Tedeschi, 
Risinger, Ogg, & Le Bihan, 1995).  The oscillating readout gradient repeatedly collects one line 
of k-space at different time points, with conventional phase encoding being applied before the 
oscillating readout gradient to encode the other spatial dimensions. 
In the most commonly used EPSI pulse sequence, three radiofrequency pulses (RF) are 
used: two for acquiring the metabolite signal and one for the water reference signal.  The water 
reference and metabolite signal are acquired in the same repetition time by exciting the water 
signal immediately after the metabolite signal acquisition.  The region of interest is selected by a 
slice selective excitation pulse and a slice selective refocusing pulse for the metabolite signal and 
by a slice selective excitation pulse for the water signal.  One line of k-space data is acquired by 




Figure 2: EPSI pulse sequence. 
Volumetric proton EPSI acquisition that incorporates an interleaved water reference acquisition.  The sequence 
includes inversion recovery (IR), CHEmical Shift Selective saturation (CHESS) water suppression and Outer 
Volume Saturation (OVS) to reduce water and lipid contamination during the metabolite acquisition.  An oscillating 
readout gradient is applied to acquire a single dimension of k-space information in a single pulse.  The water 
reference is acquired following a low flip angle excitation applied after metabolite acquisition. 
The benefit of using oscillating readout gradient in EPSI is a significant reduced scan 
time that is an order of magnitude shorter than traditional MRSI.  This acceleration of spatial 
encoding in EPSI enabled three dimensional MRSI, which was not feasible using conventional 
MRSI due prohibitive scan time requirement. 
 
Spectral Localization by Imaging 
Spectral localization by Imaging (SLIM) is a non-Fourier transformation MRSI 
localization method that uses generalized matrix inversion approaches to calculate the signal for 
each compartmental region (Hu, Levin, Lauterbur, & Spraggins, 1988).  Compartmental region 
estimates are obtained from an MRI scan of the same region.  SLIM operates by dividing the k 
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space data into several highly customizable compartments that can be defined through binary 
maps.  These compartmental maps are a spectral function given by: 
 𝜌𝑠𝑙𝑖𝑚(𝑟, 𝑓) = ∑ ?̂?𝑚
𝑀
𝑚=1 (𝑓) (13) 
where the estimate of the desired average compartmental spectrum can be represented by 
the formula: 





, 𝑓𝑜𝑟 𝑟 ∈ 𝐷𝑚
0, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 (14) 
Dm in this formula represents the compartmental geometry that was defined by the 
original anatomical image and Vm is the volume of those compartments.  This reconstruction can 
be solved using least-squares and can be represented as a vector: 
 𝑠𝑛(𝑡) = 𝐺𝑛𝑚𝑐𝑚(𝑡) (15) 
In this formula, sn(t) is the nth phase-encoded signal, cm(t) is the signal from the mth 
compartment without phase encoding, and Gnm is the SLIM geometry matrix that can be 
represented as: 
 𝐺𝑛𝑚 = ∑ (𝜉𝑚(𝑟)𝑒
−𝑗2𝜋𝑘𝑛∙𝑟)𝑟  (16) 
In Equation 17, ξm is a binary compartment which is used to identify the spatial distribution of 
the compartment(s) of interest, kn is the serialized k-space vector, and r is a spatial coordinate 
vector.  Using the least-squares fitting method to solve for cm(t), the SLIM reconstructed 
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compartmental signals-encoding vector are obtained for the compartments of interest.  Solving 
for cm(t) simply involves transforming the dataset using a complex conjugate transformation. 
  
Figure 3: Comparison of Fourier based ROI-averaging vs non-Fourier based SLIM reconstruction. 
In Fourier based ROI-averaging, the signal from each voxel used in reconstructing the compartment signal “bleeds” 
into neighboring voxels due to sidelobe effects as seen by the waveform in the top left image.  Reconstructing the 
signal using SLIM results in a spectra reconstruction that describes the exact shape of the compartment. 
The result of SLIM processing is spectra that describe regions defined by the binary 
compartment maps.  This framework allows us to overcome several limitations of current MRSI 
techniques, the biggest one being its limitation to rectangular voxel shapes for metabolite 
spectra.  SLIM is non-Fourier based, so the spectra are exact recreations of the compartmental 
areas instead of a Fourier based estimation.  Using SLIM, one could acquire the metabolic 
fingerprint of the thalamus, the hippocampus, and other gray and white matter regions easily by 
using a compartment shape that matches the exact region the object of interest occupies in the 
MRI.  Early phantom studies on SLIM have demonstrated that spectral reconstruction of water 
and fat signals originating from cylindrical bottles of oil and water can be retrieved with as few 
as two phase-encoding steps used as inputs, showing that the main benefit of SLIM is its 
capability in reconstructing compartmental signal from k space data without the need for 
acquiring large MRS datasets (Hu et al., 1988). 
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Currently, there are only a few reports that utilize non-FT based approaches for 
processing MR spectra.  Most papers that utilize MRS employ FT based voxel averaging.  Non-
FT based approaches reconstruct spectra from spatially well-defined compartments that would 
eliminate the need for accounting for partial volume fractions, various chemical shift issues, and 
point spread function effects.  The most promising fix is the reduced acquisition time needed, 
which makes SLIM a valuable tool in clinical studies.  Using an EPSI pulse acquisition 
sequence, a 4x - 8x reduction in k-space acquisitions is possible using a SLIM reconstruction 
instead of using ROI-averaging.  SLIM is an untapped resource that provides another method for 
how metabolite concentrations are analyzed in specific brain regions. 
 
Applications of MRS Techniques  
MRS has been used as a tool for studying the brains of individuals that encompass a wide 
range of phenotypical differences.  The MRS technique has been utilized in studying differences 
in the brain attributed to age, sex, and race, with some of the most notable discoveries stemming 
from studying damaged and diseased brains.  Increased spatial resolution has enabled researchers 
with the ability to study localized regions of the brain to observe spatial differences between 
brain regions.  These studies are a window to the metabolic processes in the living brain that is 
generally not observable using other techniques.  There have been many studies already done on 
the brain with MRS, and the following sections detail MRS research that has been done to study 




Tissue Type specific MRS measurements: GM and WM 
White matter MRS studies have uncovered interesting observations about the tissue type.  
For men, intelligence was associated with higher myelination and a higher number of axons, 
while intelligence in women was more closely associated with gray matter density (Dunst, 
Benedek, Koschutnig, Jauk, & Neubauer, 2014).  The synapses on axons are dynamically 
modifiable and may be a source mechanism of learning and memory (Catani et al., 2012).  
Synapse modification has been shown to occur in subjects learning a musical instrument (Ullen, 
2009) and also has been shown in adults learning to read (Carreiras et al., 2009).  Aging affects 
white matter density, where white matter increases in volume and maturity up until age 40, then 
declining at 3.1 ± 0.4 cm3 of white matter per year (Resnick et al., 2003; Sowell et al., 2003).  
Degradation of white matter neural tracts have strong correlations to decreased cognitive 
function problems in an assortment of neurological disorders (Damasio, 1984).  White matter 
lesions affect cognitive performance in arithmetic and the myelin damage is visible in an MRI 
through water accumulation at the location of the damage (Anderson et al., 2014; Matejko & 
Ansari, 2015).  In addition, degradation can be detected through reduced NAA concentrations, as 
macromolecular change in pre-lesion WM occur before a lesion becomes visible on conventional 
MRI (Fazekas et al., 2002).  Abnormal white matter connections in the uncinated fasciculus, 
frontal, and temporal thalamic projections can be found in subjects with autism spectrum 
disorders as well as in patients with cerebral palsy (Ameis & Catani, 2015; Pannek, Boyd, Fiori, 
Guzzetta, & Rose, 2014). 
In addition, gray matter MRI and MRS studies have uncovered several interesting details 
about the tissue type as well.  When factoring in differences in brain size, women have a higher 
proportion of gray matter compared to men, and there is more asymmetry in cortex tissue 
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volumes of men compared to women (Gur et al., 1999).  Longitudinal aging studies have shown 
that gray matter follows a pattern of buildup and decline, with the gray matter decline beginning 
at age 30 at a rate of 2.4 ± 0.4 cm3 per year (Resnick, Pham, Kraut, Zonderman, & Davatzikos, 
2003).  On a metabolic level, MRS studies on children diagnosed with autism spectrum disorder 
have been shown to have decreased choline, creatine & phosphocholine, myo-inositol, and NAA 
in gray matter (Friedman et al., 2006).  Gray and white matter have also been shown to differ in 
GABA concentrations, with gray matter having a concentration of 1.30 ± 0.36 µmol/g and white 
matter having a concentration of 0.16 ± 0.16 µmol/g (Choi, Lee, Merkle, & Shen, 2006). 
 
Region specific MRS measurements 
The brain can be divided into functional groups as well as gray and white matter regions, 
and these smaller regions are often the preferred target of MRS studies.  The organ can be 
characterized as three major functional regions: the brainstem, the cerebellum, and the cerebrum.  
The largest of these is the cerebrum and consists of two hemispheres that can be further divided 
into the frontal, parietal, occipital and temporal lobe.  There is also a fifth region called the 
cingulate which has been referred to as the “limbic lobe” by some groups.  At the very core of 
the brain is the basal ganglia that is comprised of the thalamus and the striatum.  These regions 
are all areas that have been previously studied using MRS. 
The brainstem is the smallest of these three main regions and plays a role in many 
autonomic processes including sleep, hearing, equilibrium, eye movement, vomiting, facial 
expressions, emotion, cardiac and respiratory processes.  Parkinson’s disease is associated with a 
loss of dopaminergic neurons in this region, reductions in NAA/Cr in the substantia nigra, and an 
increase in gamma-Aminobutyric acid in the pons and putamen (Ciurleo, Di Lorenzo, Bramanti, 
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& Marino, 2014; Duguid, De La Paz, & DeGroot, 1986; Pyatigorskaya, Gallea, Garcia-Lorenzo, 
Vidailhet, & Lehericy, 2014).  The pons has a higher choline and myo-inositol concentration 
compared to other regions, but a much lower creatine concentration (Jacobs, Horska, van Zijl, & 
Barker, 2001; Minati, Aquino, Bruzzone, & Erbetta, 2010).  Lower NAA/Cr ratios have been 
shown to correlate with more intense and frequent migraines and has been found to be lowered in 
diseased states such as Wilson’s disease and amyotrophic lateral sclerosis (ALS) (Algin et al., 
2010; Foerster et al., 2013; Lai, Fuh, Lirng, Lin, & Wang, 2012). 
Sitting behind the brainstem are the cerebellum, which are two finely grooved structures 
that sit just below the cerebrum.  The cerebellum serves as a center for motor control and 
provides some cognitive functions.  MRS studies have found higher creatine concentrations in 
the cerebellum compared to other brain regions (Minati et al., 2010).  Metabolic changes in the 
Cho/Cr ratio of cerebellum lesions are shown to be involved in the development of post-stroke 
depression (Zhang & Sui, 2017). 
 The largest region of the brain is the cerebrum, and each hemisphere is divided into four 
lobes.  The largest of these regions is the frontal lobe, and is strongly associated with reward, 
attention, motivation planning and short-term memory tasks.  In addition, the frontal lobe houses 
Broca’s area, which is a region with functions linked to speech production.  Broca’s area 
increases in gray matter density in musicians learning an instrument (Abdul-Kareem, Stancak, 
Parkes, & Sluming, 2011; Sluming et al., 2002).  When comparing men and women with 
identical brain sizes, women had larger gray matter volumes in the left orbitofrontal region, and 
the primary auditory cortex (Luders, Gaser, Narr, & Toga, 2009).  Increased gray matter in the 
dorsolateral prefrontal cortex has been found to be correlated with higher academic performance 
(S. Wang et al., 2017).  In longitudinal studies, the frontal lobes have been shown to have the 
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greatest amount of decline in gray matter with age, and this decline correlates with declined 
cognitive test performances (Sowell et al., 2003; Tisserand et al., 2004).  Patients with type 2 
diabetes mellitus who had diabetic retinopathy have been shown to have decreased NAA/Cho 
ratios in frontal white matter (Tong et al., 2014). 
 The second region is the parietal lobe, which is the main sensory receptive area for spatial 
navigation and touch.  The region is also important for language processing.  Substantial 
metabolic changes in the parietal lobe were observed in children from age 3 to 19 (Horska et al., 
2002).  Patients with obsessive compulsive disorder showed higher Cho/Cr ratios in the parietal 
white matter compared to controls (Kitamura et al., 2006). 
Beneath the lateral fissure and underneath the parietal and frontal lobe is the temporal 
lobe, which is involved in processing sensory inputs for retaining visual memory, emotional 
associations, and language comprehension.  The temporal lobe is also home to Wernicke’s area, 
which is involved in the comprehension and understanding of written and spoken language.  
When comparing men and women with identical brain sizes, women had larger gray matter 
volumes in the superior temporal gyrus, the primary auditory cortex, and Wernicke’s area 
(Luders et al., 2009).  The region is also often a source location for epileptic seizures in 
adolescents (Tramoni et al., 2011). 
The occipital lobe is the smallest lobe of the brain, which lies just above the cerebellum.  
The region is the visual processing center of the brain where visional information is analyzed for 
form recognition and object representation, as well as information about motion, color, and 
object location.  In the occipital lobe, NAA, Cr, and Cho concentrations are 20 - 90% higher in 
the gray matter compared to the white matter (Wang & Li, 1998).  Patients with chronic 
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migraines were found to have reduced or impaired energy metabolisms in the occipital lobe 
compared to controls (Reyngoudt, Paemeleire, Descamps, De Deene, & Achten, 2011). 
This last region of the brain is sometimes referred to as the limbic lobe or cingulate, 
which is an arc shaped region of cortex that surrounds the corpus callosum and inner organs that 
sit above the midbrain.  The region is vital for memory learning, motivation, and emotional 
processes, and social skills and empathy are thought to be processed through the limbic lobe.  In 
subjects with Alzheimer’s disease, patients had reduced NAA and mI in the limbic lobe (Guo et 
al., 2015).  MRS was also used to detect metabolic changes in the cingulate gyrus (Gardner et al., 
2017).  In an age-related study, gray matter in the insula declined faster than other regions of the 
brain (Sowell et al., 2003). 
At the core of the brain lies the thalamus, which behaves as a hub for receiving and 
transmitting signals to other parts of the brain.  Made primarily of gray matter, the thalamus 
plays an important role in the regulation of alertness and sleep states (Steriade & Llinas, 1988).  
Every sensory system passes through the thalamus for routing to their respective locations for 
further processing, except for the olfactory system which connects directly to the olfactory bulb.  
When comparing regions in the brain using MRS, the thalamus was observed to have a higher 
NAA concentration than the other locations (Minati et al., 2010).  In situations where the brain is 
damaged, the thalamus plays a significant role in neuronal repair after the traumatic brain injury.  
Patients recovering from a mild traumatic brain injury were observed to have a hyper-connected 
thalamus during early stages of the injury (Sours, George, Zhuo, Roys, & Gullapalli, 2015).  The 
thalamus has also been observed in many various neurological conditions using MRS.  A study 
done on subjects diagnosed with bipolar disorder found a significantly increased Glx/Cr ratio in 
the left thalamus compared to control groups (Xu et al., 2013).  MRS studies have found a 
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correlation between individuals with autism spectrum disorder (ASD) and some thalamic 
abnormalities (Hardan et al., 2008).  The thalamus likely plays a role in ALS, as a reduction in 
NAA and the NAA/Cho ratio in the thalamus was observed in subjects with ALS (Sharma, 
Saigal, Maudsley, & Govind, 2011).  A similar reduction in NAA was found in patients with 
chronic schizophrenia (Brugger, Davis, Leucht, & Stone, 2011). 
Another major brain structure in the center of the brain is the striatum.  This structure is 
comprised of several critical substructures such as the amygdala, putamen, caudate, globus 
pallidus and hippocampus.  These regions facilitate motor and reward systems and coordinate 
multiple cognitive functions including decision making, reward perception, motivation, and 
behavioral reinforcement.  Posttraumatic stress disorder (PTSD) was also found to be associated 
with the hippocampus, where affected individuals had significantly lower NAA in the 
hippocampi and higher Glu and Glu / NAA in the right hippocampus.  In addition re-
experiencing the symptoms resulted in a negative correlation of NAA in the hippocampi (Rosso, 
Crowley, Silveri, Rauch, & Jensen, 2017).  The caudate is one of several regions of the brain that 
is significantly reduced in volume of patients with Alzheimer’s disease and could be used for 
early diagnosis (Jiji, Smitha, Gupta, Pillai, & Jayasree, 2013).  The globus pallidus plays an 
important role as a pacemaker for regulating timing of voluntary movements in the body 
(Surmeier, Mercer, & Chan, 2005).  A reduced amygdala volume has been shown to correlate 
with anxiety, bipolar, and posttraumatic stress disorders, as well as an increase in frequency of 
anxiety attacks (Thomas et al., 2013; Ziabreva, Poeggel, Schnabel, & Braun, 2003). 
 Based on the previously mentioned studies, it is evident that there are significant 
observable differences in brain tissue from that varies greatly by region.  The precise roles that 
these brain regions have make it necessary to have voxels that accurately represent the area being 
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observed.  This is difficult to demonstrate in MRS studies when little consideration is taken of 
the complex boundaries that define these brain structures.  Knowing the important roles that 
these brain regions have only emphasizes the importance of precise regional measurements in 
MRS. 
MRS observations still depend on the limited spatial resolution of MRSI, which creates a 
challenge when analyzing functional brain regions.  Here, a case for SLIM is presented in which 
MRI data is utilized to create compartments for SLIM processing.  Several resolutions of MRSI 
data are run through SLIM processing and the resulting spectra are compared to the HR-MRSI 
area averaged values provided through MIDAS.  Quality of spectra in SNR and accuracy are 
assessed and compared between the two methods.  
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Chapter 2: Methods 
This section details the pre- and post-processing steps of MRI and MRS data used to 
compare SLIM and ROI averaging.  My work focused on three main areas: 1) creation of a high-
resolution compartment map for use in SLIM and ROI averaging, 2) calculation of compartment 
spectra using SLIM and ROI averaging from MIDAS and in-house programs, 3) quantification 
of metabolite concentrations from the compartmental spectra using automatic quantification 
programs, and comparison of SLIM and ROI-averaging using statistical analysis methods.  Each 
of these three main areas was organized into a pipeline represented by Figure 4: 
 
Figure 4: SLIM and ROI-Averaging Processing Pipeline. 
3D EPSI and MPRAGE were utilized to create a custom compartment map, which was used to define the 
compartment boundaries that SLIM and ROI-averaging utilize in their respective spectral reconstruction processes.  
The 3D EPSI, MPRAGE and compartment maps were processed to generate compartmentally-localized spectra.  
The metabolic concentrations were quantified and filtered using post processing filtration parameters to produce the 
datasets found in the Results section. 
 In Figure 4, the input data represented in red were raw datasets imported directly from 
MRI scanners.  Intermediates were the main forms of semi-processed data that were utilized for 
processes later in the pipeline and were represented in gray.  Regions in blue were the main 
processes described in this chapter. 
MRI and MRS data were acquired from 20 normal healthy control subjects, aged 35 ± 10 
years.  All datasets were acquired at 3 T (Skyra, Siemens) with a 16-channel head coil.  MRI 
data was acquired using a T1-weighted Magnetization Prepared Rapid Acquisition Gradient 
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Echo (MPRAGE) sequence.  The voxel resolution was 1 x 1 x 1 mm with a TR = 2000 ms, TE = 
3.98 ms, TI = 830 ms.  The field-of-view and matrix size was 256 x 256 x 176 with a flip angle 
of 8 degrees.  All MRIs were confirmed to be without any structural abnormalities via visual 
inspection.  The 1H MRSI was acquired using a 3D EPSI sequence (Maudsley et al., 2006).  The 
voxel resolution was 5.6 x 5.6 x 10 mm with a TR1 = 1551 ms, TR2 = 511 ms, TE = 16 ms, and 
TI = 198 ms.  The field-of-view was 280 x 280 x 180 with a data acquisition matrix size of 50 x 
50 x 18 with a flip angle of 71 degrees and an interpolated resolution of 5.6 x 5.6 x 5.0 mm. 
 
Construction of the Compartmental Maps  
The construction of a unique compartment map for each subject was a necessary step for 
comparing SLIM and ROI-averaging.  The brain segmentation program FreeSurfer generated 
highly parcellated maps that was used as a starting point for custom compartmental maps.  To 
optimize the compartment map for use in SLIM and ROI-averaging however, a few conditions 
needed to be met: 1) compartments must be continuous or with little fragmentation, 2) 
compartments must be relatively uniform in size, and 3) spectral data must be relatively 
homogeneous in each compartment.  The first two criteria were resolved by selective merging of 
compartments from the existing FreeSurfer map.  To address the last criteria, a linewidth 
threshold map was applied to the FreeSurfer map that passes or fails regions of data so that poor 
quality data was excluded from the final map.  An outline of this pipeline can be seen in the 




Figure 5: Process 1 – Compartment Map Generation. 
MPRAGE was processed in FreeSurfer to produce the brain segmentation map that was resliced according to the 
Desikan Killiany Atlas.  The 3D EPSI data was processed to generate a B0 linewidth map to separate the poor 
quality spectral regions.  These two maps were combined and compartments were selectively merged together to 
create the customized compartmental map. 
To generate this custom parcellated compartment map, both the MRI and the MRSI scans 
were required, with the parcellation map being generated from the MRI and the B0 linewidth 
map being generated from the MRSI.  The resulting compartment map was used for both SLIM 
and ROI-averaging processes. 
 
FreeSurfer Automatic Gray & White Matter Segmentation 
The cortical reconstruction and volumetric segmentation of the MRI was performed with 
the FreeSurfer image analysis suite (Dale, Fischl, & Sereno, 1999; Dale & Sereno, 1993; 
Jovicich et al., 2006).  FreeSurfer produced a segmentation map that divided up the brain into 
hundreds of number coded regions that allowed for a high customizability of the compartments 




Figure 6: FreeView GUI for showing the results of the FreeSurfer segmentation. 
FreeSurfer produces a segmentation map that records an index for each compartment as seen in the lower right 
corner of the Figure.  A lookup table was provided as a .txt file for referencing the numbers to each compartment. 
FreeSurfer was run on data for each subject using the default settings, with the only 
changes to the default settings being that white matter draw distance was increased to minimize 
the amount of unsegmented white matter found in the resulting segmentation map and unknown 
regions were removed from the map by incorporating the region into neighboring compartments.  
FreeSurfer contains two native cortical parcellation atlases: Desikan-Killiany (Desikan et al., 
2006) and the Destrieux cortical atlas (Destrieux, Fischl, Dale, & Halgren, 2010; Fischl et al., 
2004).  Since the Destrieux cortical atlas is a parcellation scheme that segments the brain based 
on cortex visible on the extremities of the brain, the Desikan-Killiany map was a better choice 
for retaining compartment uniformity, as the Destrieux map was prone to greater compartment 
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fragmentation than the Desikan-Killiany map.  The final output of FreeSurfer was a 3D .nii file 
known as the Desikan-Killiany Atlas (DKT_Atlas). 
 
Editing the FreeSurfer compartment map 
Because compartments in the DKT_Atlas can vary greatly in size across the ~180 
compartments, selective compartment merging was necessary to improve size homogeneity 
between compartments.  Additionally, compartment quality was improved by applying a spectral 
linewidth threshold mask that excluded regions that exceeded 12 Hz, dividing the DKT_Atlas 
into two grades of spectral quality.  The main regions affected by linewidth filtering were 
orbitofrontal and temporal regions due to their proximity to the nasal cavities and ear canal 
which were challenging to acquire quality spectra from.  Regions that passed the linewidth 
threshold were selectively merged based on compartment size, matter type, and functional 
similarity, while regions outside the threshold were merged based on size only.  Unmerged 





Figure 7: Flow diagram of the construction of the custom compartment map. 
a) The DKT_Atlas provides the starting compartmental map that will be edited to generate our final map.  b) A 
binary mask that divides the linewidth map at the 12 Hz threshold was used to segment the DKT_Atlas into good 
and poor quality spectral regions of the brain.  c) Compartmental regions that were selectively merged together 
based on their functional similarity.  d) The final compartment map after applying compartment merging and 
applying the linewidth threshold mask to the dataset.  Each color represents a compartment in the final map. 
Figure 7 lays out how the regions were merged together to generate the final 
compartment map.  Image “a” was the original Desikan-Killiany Atlas of the subject.  Image “b” 
was the region of the linewidth map that would be excluded from the final compartment map.  
Regions that resided in the blue area in image “b” would be merged together to create poor 
29 
 
quality regions.  Image “c” was the regions that were selected for merging.  Each colored region 
in image “c” represents two or more areas that were similar enough in function that they were 
considered equivalent for our purposes and were merged together.  Image “d” represents the final 
compartment map after applying compartment merging where each color represents a 
compartment. 
The following section details the compartments that were merged together: 1) the 
ventricle region was a combination of the superior and inferior lateral ventricles, the third, fourth 
and fifth ventricles, CSF, the vessels, the choroid plexus, gray and white matter hypo-intensity 
regions, as well as the optic chiasm.  2) The ventral diencephalon was a combination of ventral 
diencephalon regions and unsegmented white matter areas.  3) The Striatum regions were a 
mixture of the caudate, putamen, pallidum, hippocampus, amygdala, and the accumbens area.  
The striatum compartment was separated into left and right halves. 
 For the lobe regions, each compartment was separated into gray and white matter regions 
as well as left right side info being retained.  For the frontal lobe: 1) the Orbital Frontal regions 
consisted of the caudal middle frontal, lateral orbitofrontal, medial orbitofrontal, and the frontal 
pole.  2) The pars region consisted of the pars-opercularis, the pars-orbitalis, and the pars-
triangularis.  3) The Central region consisted of the para-central and the pre-central regions.  No 
changes were made to the parietal lobe.  In the temporal lobe: 1) the inferior temporal region was 
a combination of the banks of the temporal sulcus, the inferior temporal, and the middle 
temporal.  2) The fusiform compartments consisted of the entorhinal, fusiform, para-
hippocampal, and the temporal pole.  3) The superior temporal region was a combination of the 
superior temporal and the transverse temporal region.  For the occipital lobe: 1) the lateral 
occipital regions were a combination of the cuneus and the lateral occipital compartments.  2) 
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The lingual region was a combination of the lingual and pericalcarine regions.  The cingulate 
lobe consists of the caudal-anterior cingulate, the isthmus cingulate, the posterior cingulate, and 
the rostral-anterior cingulate.  The corpus callosum regions were merged with the right cingulate 
white matter region only, since the corpus callosum was too small of a region to be evaluated 
properly on its own and the corpus callosum was a central band of white matter. 
 The original 180 compartments were reduced to 79 compartments, and 8 poor quality 
regions that fell outside the 12 Hz region.  These compartments were further reduced to 12 main 
compartments that were selected for analysis in the study.  After merging, the smallest and 
largest compartments have a difference in size in the range of 1:4 – 1:15 across the 20 subjects, 
which was enough of a size similarity that this will not be a major source of errors in SLIM. 
 
Reconstruction of spectra using SLIM and MIDAS 
Reconstructing the spectra was done using SLIM and ROI-averaging and the 
compartment map that was discussed previously.  Quantification using ROI-averaging utilized 
the full k-space dimension of 50 x 50 x 18 and used the Metabolite Imaging and Data Analysis 
System (MIDAS) as well as a spectral reconstruction program that is currently in development 
by our laboratory at the KUMC Hoglund Brain Imaging Center.  This same in-house program 
was used to generate compartment spectra using SLIM over 4 decreasing k-space window sizes: 
50 x 50 x 12, 40 x 40 x 12, 20 x 20 x 12, and 16 x 16 x 12.  The program produced .mat files 
which needed further processing to be run using LCModel, which was a program used for 




Figure 8: Process 2 – Spectral reconstruction using ROI-averaging and SLIM. 
The MPRAGE and 3D EPSI were processed in MIDAS or using in-house programs.  The custom compartment map 
was also provided which produces the six localization methods.  The output were spectra that were run on 
metabolite quantification software later in the pipeline. 
 In Figure 8, MIDAS processed MPRAGE and 3D EPSI datasets using several built-in 
programs.  After supplying a compartment map to MIDAS, the program generated ROI-averaged 
spectra of the compartments that were provided.  The MPRAGE, 3D EPSI and the compartment 
map were also processed using in-house software to produce the SLIM and ROI-averaged 
(ROIS) datasets.  Both programs produced the raw compartment spectra that needed to be 
quantified in later processing steps. 
 
MIDAS Reconstruction 
MIDAS is a group of software programs developed at the University of Miami by the 
research core headed by Dr. Andrew Maudsley (Maudsley et al., 2006).  The software was used 
to take an MRI and MRSI dataset and return high resolution spectroscopic data across the entire 
brain.  Raw MRI and MRSI files were imported into MIDAS and were run through its volumizer 
program that converts the raw data obtained in the DICOM format into a single file for each data 
type.  The raw EPSI data from the MRI scanner was regridded to produce rectilinear sampled k-
space data by incorporating interlaced Fourier transform echo combination with chemical shift 
correction (Metzger & Hu, 1997).  After resampling the EPSI data, the SI data was reconstructed 
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using a Fourier transform of MRSI k-space data.  The MRSI dataset was then co-registered to the 
MRI dataset using MIDAS Single-Subject Rigid Regristritation (MSREG), which is a program 
that performs rigid registration between image series for MRI and MRSI 3D volumes.  This 
program was designed to standardize coregistration of patient data between scans, so a subject 
that has been scanned before and after a treatment will have proper alignment between the two 
scans.  After image registration was performed, the water-reference was used to create B0 shifts, 
eddy current corrections, lineshape distortions, and phase correction maps.  SI datasets were then 
Fourier transformed to convert the spectra from the time domain to the frequency domain.  A 
mask was applied to extract the brain from the skull and scalp regions on the MRI and lipid 
extrapolation was applied to the k-space data. 
The final steps of the program involved recovering weaker signals to normalize the 
signal, and filling “holes” in the SI map by running an intermediate fit of smoothed SI data to 
help recover some of the weaker spectra in the image.  After these processing steps, the data was 
evaluated using ROI-averaging on the compartment map generated earlier.  MIDAS included a 
built-in program used for importing indexed masks of the subject.  The program known as 
“Mapper” stored the compartments as a mask that was used in MIDAS’ ROI-averaging software 
“Map INTegrated spectrum” (MINT).  After running MINT, the files were exported as a 
collection of reconstructed spectra, with each spectra representing the chemical composition of a 
region in the brain. 
 
SLIM & ROI-averaging reconstruction 
SLIM and ROI-averaging also was done using programs developed in-house.  After 
requesting the MRI and MRSI datasets, the program parsed file ID information, read the datasets 
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and co-registered the files into the same reference frame.  SPM12 was run on the MRI and the 
lipid layer was used as a mask for later processes.  The EPSI data was read, B0 field was 
calculated and then the coil data was combined.  B0 correction was applied and produced a 
linewidth map that was used during the merging of the DKT_Atlas compartments mentioned 
earlier.  After compartment merging has been done, the merged compartment map was loaded 
into the program and lipid suppression was applied to the EPSI dataset using the PG algorithm.  
At this point, the data was ready to be processed in ROI-averaging and SLIM.  Here, the data 
was resliced to provide different k-space sizes.  The files were exported as MATLAB .mat files 
which were converted to LCModel format for metabolite quantification later in the pipeline. 
 
Quantification of metabolites and post-processing filtration 
Metabolite quantification was run on the compartments using the spectra quantification 
software LCModel (Provencher, 1993).  To assist in processing the large quantity of data, scripts 
were written for MIDAS and our in-house program to convert their outputs into a format that 
would be readable in LCModel as a batch process.  The script produced a .RAW and .H2O file 
for each spectra, then edited a preexisting .control file that pointed to those newly created .RAW 
and .H2O files.  The program then ran LCModel by starting a launcher file that ran the program 
using the .control settings.  This process then looped through all the compartments for that run 
and then over the course of the 20 subjects under all 6 SLIM, MINT and ROIS settings, resulting 
in thousands of LCModel runs.  Upon completion, the program collected the .csv outputs and 




Figure 9: Process 2 – Metabolite Quantification. 
Spectra from the six localization methods were processed through metabolite quantification in LCModel to produce 
metabolite concentrations for the compartments.  A post-LCModel filtration step was applied after LCModel 
quantification to screen out poor quality spectra based on inclusion criteria based on linewidth, SNR, and lipid 
concentrations in the spectra. 
 A data quality filter was applied as a post-LCModel analysis processing step.  Four 
parameters were used as metrics for data quality: 1) Linewidth of the fitted compartment spectra, 
2) SNR of the LCModel fit, 3) The ratio of lipid and macromolecule signal to creatine near the 
NAA peak, and 4) The ratio of miscellaneous lipid and macromolecule signals to creatine signal.  
The data was also filtered to guarantee the existence of an NAA, Cr, and Cho peak.  Metabolite 
data was filtered so that no compartments had a linewidth that exceeded 0.1 ppm, or had a 
signal-to-noise ratio 5 or less (Kreis, 2004).  Compartments were also screened out if the NAA 
lipid and macromolecule signal exceeded a ratio of 10, or if the miscellaneous lipid and 
macromolecule signal exceeded a ratio of 27.  Lipids were screened out at these ratios because 
these concentrations were causing wide distortions to the spectral baseline and were destroying 
any retrievable signal from the spectra. 
The MINT dataset concentrations were several magnitudes greater than the in-house ROI 
and SLIM datasets.  This was caused to the differences in the processing methods, so the MINT 
data was scaled to match the ROIS dataset.  The average metabolite concentration of NAA, 
Creatine and Choline were calculated for MINT and the ROIS datasets creating three possible 
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scaling factors.  The average of these three scaling factors was used to scale every MINT value 
to preserve local variation in the MINT dataset.  By doing this, differences in MINT and ROIS 
should be minimized to LCModel fitting rather than actual differences in concentration.  
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Chapter 3: Results 
To compare quantification outcomes of the two MRS data reconstruction methods, 
statistical analysis of the LCModel outputs (.csv files) was applied to the dataset using in-house 
MATLAB programs.  The pipeline produced 6 ways of localizing the metabolite signal to the 
compartments.  Two of these localization datasets were ROI-averaging with one process being 
ran in MIDAS and the other being ran using our in-house programs.  The other four localization 
datasets were processed in SLIM by cropping the k-space into four sizes: 50 x 50 x 12, 40 x 40 x 
12, 20 x 20 x 12, and 16 x 16 x 12.  LCModel was run on the six localization methods, across all 
79 compartments and across all 20 subjects, which resulted in a total of 9,480 possible LCModel 
printouts.  Of the 9,480 LCModel runs, 465 of these spectra were excluded based on low SNR, 
high full-width half-maximum (FWHM), or excessive lipid & macromolecule concentrations as 
described in the Methods section.  All data calculations were applied twice, with the first 
evaluation calculated across all compartments and the second evaluation calculated across a 
smaller collection of compartments. 
Twenty-four regions of the brain were merged with their left or right sided counterpart to 
create twelve bilaterally symmetrical regions.  These compartments were chosen based on their 
functional roles in the brain, as well as their optimal location in the brain where the quality of B0 
shimming was optimal.  Calculations of all the compartments were placed in the appendix 
section of this report.  The regions selected were: the thalamus and striatum, as well as the gray 
and white matter regions of the central motor strip, cingulate, insula, postcentral, and precuneus.  
The thalamus acts as an information relay hub that transmits information between areas of the 
brain.  The striatum is a collection of regions that include the hippocampus, globus pallidus and 
amygdala and this area is involved in memory and emotion.  The central motor strip is involved 
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in executing voluntary motor movements.  The postcentral is the region of the brain where sense 
of touch is processed.  The cingulate is the main component of the limbic system which regulates 
emotion, memory and behavior.  The insula is involved in awareness and is involved in 
processing emotions.  The precuneus plays a role in visuospatial imagery and memory.  Due to 
the wide variety of functions of these regions and their optimal position in the brain for B0 
shimming, these regions were optimal candidates for a more detailed inspection. 
 
Figure 10: Selection of 24 compartments chosen for data processing. 
A selection of the 79 compartments that were chosen for a detailed analysis in the Results section.  The regions were 
selected based on their location within the B0 shimming window (white rectangle) as well as their functional purpose 
in the brain as research areas of interest.  Regions were merged with their left or right-handed equivalent regions to 
create 12 functional areas.  10 of these areas have gray and white matter counterparts and include the central motor 
strip which is involved in executing voluntary motor movements, the postcentral where sense of touch is primarily 
processed, the cingulate which is the primary component of the limbic system, the insula which is involved in the 
processing of emotions and environmental awareness, and the precuneus which is involved in processing 
visuospatial imagery.  The thalamus which acts as an information relay hub and the striatum which is involved in 
memory and emotion were also included in this list as areas of research interest. 
 
Average metabolite concentrations by method 
After applying post-LCModel filtration, the average metabolite concentration was 
calculated for each compartment by averaging the data across the 20 subjects and was repeated 
to calculate the average creatine ratios for the compartments as well.  Table 1 shows the average 
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metabolite concentrations of the central gray matter motor strip and the striatum across the five 
metabolites and across the in-house SLIM and ROIS processes. 
Table 1: Average metabolite concentrations and standard deviations of the Central Gray Matter (1a) and Striatum 
(1b). 
  
Note: Concentrations of NAA, Cr and Cho were stable for both the central gray matter and striatum across the five 
localization methods that used the in-house programs.  Glx had a high amount of standard deviation that caused the 
Glx results to be unreliable.  Metabolite concentrations were shown in Institutional Units (IU). 
The concentrations in Table 1 indicate that the differences in concentration between N-
acetyl aspartate (NAA), creatine (Cr), choline (Cho), and myo-inositol (mI) do not deviate 
significantly between the five in-house localization methods.  This was supported by the 
similarity in creatine ratios of the respective metabolites.  The apparent overestimation of NAA 
in SLIM disappears when calculated as a creatine ratio, so the processes did not appear to affect 
concentrations significantly.  Of the five metabolites observed, only glutamate (Glx) showed 
a ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
NAA 33.6 ± 4.8 32.1 ± 4.7 31.9 ± 4.9 29.9 ± 6.8 29.1 ± 5.6
Cr 24.6 ± 4.1 23.9 ± 4.4 23.2 ± 5.5 21.1 ± 5.7 20.1 ± 5.5
Cho 4.3 ± 1.0 3.9 ± 0.9 3.8 ± 0.9 3.3 ± 1.3 3.4 ± 1.2
mI 10.5 ± 4.1 10.0 ± 2.9 9.5 ± 3.5 8.3 ± 3.4 7.7 ± 4.0
Glx 8.7 ± 8.2 7.6 ± 6.4 9.8 ± 12.5 7.9 ± 6.8 6.3 ± 5.7
NAA / Cr 1.4 ± 0.1 1.4 ± 0.2 1.4 ± 0.2 1.5 ± 0.3 1.5 ± 0.3
Cho / Cr 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0
mI / Cr 0.4 ± 0.1 0.4 ± 0.1 0.8 ± 2.4 0.4 ± 0.1 0.4 ± 0.2
Glx / Cr 0.4 ± 0.4 0.3 ± 0.3 9.2 ± 36.5 0.4 ± 0.4 0.4 ± 0.6
b ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
NAA 25.2 ± 5.9 24.8 ± 5.3 24.8 ± 5.6 22.5 ± 5.1 21.0 ± 6.1
Cr 23.4 ± 5.2 24.5 ± 5.2 24.6 ± 5.1 25.6 ± 7.0 24.0 ± 7.4
Cho 6.1 ± 1.5 6.6 ± 1.5 6.7 ± 1.6 6.6 ± 1.7 6.3 ± 1.8
mI 12.9 ± 3.9 13.9 ± 5.4 14.6 ± 7.5 12.5 ± 6.4 13.8 ± 7.5
Glx 9.6 ± 4.1 7.1 ± 4.5 7.3 ± 5.3 9.4 ± 5.1 11.5 ± 9.4
NAA / Cr 1.1 ± 0.1 1.0 ± 0.1 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.2
Cho / Cr 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1
mI / Cr 0.6 ± 0.2 0.6 ± 0.1 0.6 ± 0.2 0.5 ± 0.2 0.6 ± 0.3




















significant differences between the processes, but this was likely due to poor LCModel fitting of 
Glx. 
A second calculation was applied to the average concentrations by subtracting the 
difference between ROIS and the four SLIM localization methods, then dividing that result by 
the ROIS value.  This was done to calculate the fractional difference in the metabolite 
concentrations of the SLIM localization methods using ROIS as the reference localization 
method.  Negative values indicate that SLIM undersampled the concentration compared to ROIS 
while positive values indicate an oversampling of the concentration (i.e., a -0.10 indicates that 
the SLIM concentration was 10% less, while 0.05 is 5% greater than the concentration of ROIS). 
Table 2: Relative metabolite concentration differences between the four SLIM localization methods and the ROI-
averaged method in the Central Gray Matter (2a) and Striatum (2b). 
  
Note: Relative differences between ROI-average and SLIM became greater with smaller k-space sample sizes.  The 
central gray matter region showed an over sampling of the concentrations compared to ROIS, while there was a 
trend towards under sampling of the metabolites in the striatum. 
a SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
NAA 0.04 0.05 0.11 0.13
Cr 0.03 0.06 0.14 0.18
Cho 0.08 0.13 0.22 0.21
mI 0.09 0.13 0.24 0.31
Glx 0.10 -0.33 0.17 0.28
NAA / Cr 0.01 0.01 -0.06 -0.10
Cho / Cr 0.05 0.10 0.09 0.02
mI / Cr 0.03 -0.80 0.06 0.14
Glx / Cr -0.03 -32.99 -0.09 -0.11
b SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
NAA 0.01 0.02 0.11 0.16
Cr -0.05 -0.05 -0.10 -0.03
Cho -0.08 -0.09 -0.08 0.00
mI -0.07 -0.13 0.03 -0.08
Glx 0.29 0.30 0.01 -0.13
NAA / Cr 0.06 0.06 0.17 0.17
Cho / Cr -0.04 -0.05 -0.02 -0.01
mI / Cr 0.01 -0.03 0.14 -0.10




















The average metabolite concentrations of the 12 compartments were plotted into bar 
graphs to observe local differences in concentrations between the compartments and to observe 
differences in standard deviation. 
 
Figure 11: Average concentration and standard deviation for all five metabolites across all six localization methods 
and across the 12 compartments. 
The average concentration and standard deviation of each metabolite was averaged across the twenty subjects and 
were compared with their localization method equivalents.  Concentrations were expressed in Institutional Units 
(IU).  N-acetyl aspartate, Creatine, and Choline showed stable concentrations across the localization methods, while 




Figure 12: Average concentration ratios of metabolites to creatine and standard deviation for all five metabolites 
across all six localization methods and across the 12 compartments. 
The average creatine ratio and standard deviation of each metabolite was averaged across the twenty subjects and 
were compared with their localization method equivalents.  N-acetyl aspartate, Creatine, and Choline showed stable 
creatine ratios across the localization methods, while Glutamate showed larger variation between localization 
methods due to poor fitting in LCModel. 
Figure 11 and 12 show that the metabolite concentrations of NAA, Creatine and Choline 
were found to be relatively consistent between the six localization methods and fall within the 
standard deviation of the other 5 localization methods, except for in a couple of the 
compartments where SLIM recorded higher concentrations than in the ROI-averaged runs.  The 
creatine ratios were more stable, except for Glx which was found to be unreliable and had high 
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standard deviations between the localizations.  Myo-Inositol was found to be stable in most 
compartments except for SLIM processes with lower k-space sizes. 
In addition to calculating average concentrations, the mean and standard deviation of 
MINT 50 x 50 x 18 and the four k-space SLIM localization methods were calculated as ratios of 
ROIS 50 x 50 x 18.  Processing the data in this manner inherently normalizes the mean relative 
to a magnitude of 1.0 and demonstrates similarities between the two methods using ROI-
averaging as the standard.  Averaging method pairs with values close to 1 and a low standard 
deviation indicate relative agreement between the methods.  This was calculated across all 
compartments and on a compartment basis as well. 
Table 3: Mean and standard deviation of the ratios of five different localization methods to ROI-averaging method. 
  
Note: Mean values near 1.0 with a small standard deviation (e.g., ~0.1) indicate relative agreement.  NAA, Cr, Cho, 
and mI show strong levels of relative agreement with ROIS and the five other localization methods.  Only Glx 
showed little correlation between the methods. 
 In Table 3, NAA, Cr, Cho, and mI had mean ratios within 0.06 units of 1 for all points in 
the dataset with a low standard deviation.  Only Glx did not have a mean ratio close to 1 which 
was likely caused by the poor LCModel fitting of Glx. 
 
Signal-to-Noise Ratio & Full-Width Half-Maximum of compartmental spectra 
MINT 50x50x18 SLIM 16x16x12 SLIM 20x20x12 SLIM 40x40x12 SLIM 50x50x12
NAA 0.97 ± 0.2 1.00 ± 0.2 1.00 ± 0.1 1.01 ± 0.1 1.00 ± 0.1
Cr 1.06 ± 0.2 0.98 ± 0.2 0.99 ± 0.1 1.00 ± 0.1 1.01 ± 0.1
Cho 0.99 ± 0.2 1.04 ± 0.2 1.03 ± 0.2 1.02 ± 0.2 1.02 ± 0.1
mI 1.04 ± 0.3 0.99 ± 0.4 0.98 ± 0.3 1.01 ± 0.3 1.00 ± 0.3
Glx 2.66 ± 8.0 8.01 ± 42.3 5.01 ± 20.8 2.41 ± 6.2 2.46 ± 6.8
NAA / Cr 0.91 ± 0.1 1.03 ± 0.1 1.01 ± 0.1 1.01 ± 0.1 1.00 ± 0.1
Cho / Cr 0.94 ± 0.1 1.06 ± 0.2 1.04 ± 0.2 1.02 ± 0.2 1.02 ± 0.1
mI / Cr 0.98 ± 0.3 1.03 ± 0.4 0.99 ± 0.3 1.00 ± 0.3 1.00 ± 0.3














Table 4: Average SNR across all compartments and the 12 selected compartments. 
  
Note: The SNR was retrieved from LCModel outputs where the value was calculated as the ratio of the maximum in 
the spectrum-minus-baseline to twice the root mean square (RMS) residuals.  RMS refers to the square root of the 
mean square.  These values were averaged across the subjects to produce the average SNR across all compartments 
and the average SNR across the 12 selected compartments. 
 SNR values were retrieved from the LCModel printouts and their values were averaged 
across the 20 subjects.  The SNR was calculated as the ratio of the maximum in the baseline 
subtracted spectrum to twice the rms residuals.  The results in Table 3 indicated that the SNR 
decreases as the k-space was reduced in SLIM, as k-space points were being removed from the 
final SLIM reconstruction of the compartments.  Because MIDAS applies spatial smoothing to 
their spectral data, they obtain higher SNR values than the in-house processes, which do not 
apply spatial smoothing to the datasets.  Generally, compartments saw a ~30% reduction in SNR 
between the 50 x 50 x 12 and the 16 x 16 x 12. 
 Another area of interest was the differences in FWHM of the spectra across the 
localization methods.  FWHM values were retrieved from LCModel and were averaged across 
the 20 subjects to identify any trends in the data for the 12 compartments and for all the 
compartments overall. 
MINT 50x50x18 ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
All Compartments 21.2 14.8 13.2 12.8 10.9 10.1
Central GM 24.2 17.0 15.4 14.6 10.6 9.5
Central WM 23.5 14.5 13.9 14.1 13.3 12.9
Cingulate GM 16.7 14.7 12.9 12.9 11.2 10.4
Cingulate WM 18.5 15.6 14.3 14.0 13.0 12.2
Insula GM 18.8 13.3 12.7 12.1 10.2 9.2
Insula WM 21.6 17.3 15.5 15.1 13.3 12.5
Post-Central GM 24.0 16.7 13.2 12.2 10.4 10.6
Post-Central WM 23.9 16.1 13.0 12.6 11.0 8.8
Pre-Cuneus GM 20.4 15.5 14.1 13.2 11.3 9.9
Pre-Cuneus WM 22.0 15.2 14.3 13.9 10.7 10.4
Striatum 24.4 12.1 10.6 10.3 7.7 7.2
Thalamus 16.2 9.7 8.5 8.6 8.1 7.4
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Table 5: Average FWHM across all compartments and the select compartments. 
  
Note: FWHM was retrieved from LCModel which was an estimation of the linewidth of the in vivo spectra.  The 
FWHM was consistent between all datasets indicating that linewidth was not significantly affected by the 
localization method used. 
The regions observed in Table 4 did not show a significant trend in variation between the 
localization methods or significant differences in the compartments.  This suggests that SLIM 
does significantly affect the resulting FWHM. 
 
Correlation of ROI-averaging and other localization methods 
Pearson correlation coefficients were calculated between ROIS 50 x 50 x 18 and the five 
other averaging methods.  This too was calculated on a compartment basis, as well as across all 
compartments.  The results show a high level of correlation between SLIM and ROI-averaging 
for NAA, Cr, and Cho at 0.81 and higher.  Glx showed very weak correlation due to poor fitting 
in LCModel and cannot be used as a reliable indicator of correlation.  mI showed a fair amount 
of correlation between SLIM and ROI-averaging using in-house programs, but became less 
reliable at lower SLIM k-space sizes.  Correlation results between MINT and ROI-averaging 
Compartment MINT 50x50x18 ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
All 0.046 ppm (5.9 Hz) 0.045 ppm (5.7 Hz) 0.05 ppm (6.4 Hz) 0.052 ppm (6.6 Hz) 0.054 ppm (6.9 Hz) 0.053 ppm (6.8 Hz)
Central GM 0.057 ppm (7.3 Hz) 0.047 ppm (6.0 Hz) 0.058 ppm (7.4 Hz) 0.061 ppm (7.8 Hz) 0.056 ppm (7.2 Hz) 0.057 ppm (7.3 Hz)
Central WM 0.045 ppm (5.7 Hz) 0.052 ppm (6.6 Hz) 0.052 ppm (6.6 Hz) 0.05 ppm (6.4 Hz) 0.055 ppm (7.0 Hz) 0.04 ppm (5.1 Hz)
Cingulate GM 0.053 ppm (6.8 Hz) 0.052 ppm (6.6 Hz) 0.045 ppm (5.7 Hz) 0.055 ppm (7.0 Hz) 0.048 ppm (6.1 Hz) 0.047 ppm (6.0 Hz)
Cingulate WM 0.048 ppm (6.1 Hz) 0.051 ppm (6.5 Hz) 0.048 ppm (6.1 Hz) 0.048 ppm (6.1 Hz) 0.052 ppm (6.6 Hz) 0.055 ppm (7.0 Hz)
Insula GM 0.055 ppm (7.0 Hz) 0.063 ppm (8.0 Hz) 0.059 ppm (7.5 Hz) 0.055 ppm (7.0 Hz) 0.059 ppm (7.5 Hz) 0.062 ppm (7.9 Hz)
Insula WM 0.053 ppm (6.8 Hz) 0.047 ppm (6.0 Hz) 0.045 ppm (5.7 Hz) 0.055 ppm (7.0 Hz) 0.052 ppm (6.6 Hz) 0.052 ppm (6.6 Hz)
Post-Central GM 0.063 ppm (8.0 Hz) 0.057 ppm (7.3 Hz) 0.058 ppm (7.4 Hz) 0.063 ppm (8.0 Hz) 0.06 ppm (7.7 Hz) 0.056 ppm (7.2 Hz)
Post-Central WM 0.056 ppm (7.2 Hz) 0.051 ppm (6.5 Hz) 0.047 ppm (6.0 Hz) 0.051 ppm (6.5 Hz) 0.055 ppm (7.0 Hz) 0.056 ppm (7.2 Hz)
Pre-Cuneus GM 0.049 ppm (6.3 Hz) 0.052 ppm (6.6 Hz) 0.05 ppm (6.4 Hz) 0.055 ppm (7.0 Hz) 0.054 ppm (6.9 Hz) 0.055 ppm (7.0 Hz)
Pre-Cuneus WM 0.054 ppm (6.9 Hz) 0.048 ppm (6.1 Hz) 0.051 ppm (6.5 Hz) 0.05 ppm (6.4 Hz) 0.045 ppm (5.7 Hz) 0.038 ppm (4.9 Hz)
Striatum 0.055 ppm (7.0 Hz) 0.058 ppm (7.4 Hz) 0.068 ppm (8.7 Hz) 0.073 ppm (9.3 Hz) 0.069 ppm (8.8 Hz) 0.065 ppm (8.3 Hz)
Thalamus 0.055 ppm (7.0 Hz) 0.058 ppm (7.4 Hz) 0.064 ppm (8.2 Hz) 0.061 ppm (7.8 Hz) 0.063 ppm (8.0 Hz) 0.065 ppm (8.3 Hz)
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using in-house programs indicate that the processing methods were different enough that a direct 
comparison between MINT and SLIM would not be meaningful. 
Table 6: Pearson Correlation Coefficients across all compartments. 
  
Note: Pearson correlation coefficients were calculated for the five localization methods against the ROI-averaged 
localization method using in-house tools.  Correlation of SLIM performed better against the in-house ROI-averaged 
set than the MINT correlation, indicating that a direct comparison with SLIM and MINT would not be an accurate 
comparison due to the differences in processing methods of the two programs.  SLIM and ROI-averaged datasets 
correlate quite well at high SLIM resolutions for NAA, Cr, and Cho and have a fair correlation for mI.  Glx does not 
correlate well because of poor fitting in LCModel. 
 The correlation data of metabolite concentrations were plotted as scatterplots as pairs of 
data between the five localization methods and ROI averaging.  Similar plots were also created 
for metabolite ratios to creatine.  The 95% confidence and predictive intervals were also 
calculated, and a linear regression with one degree of freedom (slope) was calculated, i.e., the 
regression line y-intercept was constrained to zero. 
MINT 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
NAA 0.72 0.95 0.92 0.86 0.81
Cr 0.69 0.92 0.92 0.86 0.83
Cho 0.70 0.91 0.87 0.86 0.81
mI 0.58 0.75 0.76 0.74 0.54
Glx 0.14 0.34 0.47 0.25 0.24
NAA / Cr 0.66 0.90 0.88 0.82 0.79
Cho / Cr 0.82 0.91 0.86 0.86 0.83
mI / Cr 0.54 0.74 0.79 0.71 0.56















Figure 13: Correlation scatterplots of metabolite concentrations for five localization methods vs ROI averaging. 
Correlation scatterplots were calculated across all five metabolites and all five localization methods.  The dotted line 
was the linear regression of the dataset, the solid lines were the confidence interval of the linear regression at the 95th 
percentile, and the dashed lines were the prediction intervals of the data at the 95th percentile.  Slope indicates the 
slope of the linear regression while the Pearson correlation coefficient (Cor) indicates the measure of correlation 
between ROIS 50 x 50 x 18 and the other localization methods.  The orange histograms on the x and y axes 
demonstrate data distribution for the SLIM and ROI-averaged data.  All concentrations were expressed in 




Figure 14: Correlation scatterplots of metabolite creatine ratios for five localization methods vs ROI averaging. 
Correlation scatterplots were calculated across all four metabolites and all five localization methods.  The dotted line 
was the linear regression of the dataset, the solid lines were the confidence interval of the linear regression at the 95th 
percentile, and the dashed lines were the prediction intervals of the data at the 95th percentile.  Slope indicates the 
slope of the linear regression while the Pearson correlation coefficient (Cor) indicates the measure of correlation 
between ROIS 50 x 50 x 18 and the other localization methods.  The orange histograms on the x and y axes 
demonstrate data distribution for the SLIM and ROI-averaged data. 
 The SLIM localization methods with high k-space sizes showed higher correlation 
coefficients and the slope closer to 1.0 than the ROIS 50 x 50 x 18 localization method for NAA, 
Cr, and Cho.  Glx showed little to no correlation for both the absolute metabolite concentrations 
and the creatine ratios for all localization method.  The SLIM localization methods at higher k-




Spectral Quality Inclusion Criteria 
 As a method of filtering out poor-quality spectra, LCModel outputs were screened based 
on metabolite FWHM, SNR and lipid concentration.  First, spectra with a FWHM of 0.1 ppm or 
greater, or spectra with a SNR of 3 or less were filtered out of the final dataset.  Second, lipid-
creatine ratios were calculated for the lipid macromolecules near the NAA peak and for 
miscellaneous lipid signals in the spectra.  Spectra with a lipid NAA creatine ratio greater than 
10 or spectra with a miscellaneous lipid creatine ratio greater than 27 were filtered out of the 
final dataset. 
The filtered dataset was then collected and calculated to identify where data were being 
excluded from the results.  Percentages of included data were calculated by compartment, 
metabolite, averaging system, and by subject to assist in determining the quality of the dataset 
overall.  Each calculation was done as a ratio of data that passed the inclusion criteria divided by 
total data possible for each set.  For example, the calculation for central gray matter region was a 
ratio of all the central gray matter data points that passed the inclusion criteria divided by the 




Table 7: Percentage of MRS data that passed inclusion criteria based on linewidth, SNR, and lipid signals. 
  
Note: Percentages were calculated as total data that passed the inclusion criteria over total data.  Compartment 
selection played a minor role in the percentage of data that failed to pass the inclusion criteria as the precuneus white 
matter and the thalamus were poorer quality than regions like the striatum.  Of the five metabolites, Glx was the 
main metabolite that consistently failed to pass the inclusion criteria.  Localization method did not play a significant 
factor in the inclusion criteria.  Subject variation played a small role in the inclusion of data, but only in a couple of 
the subjects observed in this study. 
When examining Table 10, it was interesting to note that the percent of included data 
calculated by-localization-method showed the least variance out of the four ways of percent data 
calculation.  This indicates that t spectral quality did not significantly differ among localization 
methods.  Among metabolites, Glx showed the lowest percent of data passing the inclusion 
criteria, which was caused by poor metabolite fitting in LCModel.  Among compartments, the 
region with the highest percentage of data that passed the inclusion criteria was the striatum, 
while the precuneus white matter, thalamus, and the white matter of the insula had the lowest 
percentage of data that passed the inclusion criteria.  These differences indicate that spectral 
quality was dependent on the compartment. 
Central GM 94% Central WM 91% Cingulate GM 92% Cingulate WM 90%
Insula GM 90% Insula WM 89% Post-Central GM 92% Post-Central WM 92%
Pre-Cuneus GM 91% Pre-Cuneus WM 84% Striatum 96% Thalamus 88%
All 91%
NAA 99% NAA / Cr 99% Cho 99% Cho / Cr 99%
mI 99% mI / Cr 99% Glx 61% Glx / Cr 61%
Cr 99%
SLIM 16x16x12 91% SLIM 20x20x12 91% SLIM 40x40x12 91% SLIM 50x50x12 91%
MINT 50x50x18 90% ROIS 50x50x18 91%
Subject 008 94% Subject 009 91% Subject 010 89% Subject 012 90%
Subject 013 84% Subject 014 92% Subject 015 91% Subject 016 93%
Subject 017 93% Subject 018 92% Subject 019 90% Subject 020 92%
Subject 021 86% Subject 022 92% Subject 023 92% Subject 024 96%
Subject 025 88% Subject 026 94% Subject 027 89% Subject 028 91%
% data obtained by compartment
% data obtained by metabolite
% data obtained by localization method




Figure 15: Comparison of compartmental spectra from five regions of the brain across all six localization methods. 
The metabolite peaks of NAA, Cr, and Cho were visually similar for the six localization methods and were easily 
quantifiable in LCModel.  Unlike MINT which automatically corrects for baseline distortion, baseline correction in 
the in-house programs used to process SLIM and ROI-averaging was not applied to the spectra since LCModel 
automatically corrects for this when calculating metabolite quantification.  This can be seen especially in the right 
insular gray matter compartment. 
 As an initial examination of the metabolite spectra, several compartments of the brain 
were visually compared for similarity.  One of the twenty subjects was chosen and the spectra 
from the six localization methods were graphed and evaluated across five compartments: right 
central white matter, left cingulate gray matter, right insula gray matter, left postcentral white 
matter, and the right precuneus white matter.  A visual inspection of the spectra verifies that the 
two processes provide comparable results.  In Figure 15, we see that reductions in the k-space 
dimensions for the SLIM localization methods resulted in no immediately visible differences 
between the datasets across a wide range of brain regions, with the main difference between 





Chapter 4: Discussion 
 Overall this study demonstrates that the SLIM localization methods could provide 
reliable quantification of compartmental spectra over varying k-space sample sizes.  The SLIM 
reconstruction method with the full k-space data showed highly comparable outcomes to the ROI 
averaged data in terms of SNR, spectral quality, and metabolite concentrations.  A reduction in 
k-space size in SLIM reconstruction methods showed a correlation with a reduction of SNR, 
which was the result of reduced effective averaging. Despite this observation, we saw no 
significant difference in metabolite concentrations for NAA, Cr, and Cho between SLIM and the 
FT-based reconstruction methods.  Therefore, these results suggest that the SLIM localization 
method can provide reliable quantification of compartmental spectra without requiring 
acquisition of large resolution k-space data, resulting in shorter scan time by a factor of 4 – 8 
times compared with ROI averaging. 
 Our metabolite creatine ratios matched the results of other studies that have been 
published.  A recent study using MIDAS provided choline creatine ratios observed for the gray 
and white matter of the frontal, parietal, occipital, temporal and the cerebellum (Goryawala, 
Sheriff, Stoyanova, & Maudsley, 2018).  In addition, the same study observed the choline 
creatine ratios of the thalamus and putamen.  The MINT choline creatine ratios from the study of 
the regions range from 0.18 - 0.30, which match the results obtained by SLIM, which fall within 
a range of 0.20 - 0.30 for their respective compartments.  The study observed NAA creatine 
ratios for the Thalamus and Putamen as well at ratios of ~1.4, which closely align with the ratios 
of the Thalamus and striatum (a compartment which contains the putamen) of this study with a 
ratio of ~1.3. 
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 Another recent study mapped the NAA and choline ratios of creatine from MIDAS where 
they recorded these ratios from the gray and white matter regions of the four lobes of the 
cerebrum (Maudsley et al., 2009).  They observed gray matter NAA/Cr ratios of ~1.4 for gray 
matter and ~1.7 for white matter and Cho/Cr ratios of ~0.2 for gray matter and ~0.3 for white 
matter.  Our creatine ratios showed a wider variation in values, with a NAA/Cr ratio of ~1.3 for 
gray matter and ~1.5 for white matter and Cho/Cr ratios of ~0.2 for gray matter and ~0.3 for 
white matter.  Interestingly, these differences carried over to our MINT run of the same dataset, 
which indicates that there was likely a difference in processing between their MINT process and 
the one used in this study. 
 In this study we used k-space sizes of 40 x 40 x 12, 20 x 20 x 12 and 16 x 16 x 12 to 
demonstrate the effect of the reduced k-space data.  Because 3D EPSI measures a single line of 
k-space data (i.e., one dimensional k-space) in a single read, reducing the size of k-space samples 
in the read direction does not reduce scan time.  Instead, reducing k-space sizes by acquiring 
fewer phase encoding steps from the other spatial encoding directions could be translated into an 
actual reduced scan time.  Further study is necessary to investigate the effect of non-isotropic 
reduction of the k-space size, e.g., 50 x 10 x 10, on the SLIM localization methods. 
 While the high correlation between SLIM and ROIS showed that SLIM performs 
comparatively with the ROI-averaged counterpart, there were improvements that can be made to 
the post-LCModel filtration settings.  One post-LCModel filtration setting that would be useful 
to implement in future studies is the inclusion of a filtration parameter that filters out metabolite 
data points based on CRLB results.  The current iteration of post-LCModel filtration only filtered 
out poor quality spectra based on FWHM, SNR, and lipid concentrations, but a more refined 
filtration system could be programmed that filtered metabolic data on a metabolite basis instead 
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of simply filtering out whole spectra.  A metabolite-based filtration system will be added to 
future studies as this will likely improve the correlation results observed in the results section.  
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Chapter 5: Conclusions 
 SLIM offers a way for us to obtain MR spectra from well-defined compartments with 
complex shapes.  In addition, SLIM provides MR spectra without the need for large k-space 
acquisitions as is the case with ROI-averaging localization methods.  SLIM has the potential to 
reduce the scan time by 4-8 times with comparable spectral quality of conventional FT-based 
MRS. Thus, SLIM can be utilized in acquiring MRS for patients who struggle with staying still 
in an MR scanner such as young children and subjects with minor neurological disorders. 
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NAA 31.2 32.5 32.9 32.8 33.5 33.8 NAA 12.7 17.6 18.2 18.1 18.0 18.2
Cr 26.8 26.0 26.3 26.2 26.7 26.9 Cr 17.1 20.0 20.6 20.5 21.4 22.4
Cho 5.5 5.7 5.8 5.8 5.9 6.0 Cho 5.2 6.0 6.3 6.6 6.5 6.5
mI 15.1 15.5 15.3 15.2 15.3 15.5 mI 13.1 12.7 13.6 13.6 12.5 15.1
Glx 9.8 9.6 9.8 10.0 11.4 12.4 Glx 4.4 6.6 6.9 4.7 3.4 2.7
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 0.8 0.9 0.9 0.9 0.9 0.9
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.3 0.3 0.3 0.4 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.8 0.7 0.7 0.7 0.6 0.7
Glx / Cr 0.4 0.4 0.4 0.4 0.4 0.5 Glx / Cr 0.3 0.3 0.3 0.3 0.2 0.2
NAA 35.6 33.5 31.7 31.2 28.5 27.3 NAA 34.8 36.6 37.9 38.3 40.4 41.4
Cr 27.3 24.4 23.7 23.6 20.7 19.0 Cr 25.8 26.3 26.9 26.9 27.7 27.5
Cho 4.8 4.4 4.1 3.9 3.3 3.5 Cho 4.9 5.3 5.7 5.7 6.1 6.2
mI 12.7 11.4 10.2 10.2 8.3 7.9 mI 11.8 13.2 13.9 13.4 13.8 14.1
Glx 7.5 10.0 6.3 11.7 7.7 4.1 Glx 6.3 9.3 8.3 6.5 6.4 12.5
NAA / Cr 1.3 1.4 1.4 1.3 1.4 1.5 NAA / Cr 1.4 1.4 1.4 1.4 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.4 0.4 0.4 0.4 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5
Glx / Cr 0.3 0.4 0.3 0.5 0.4 0.2 Glx / Cr 0.3 0.4 0.3 0.3 0.2 0.4
NAA 21.8 26.3 27.1 27.8 28.7 28.3 NAA 20.8 24.6 26.2 26.2 27.2 28.6
Cr 30.5 38.4 38.5 38.5 39.5 38.0 Cr 31.4 36.6 38.4 38.4 41.2 44.1
Cho 5.8 8.5 8.2 8.3 8.3 7.8 Cho 6.5 8.5 9.0 9.3 9.5 10.2
mI 15.7 18.1 18.5 18.0 19.8 17.8 mI 16.4 20.8 20.8 19.9 20.3 20.6
Glx 14.5 14.7 12.5 14.1 12.4 12.7 Glx 9.7 11.5 14.1 12.1 9.0 13.7
NAA / Cr 0.7 0.7 0.7 0.8 0.7 0.8 NAA / Cr 0.7 0.7 0.7 0.7 0.7 0.7
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5 mI / Cr 0.5 0.6 0.6 0.5 0.5 0.5
Glx / Cr 0.5 0.4 0.3 0.5 0.3 0.4 Glx / Cr 0.3 0.3 0.4 0.3 0.3 0.3
NAA 30.2 34.2 34.8 34.5 36.9 38.1 NAA 26.4 32.7 32.3 32.1 30.7 29.3
Cr 27.6 27.3 29.8 29.4 31.5 30.9 Cr 22.2 23.0 22.1 21.8 20.3 19.4
Cho 5.8 6.5 6.6 6.4 6.8 7.1 Cho 5.8 6.3 6.6 6.6 6.3 6.0
mI 15.6 17.3 18.3 18.2 18.9 18.4 mI 13.4 15.4 15.2 15.2 15.3 13.5
Glx 4.2 4.3 7.2 10.6 8.3 11.5 Glx 2.8 7.8 8.3 10.2 6.7 6.8
NAA / Cr 1.1 1.3 1.2 1.2 1.2 1.3 NAA / Cr 1.2 1.4 1.5 1.5 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.8 0.7
Glx / Cr 0.2 0.2 0.3 0.4 0.3 0.4 Glx / Cr 0.1 0.4 0.4 0.5 0.4 0.4
NAA 24.1 29.7 29.9 29.3 31.4 28.6 NAA 24.4 30.2 29.5 30.2 30.4 38.8
Cr 21.8 26.8 26.6 26.4 29.4 27.9 Cr 20.9 25.1 23.9 24.2 22.7 32.5
Cho 4.9 6.2 6.4 6.4 6.9 6.6 Cho 5.2 6.2 7.1 7.2 7.1 9.5
mI 13.9 16.1 15.9 16.0 18.6 17.1 mI 13.1 16.3 15.6 15.8 18.6 25.3
Glx 8.9 10.7 11.6 9.2 14.8 16.4 Glx 8.0 7.6 4.3 6.7 2.8 9.2
NAA / Cr 1.1 1.1 1.1 1.1 1.1 1.0 NAA / Cr 1.2 1.2 1.3 1.3 1.4 1.3
Cho / Cr 0.2 0.2 0.2 0.3 0.2 0.2 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.7 0.6 0.6 0.6 0.6 0.8 mI / Cr 0.7 0.7 0.7 0.7 0.8 0.9








































































































NAA 20.3 20.9 19.2 19.0 19.7 19.1 NAA 22.9 25.8 23.9 24.3 23.5 24.6
Cr 18.4 17.9 17.5 17.7 18.1 17.4 Cr 19.1 18.7 16.8 16.7 16.4 17.3
Cho 5.4 5.8 5.6 5.7 5.5 5.6 Cho 6.0 5.6 5.5 5.6 5.7 5.9
mI 11.8 12.0 12.4 12.3 13.7 11.9 mI 12.2 14.5 13.7 14.4 13.0 14.6
Glx 6.8 8.0 7.0 8.0 12.5 5.5 Glx 3.9 6.2 4.2 5.0 3.2 5.6
NAA / Cr 1.1 1.2 1.1 1.1 1.1 1.1 NAA / Cr 1.2 1.4 1.4 1.5 1.5 1.4
Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.4 0.4
mI / Cr 0.7 0.7 0.7 0.7 0.8 0.7 mI / Cr 0.6 0.8 0.8 0.9 0.8 0.8
Glx / Cr 0.4 0.5 0.4 0.4 0.6 0.3 Glx / Cr 0.2 0.3 0.2 0.3 0.2 0.3
NAA 35.8 33.6 32.5 32.8 33.1 31.6 NAA 36.2 35.3 35.8 36.3 36.4 36.4
Cr 28.5 24.9 24.0 24.2 23.3 22.3 Cr 27.9 25.4 25.3 25.3 24.8 24.9
Cho 4.9 4.2 3.8 3.6 3.6 3.5 Cho 5.3 4.9 5.0 5.1 5.2 5.3
mI 13.1 10.7 9.9 9.5 8.9 8.0 mI 13.1 12.4 11.4 12.7 13.6 13.2
Glx 7.1 6.9 8.1 7.1 7.6 7.7 Glx 3.4 17.2 13.3 20.5 21.3 19.6
NAA / Cr 1.3 1.4 1.4 1.4 1.5 1.5 NAA / Cr 1.3 1.4 1.4 1.5 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.4 0.4 0.4 0.4 0.4 mI / Cr 0.5 0.5 0.5 0.5 0.6 0.5
Glx / Cr 0.3 0.3 0.4 0.3 0.4 0.4 Glx / Cr 0.1 0.7 0.7 0.9 1.0 1.0
NAA 25.6 23.6 25.5 25.4 26.3 24.5 NAA 24.6 23.7 23.5 23.6 23.6 24.8
Cr 36.5 34.0 33.8 33.8 33.7 32.4 Cr 36.9 33.9 36.0 36.0 38.3 37.7
Cho 7.4 7.5 6.8 6.8 7.0 6.7 Cho 7.8 7.8 8.6 8.6 8.5 9.0
mI 19.6 16.4 16.8 16.6 16.0 15.4 mI 17.9 18.3 19.0 19.2 20.2 21.9
Glx 18.1 10.0 14.3 12.1 11.6 11.9 Glx 10.9 10.4 8.9 9.8 11.2 9.1
NAA / Cr 0.7 0.7 0.7 0.7 0.8 0.8 NAA / Cr 0.7 0.7 0.7 0.7 0.6 0.6
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.3 0.3 0.2
mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5 mI / Cr 0.5 0.6 0.6 0.6 0.6 0.6
Glx / Cr 0.6 0.3 0.4 0.4 0.3 0.4 Glx / Cr 0.3 0.3 0.3 0.4 0.4 0.3
NAA 31.3 32.7 34.0 34.3 33.6 34.1 NAA 27.6 29.8 29.5 29.2 28.6 27.2
Cr 28.9 25.4 28.2 28.2 27.3 27.4 Cr 23.3 21.2 20.1 19.4 19.2 18.1
Cho 5.9 6.1 6.6 6.7 6.5 6.7 Cho 5.9 6.0 6.2 6.2 6.0 5.7
mI 16.0 17.5 18.7 19.0 18.4 19.6 mI 13.8 15.7 14.7 14.7 14.4 13.5
Glx 3.7 12.6 12.7 14.0 9.5 6.5 Glx 4.3 6.0 5.2 6.0 4.4 6.3
NAA / Cr 1.1 1.3 1.2 1.2 1.3 1.3 NAA / Cr 1.2 1.4 1.5 1.5 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7 mI / Cr 0.6 0.8 0.7 0.8 0.8 0.8
Glx / Cr 0.1 0.5 0.5 0.5 0.4 0.3 Glx / Cr 0.2 0.3 0.3 0.3 0.3 0.5
NAA 28.7 25.5 26.2 25.9 27.6 28.9 NAA 28.0 27.2 25.2 25.3 26.6 30.7
Cr 26.8 23.2 23.3 24.0 27.1 27.3 Cr 23.6 22.3 20.9 20.9 21.4 25.6
Cho 5.9 5.7 5.8 5.7 6.3 6.3 Cho 6.2 5.6 5.5 5.7 5.9 7.1
mI 16.8 14.0 14.4 14.4 16.2 20.2 mI 15.3 14.3 14.9 15.0 15.9 21.8
Glx 11.1 7.2 7.5 8.3 7.4 13.7 Glx 9.2 6.1 6.0 5.5 6.3 15.3
NAA / Cr 1.1 1.1 1.1 1.1 1.0 1.1 NAA / Cr 1.2 1.2 1.2 1.2 1.3 1.3
Cho / Cr 0.2 0.3 0.3 0.2 0.2 0.2 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.8 mI / Cr 0.7 0.7 0.7 0.8 0.8 0.9





















































































































NAA 37.3 38.4 38.6 39.1 41.0 40.5 NAA 34.0 38.0 38.5 38.2 37.8 38.3
Cr 30.0 28.0 29.8 30.2 32.5 32.3 Cr 27.8 25.9 26.0 25.9 24.4 24.4
Cho 5.3 5.4 5.3 5.4 5.4 5.2 Cho 5.0 5.7 5.8 5.8 6.2 6.6
mI 16.7 19.7 19.8 19.6 20.6 20.7 mI 15.7 18.1 17.5 17.1 15.6 14.7
Glx 12.7 10.5 11.4 11.6 17.7 18.2 Glx 12.4 7.3 4.4 6.8 5.7 32.1
NAA / Cr 1.2 1.4 1.3 1.3 1.3 1.3 NAA / Cr 1.2 1.5 1.5 1.5 1.6 1.6
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.3 0.3
mI / Cr 0.6 0.7 0.7 0.7 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.6
Glx / Cr 0.4 0.4 0.4 0.4 0.6 0.6 Glx / Cr 0.4 0.3 0.2 0.2 0.3 1.3
NAA 28.5 30.3 32.9 32.8 32.4 30.8 NAA 27.3 30.2 29.6 29.7 31.0 31.2
Cr 24.2 23.2 26.0 26.0 25.9 25.1 Cr 22.8 21.9 21.3 21.2 22.1 22.5
Cho 4.8 5.4 5.6 5.5 5.5 5.4 Cho 4.9 6.0 6.1 6.1 6.4 6.2
mI 15.2 14.7 15.0 15.1 13.9 13.2 mI 14.7 15.0 14.8 15.0 16.1 15.1
Glx 12.8 11.2 13.5 13.6 10.0 8.5 Glx 9.2 6.8 9.2 8.0 6.5 2.6
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 1.2 1.4 1.4 1.4 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7
Glx / Cr 0.5 0.5 0.5 0.5 0.4 0.3 Glx / Cr 0.4 0.3 0.4 0.4 0.4 0.1
NAA 31.1 34.2 35.0 35.2 36.9 39.3 NAA 27.3 31.6 31.9 31.7 33.0 34.3
Cr 29.0 29.2 30.5 30.5 33.0 35.3 Cr 22.8 23.1 22.7 22.3 21.9 22.1
Cho 7.0 7.1 7.1 7.4 8.1 8.8 Cho 6.1 6.4 6.6 6.6 6.6 6.8
mI 16.6 17.1 19.1 17.3 17.9 18.8 mI 12.7 13.8 13.8 13.5 12.9 13.0
Glx 6.1 4.9 15.4 9.4 6.9 25.2 Glx 6.3 7.1 4.4 3.9 6.5 10.5
NAA / Cr 1.1 1.2 1.2 1.2 1.1 1.1 NAA / Cr 1.2 1.4 1.4 1.4 1.5 1.6
Cho / Cr 0.2 0.3 0.2 0.3 0.3 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.5 mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6
Glx / Cr 0.2 0.2 0.5 0.3 0.2 0.7 Glx / Cr 0.3 0.3 0.2 0.2 0.3 0.4
NAA 29.0 35.1 35.7 36.2 37.7 40.0 NAA 30.2 36.3 38.7 38.5 43.9 44.7
Cr 23.1 27.3 27.5 27.6 27.9 28.9 Cr 23.5 27.1 27.4 27.7 30.4 30.3
Cho 3.8 4.9 4.8 4.9 4.8 5.1 Cho 3.9 5.4 5.6 5.5 5.7 5.3
mI 14.1 16.3 15.7 15.5 15.3 16.2 mI 14.7 18.0 17.5 17.6 18.4 16.7
Glx 14.1 13.9 10.8 11.2 18.6 17.9 Glx 7.5 8.3 8.1 8.8 19.7 4.4
NAA / Cr 1.3 1.3 1.3 1.3 1.4 1.4 NAA / Cr 1.3 1.3 1.4 1.4 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.6 0.6
Glx / Cr 0.7 0.5 0.4 0.4 0.7 0.6 Glx / Cr 0.3 0.3 0.3 0.3 0.6 0.1
NAA 28.2 34.0 33.0 32.9 33.1 30.8 NAA 28.1 34.7 38.3 38.7 40.4 38.5
Cr 23.8 28.7 27.6 27.5 28.9 27.5 Cr 22.9 26.6 26.5 26.9 27.2 26.5
Cho 3.7 4.7 4.4 4.4 4.0 4.2 Cho 4.1 5.1 5.7 5.7 6.3 6.6
mI 14.6 18.9 17.0 16.8 15.2 15.2 mI 14.7 17.6 18.7 17.8 19.8 17.3
Glx 7.0 12.1 9.6 7.6 5.3 6.4 Glx 5.1 9.8 16.6 11.8 23.0 4.1
NAA / Cr 1.2 1.2 1.2 1.2 1.2 1.2 NAA / Cr 1.2 1.3 1.5 1.4 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.1 0.1 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.3
mI / Cr 0.6 0.7 0.6 0.6 0.5 0.6 mI / Cr 0.7 0.7 0.7 0.7 0.7 0.7
































































































































NAA 36.2 36.3 36.6 36.4 40.2 36.3 NAA 35.8 35.1 35.4 35.6 35.1 35.6
Cr 29.5 27.4 29.7 30.4 30.4 30.5 Cr 29.1 24.8 25.4 24.9 24.3 24.8
Cho 5.5 5.4 5.6 5.4 5.1 5.2 Cho 5.2 5.6 5.7 5.7 5.8 6.0
mI 17.3 17.9 17.0 16.3 16.1 16.2 mI 16.6 17.4 17.9 17.7 17.1 16.8
Glx 15.4 12.0 8.8 8.3 21.9 20.9 Glx 7.3 6.5 7.5 14.0 12.9 14.6
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 1.2 1.4 1.4 1.4 1.5 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.6 0.7 0.6 0.6 0.5 0.5 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7
Glx / Cr 0.6 0.5 0.3 0.3 0.7 0.5 Glx / Cr 0.2 0.3 0.3 0.6 0.6 0.6
NAA 31.5 29.8 30.1 30.2 29.7 30.6 NAA 31.5 28.2 27.9 28.0 28.6 29.5
Cr 25.9 23.5 24.5 25.4 25.1 24.8 Cr 25.5 22.0 22.1 21.9 22.2 22.8
Cho 5.5 5.4 4.8 4.7 4.9 5.3 Cho 5.5 5.5 5.4 5.4 5.4 5.6
mI 16.7 13.7 12.4 13.0 14.3 14.2 mI 16.0 14.3 14.2 14.4 14.3 12.7
Glx 17.6 12.1 13.6 13.6 15.9 14.2 Glx 14.1 9.7 6.1 6.7 6.1 7.7
NAA / Cr 1.2 1.3 1.3 1.2 1.3 1.3 NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.7 0.6 0.5 0.5 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.6
Glx / Cr 0.7 0.5 0.6 0.6 0.5 0.5 Glx / Cr 0.5 0.5 0.3 0.3 0.3 0.3
NAA 32.7 33.3 33.6 33.9 33.7 35.3 NAA 28.3 30.2 30.4 30.4 31.4 32.1
Cr 29.7 29.6 31.6 32.2 33.5 33.7 Cr 24.0 23.2 23.3 23.0 21.6 22.0
Cho 7.3 7.1 7.0 7.2 7.7 8.6 Cho 6.1 6.2 6.4 6.3 6.3 6.3
mI 17.2 17.6 17.4 17.6 19.2 21.8 mI 12.0 15.1 14.8 14.7 14.1 13.0
Glx 5.6 11.4 13.8 9.8 15.7 16.7 Glx 5.2 8.2 7.8 7.4 7.8 0.8
NAA / Cr 1.1 1.1 1.1 1.1 1.0 1.1 NAA / Cr 1.2 1.3 1.3 1.3 1.5 1.5
Cho / Cr 0.3 0.2 0.2 0.2 0.2 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.7 mI / Cr 0.5 0.7 0.6 0.6 0.7 0.6
Glx / Cr 0.2 0.4 0.4 0.3 0.5 0.5 Glx / Cr 0.2 0.4 0.3 0.3 0.4 0.0
NAA 30.2 34.0 33.1 32.2 31.6 31.4 NAA 33.9 33.4 35.1 35.1 38.6 40.3
Cr 25.2 26.2 25.8 25.1 23.2 23.2 Cr 26.4 26.2 27.0 26.9 29.4 31.0
Cho 4.3 4.5 4.1 4.1 4.5 3.9 Cho 4.6 4.6 4.8 4.7 4.9 4.7
mI 14.2 14.8 13.3 13.5 13.3 11.0 mI 15.8 15.0 14.4 14.3 15.0 14.6
Glx 15.8 9.9 10.5 8.3 8.0 12.2 Glx 16.4 10.9 7.9 8.9 8.1 4.8
NAA / Cr 1.3 1.3 1.3 1.3 1.4 1.4 NAA / Cr 1.3 1.3 1.3 1.3 1.3 1.3
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.6 0.6 0.5 0.5 0.6 0.5 mI / Cr 0.6 0.6 0.6 0.6 0.5 0.5
Glx / Cr 0.6 0.4 0.4 0.4 0.4 0.6 Glx / Cr 0.6 0.4 0.3 0.3 0.3 0.2
NAA 33.4 30.5 29.9 29.9 30.0 30.2 NAA 32.6 31.5 32.3 32.3 35.6 38.0
Cr 28.7 25.1 25.3 25.0 25.8 25.9 Cr 27.2 24.2 22.9 22.7 24.2 25.3
Cho 4.2 4.4 4.0 4.0 4.0 4.2 Cho 4.5 4.7 5.1 5.1 5.5 5.7
mI 16.8 17.1 15.4 15.1 15.6 14.8 mI 16.0 16.7 16.9 16.4 15.8 18.0
Glx 14.6 8.2 7.9 7.8 9.9 6.4 Glx 9.2 7.5 4.7 8.3 3.4 8.3
NAA / Cr 1.2 1.2 1.2 1.2 1.2 1.2 NAA / Cr 1.2 1.3 1.4 1.4 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.6 0.7 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.7 0.8 0.7 0.7 0.7






































































































































NAA 34.2 34.4 35.4 35.4 39.7 40.7 NAA 30.8 33.8 32.5 32.8 32.9 33.0
Cr 27.4 25.1 25.7 26.0 29.1 30.0 Cr 24.4 25.2 24.1 23.7 23.9 23.5
Cho 5.3 5.5 5.2 5.2 5.1 5.1 Cho 5.7 6.1 6.4 6.5 6.6 6.6
mI 14.7 12.3 13.3 12.6 15.5 17.1 mI 12.5 14.4 13.5 13.3 13.0 13.4
Glx 7.0 10.7 16.4 17.2 15.1 17.8 Glx 6.0 10.9 5.5 6.2 3.4 5.2
NAA / Cr 1.3 1.4 1.4 1.4 1.4 1.5 NAA / Cr 1.3 1.4 1.4 1.4 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.3 0.3 0.3 0.3
mI / Cr 0.5 0.5 0.5 0.5 0.6 0.7 mI / Cr 0.5 0.6 0.6 0.6 0.6 0.6
Glx / Cr 0.2 0.5 0.7 0.7 0.6 0.6 Glx / Cr 0.2 0.4 0.2 0.3 0.1 0.2
NAA 35.6 38.4 39.7 39.6 40.3 41.1 NAA 34.0 37.0 36.6 36.9 35.2 36.9
Cr 29.2 28.6 30.2 31.1 32.6 32.5 Cr 27.0 26.0 26.0 25.7 24.1 26.9
Cho 5.9 6.4 6.7 6.7 7.1 6.8 Cho 6.1 6.6 6.7 6.8 6.4 7.0
mI 17.9 18.2 20.8 20.4 19.6 17.7 mI 16.0 17.3 14.3 14.0 14.1 16.9
Glx 16.5 11.3 6.7 13.9 8.0 11.4 Glx 8.8 8.5 2.9 4.7 5.0 3.6
NAA / Cr 1.2 1.3 1.3 1.3 1.2 1.3 NAA / Cr 1.3 1.4 1.4 1.5 1.5 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.7 0.7 0.6 0.6 mI / Cr 0.6 0.7 0.6 0.6 0.7 0.6
Glx / Cr 0.5 0.4 0.2 0.5 0.3 0.5 Glx / Cr 0.3 0.3 0.1 0.2 0.2 0.2
NAA 34.5 31.9 30.0 29.3 26.8 29.1 NAA 35.3 35.8 39.0 40.8 46.8 49.0
Cr 28.0 24.7 23.4 23.1 21.3 24.0 Cr 27.7 26.7 27.3 27.9 30.1 30.1
Cho 4.7 4.3 4.1 4.1 3.9 4.4 Cho 4.7 4.8 5.5 5.7 6.7 6.9
mI 14.5 12.1 11.4 10.8 9.2 10.0 mI 13.7 13.1 13.7 14.4 15.7 14.5
Glx 11.3 7.0 9.5 8.0 9.4 6.4 Glx 6.6 10.3 2.3 15.4 16.4 9.2
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 1.3 1.4 1.4 1.5 1.6 1.7
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.5 0.5 0.5 0.4 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5
Glx / Cr 0.4 0.3 0.4 0.4 0.6 0.3 Glx / Cr 0.3 0.4 0.1 0.7 0.6 0.3
NAA 31.0 33.9 34.6 34.3 35.1 35.0 NAA 29.6 34.7 34.7 34.6 34.5 34.2
Cr 26.7 27.2 27.9 27.9 27.9 27.5 Cr 24.3 24.3 23.7 23.6 23.0 22.3
Cho 4.1 4.6 4.3 4.1 3.9 3.8 Cho 4.7 5.5 5.6 5.6 5.9 5.7
mI 14.4 16.3 16.2 15.5 15.3 14.9 mI 13.8 16.4 15.4 15.2 14.7 15.0
Glx 9.2 16.1 10.7 7.1 14.6 16.3 Glx 3.5 14.2 8.6 7.4 1.9 25.5
NAA / Cr 1.2 1.3 1.3 1.2 1.3 1.3 NAA / Cr 1.2 1.4 1.5 1.5 1.5 1.6
Cho / Cr 0.2 0.2 0.2 0.2 0.1 0.1 Cho / Cr 0.2 0.2 0.2 0.2 0.3 0.3
mI / Cr 0.5 0.6 0.6 0.5 0.5 0.5 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7
Glx / Cr 0.4 0.6 0.4 0.2 0.5 0.6 Glx / Cr 0.1 0.6 0.3 0.3 0.1 1.1
NAA 38.3 37.7 38.8 38.4 37.6 39.5 NAA 36.5 38.9 38.9 38.9 39.7 37.8
Cr 31.8 30.0 31.1 30.3 33.0 30.5 Cr 29.1 28.6 28.3 28.2 29.4 28.2
Cho 6.1 6.2 5.8 5.5 4.8 5.3 Cho 6.5 7.3 7.7 7.8 8.0 8.3
mI 19.3 20.0 21.0 19.8 20.5 19.8 mI 17.9 19.6 19.9 19.7 19.0 17.6
Glx 12.9 10.6 10.6 14.0 11.5 15.1 Glx 6.9 11.8 11.3 10.9 12.7 6.4
NAA / Cr 1.2 1.3 1.3 1.3 1.2 1.4 NAA / Cr 1.3 1.4 1.4 1.4 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.7 0.7 0.7 0.6 0.8 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.6








































































































































NAA 34.3 35.9 38.5 39.7 39.7 41.1 NAA 30.7 34.7 35.2 35.0 35.2 34.6
Cr 27.3 27.5 31.2 31.9 38.4 42.6 Cr 24.6 25.2 24.9 25.1 24.6 23.6
Cho 5.6 5.3 5.7 5.8 5.3 5.8 Cho 5.6 6.0 6.2 6.2 6.4 6.3
mI 15.1 13.7 14.3 14.6 15.9 20.6 mI 12.5 14.3 14.1 14.1 14.5 14.6
Glx 9.3 10.4 11.9 10.8 17.1 22.7 Glx 10.0 7.8 11.0 6.3 2.3 9.3
NAA / Cr 1.3 1.3 1.3 1.3 1.2 1.1 NAA / Cr 1.3 1.4 1.4 1.4 1.4 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.3 0.3 0.3 0.3
mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5 mI / Cr 0.5 0.6 0.6 0.6 0.6 0.6
Glx / Cr 0.3 0.4 0.4 0.4 0.7 0.8 Glx / Cr 0.5 0.3 0.4 0.3 0.1 0.4
NAA 37.6 36.5 36.8 37.4 39.6 40.9 NAA 35.7 35.5 36.6 34.5 35.3 35.6
Cr 30.5 29.0 29.6 30.8 31.3 34.1 Cr 28.7 26.4 26.8 25.1 25.3 24.9
Cho 6.3 6.3 6.3 6.4 6.7 6.6 Cho 6.6 6.5 7.3 6.7 7.4 7.2
mI 17.4 18.5 16.8 17.4 15.3 15.6 mI 16.3 17.3 17.6 16.0 17.6 15.9
Glx 18.1 12.1 10.0 10.6 15.8 15.1 Glx 8.7 10.4 11.2 12.6 5.0 8.8
NAA / Cr 1.2 1.3 1.2 1.2 1.3 1.2 NAA / Cr 1.2 1.3 1.4 1.6 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.5 0.5 mI / Cr 0.6 0.7 0.7 0.8 0.7 0.7
Glx / Cr 0.6 0.4 0.3 0.3 0.5 0.4 Glx / Cr 0.3 0.4 0.4 3.3 0.2 0.3
NAA 34.5 31.7 30.4 30.0 28.4 28.8 NAA 35.2 34.8 37.8 39.1 41.5 40.8
Cr 28.9 24.9 23.5 23.2 22.4 22.9 Cr 28.9 26.6 27.2 27.7 28.5 28.1
Cho 4.6 3.9 3.8 3.7 3.6 4.0 Cho 5.0 4.6 5.2 5.2 5.6 5.8
mI 15.1 10.8 9.6 9.0 8.6 8.5 mI 14.6 13.1 12.9 13.7 15.4 13.3
Glx 8.7 3.9 12.2 11.7 11.6 6.4 Glx 7.0 7.6 6.4 15.2 32.1 3.7
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 1.2 1.3 1.4 1.4 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.4 0.4 0.4 0.4 0.4 mI / Cr 0.5 0.5 0.5 0.5 0.6 0.5
Glx / Cr 0.4 0.2 0.6 0.5 0.6 0.3 Glx / Cr 0.3 0.3 0.2 0.5 1.1 0.1
NAA 34.1 32.5 32.9 32.7 33.7 35.8 NAA 33.4 31.6 31.0 30.9 28.8 29.1
Cr 29.6 25.4 26.1 26.5 27.3 27.7 Cr 27.8 22.6 21.8 21.5 19.0 18.8
Cho 4.5 4.4 4.1 4.0 3.8 3.8 Cho 4.9 5.1 5.2 5.2 5.4 5.3
mI 16.0 15.7 15.6 15.3 13.9 13.6 mI 15.4 15.5 15.7 15.7 14.7 14.9
Glx 13.3 8.1 15.7 12.0 15.8 16.4 Glx 11.8 8.6 7.2 6.2 3.5 7.0
NAA / Cr 1.2 1.3 1.3 1.2 1.3 1.3 NAA / Cr 1.2 1.4 1.4 1.4 1.5 1.6
Cho / Cr 0.2 0.2 0.2 0.2 0.1 0.1 Cho / Cr 0.2 0.2 0.2 0.2 0.3 0.3
mI / Cr 0.5 0.6 0.6 0.6 0.5 0.5 mI / Cr 0.6 0.7 0.7 0.7 0.8 0.8
Glx / Cr 0.4 0.3 0.6 0.4 0.6 0.6 Glx / Cr 0.4 0.4 0.3 0.3 0.2 0.4
NAA 39.6 39.2 39.4 39.5 41.4 41.8 NAA 36.8 38.1 38.5 37.8 38.5 37.8
Cr 32.1 31.2 31.7 32.0 34.0 34.3 Cr 29.1 28.6 29.0 28.3 29.2 28.6
Cho 6.4 6.5 6.5 6.3 6.4 5.9 Cho 6.8 7.2 7.3 7.3 7.6 7.5
mI 18.9 19.8 20.1 18.9 18.9 17.6 mI 16.7 19.3 20.2 20.6 21.7 21.1
Glx 9.3 14.7 10.2 11.8 11.3 11.6 Glx 5.0 14.2 11.2 13.5 5.7 8.1
NAA / Cr 1.2 1.3 1.3 1.2 1.2 1.2 NAA / Cr 1.3 1.3 1.3 1.4 1.3 1.3
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.5 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7








































































































































NAA 36.1 35.0 35.6 33.9 33.9 32.3 NAA 34.4 36.7 37.5 37.8 39.5 41.6
Cr 29.1 26.4 25.8 25.1 23.9 25.9 Cr 27.2 27.9 29.4 29.4 30.8 32.1
Cho 6.3 5.8 5.6 5.4 5.5 5.0 Cho 6.3 6.4 6.6 6.7 7.2 7.4
mI 14.1 12.1 11.0 10.3 11.7 18.8 mI 13.3 13.7 14.7 14.8 14.0 18.0
Glx 9.9 13.0 10.7 9.6 15.5 26.7 Glx 7.1 9.5 11.7 8.5 5.4 16.3
NAA / Cr 1.3 1.3 1.4 1.4 1.5 1.3 NAA / Cr 1.3 1.3 1.3 1.3 1.3 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.4 0.4 0.5 0.7 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.6
Glx / Cr 0.3 0.6 0.4 0.4 0.6 0.8 Glx / Cr 0.3 0.3 0.4 0.3 0.2 0.5
NAA 30.3 32.8 30.6 29.6 26.8 27.0 NAA 31.7 36.4 38.5 38.9 42.5 45.5
Cr 25.3 26.0 24.9 23.8 22.0 18.5 Cr 25.7 26.5 27.9 28.4 31.3 33.9
Cho 3.8 4.2 3.4 3.3 3.3 2.9 Cho 4.4 5.4 5.5 5.6 6.0 6.2
mI 12.6 14.4 11.2 11.1 7.9 7.3 mI 13.3 16.5 17.4 17.3 17.9 18.2
Glx 4.6 9.6 6.9 7.9 14.0 12.8 Glx 9.0 11.8 21.9 21.6 18.7 26.3
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.5 NAA / Cr 1.2 1.4 1.4 1.4 1.4 1.4
Cho / Cr 0.2 0.2 0.1 0.1 0.2 0.2 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.4 0.5 0.4 0.4 mI / Cr 0.5 0.6 0.6 0.6 0.6 0.5
Glx / Cr 0.2 0.4 0.3 0.4 0.6 0.8 Glx / Cr 0.4 0.5 0.8 0.8 0.6 0.8
NAA 31.2 31.3 31.8 31.6 31.9 31.5 NAA 28.6 31.8 34.1 33.2 34.1 37.7
Cr 27.4 25.9 28.4 28.2 28.3 27.7 Cr 25.3 24.1 24.9 24.2 24.3 28.2
Cho 5.5 5.7 5.9 5.9 6.2 5.9 Cho 5.2 6.0 6.1 6.1 6.3 6.6
mI 17.8 15.6 15.8 15.4 15.2 13.9 mI 15.4 15.9 14.6 14.1 14.4 15.0
Glx 10.2 8.6 9.4 6.1 14.1 8.3 Glx 9.1 9.6 10.3 5.0 21.4 21.6
NAA / Cr 1.1 1.2 1.2 1.1 1.2 1.2 NAA / Cr 1.1 1.3 1.4 1.4 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.2 0.3 0.3 0.3
mI / Cr 0.7 0.6 0.6 0.6 0.5 0.5 mI / Cr 0.6 0.7 0.6 0.6 0.6 0.6
Glx / Cr 0.4 0.3 0.3 0.2 0.5 0.3 Glx / Cr 0.4 0.5 0.5 0.3 0.8 0.7
NAA 37.1 36.4 36.3 36.0 36.5 38.3 NAA 35.1 39.2 39.2 39.5 39.0 37.9
Cr 31.5 27.7 27.7 27.5 28.5 30.0 Cr 28.9 27.1 26.1 26.1 24.8 24.0
Cho 5.7 5.2 5.0 4.9 4.8 4.7 Cho 5.6 6.1 6.4 6.4 6.6 6.5
mI 18.1 17.2 17.1 16.7 17.1 17.5 mI 16.1 17.3 16.1 15.9 16.0 14.8
Glx 13.7 6.8 9.7 8.3 10.1 13.3 Glx 6.7 5.7 4.9 9.6 11.0 3.0
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.3 NAA / Cr 1.2 1.5 1.5 1.5 1.6 1.6
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.6 0.6 0.6 0.7 0.6
Glx / Cr 0.4 0.2 0.3 0.3 0.4 0.4 Glx / Cr 0.2 0.2 0.2 0.3 0.4 0.1
NAA 23.4 24.8 24.7 24.8 21.9 21.6 NAA 21.8 25.1 25.4 25.3 24.9 23.6
Cr 22.7 22.4 23.8 24.0 24.1 23.5 Cr 19.9 20.1 20.7 20.7 21.3 20.1
Cho 5.7 6.0 6.7 6.8 6.4 6.6 Cho 5.0 6.0 6.2 6.1 6.2 5.9
mI 13.1 11.6 12.4 13.1 11.6 12.9 mI 10.5 9.8 9.2 9.4 9.3 9.7
Glx 8.3 10.1 6.7 6.8 8.9 9.0 Glx 5.0 7.5 6.6 8.4 7.8 10.3
NAA / Cr 1.0 1.1 1.0 1.0 0.9 0.9 NAA / Cr 1.1 1.3 1.2 1.2 1.2 1.2
Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.5 0.5 0.5 0.5 0.6 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5























































































































































NAA 35.7 35.9 35.7 35.5 35.8 33.2 NAA 32.9 36.6 37.2 37.2 38.8 39.8
Cr 29.6 27.6 26.6 26.3 25.5 23.8 Cr 27.2 28.1 27.9 28.1 29.0 29.7
Cho 6.1 5.9 5.8 5.7 5.3 6.0 Cho 6.4 6.4 6.7 6.7 6.9 7.0
mI 14.3 12.7 13.0 13.0 13.0 15.4 mI 13.8 14.9 15.1 14.5 14.4 13.0
Glx 13.2 8.8 11.9 12.5 11.6 17.4 Glx 10.1 9.8 15.7 9.3 14.4 17.8
NAA / Cr 1.2 1.3 1.4 1.4 1.4 1.4 NAA / Cr 1.2 1.3 1.3 1.3 1.4 1.4
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.3 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.5 0.5 0.5 0.6 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.4
Glx / Cr 0.5 0.3 0.5 0.5 0.5 0.7 Glx / Cr 0.4 0.3 0.5 0.3 0.5 0.7
NAA 32.1 31.9 31.9 30.7 32.8 27.4 NAA 33.2 34.1 35.7 36.0 37.4 38.9
Cr 26.9 25.2 25.3 24.1 25.1 23.0 Cr 27.4 25.8 26.9 27.1 27.7 29.1
Cho 4.3 3.9 3.5 3.2 3.7 3.1 Cho 4.8 4.9 5.1 5.1 5.2 5.4
mI 14.4 12.7 9.8 8.2 7.5 6.2 mI 14.8 15.6 15.3 15.5 15.4 16.6
Glx 11.7 8.5 9.4 12.8 21.7 27.2 Glx 11.9 11.3 13.8 13.4 18.6 23.1
NAA / Cr 1.2 1.3 1.3 1.3 1.3 1.4 NAA / Cr 1.2 1.3 1.3 1.3 1.4 1.4
Cho / Cr 0.2 0.2 0.1 0.1 0.2 0.1 Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2
mI / Cr 0.5 0.5 0.4 0.3 0.3 0.3 mI / Cr 0.5 0.6 0.6 0.6 0.6 0.6
Glx / Cr 0.4 0.3 0.4 0.6 0.8 1.2 Glx / Cr 0.5 0.4 0.5 0.5 0.7 0.8
NAA 34.3 31.5 33.3 32.8 34.1 33.2 NAA 30.8 30.2 30.6 30.8 29.7 26.3
Cr 29.5 26.2 28.3 28.3 27.6 26.3 Cr 26.2 24.6 24.2 24.0 22.9 21.2
Cho 6.3 5.8 6.0 5.9 6.2 5.7 Cho 5.9 5.6 5.9 6.0 5.8 5.1
mI 18.0 14.5 16.2 15.4 14.7 15.0 mI 16.0 15.4 15.6 14.6 14.2 14.3
Glx 9.7 8.7 9.9 8.6 8.7 9.8 Glx 8.0 9.2 5.3 9.1 6.7 13.3
NAA / Cr 1.2 1.2 1.2 1.2 1.3 1.3 NAA / Cr 1.2 1.2 1.3 1.3 1.3 1.3
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.2 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.5 0.6 mI / Cr 0.6 0.6 0.7 0.6 0.6 0.8
Glx / Cr 0.3 0.3 0.4 0.3 0.3 0.5 Glx / Cr 0.3 0.4 0.3 0.5 0.3 0.7
NAA 38.5 35.5 37.6 37.5 39.5 39.8 NAA 36.2 34.4 34.3 34.3 33.8 33.4
Cr 32.5 28.4 30.8 30.5 31.9 31.9 Cr 29.1 24.2 23.4 23.4 23.1 22.6
Cho 5.7 5.4 5.0 5.0 5.1 5.3 Cho 5.9 6.0 6.1 6.1 6.1 6.1
mI 18.7 17.4 17.5 17.7 18.3 18.8 mI 16.5 16.1 16.1 15.8 16.0 15.1
Glx 10.1 9.1 10.0 10.2 19.4 23.0 Glx 5.4 8.3 14.1 18.6 13.2 10.3
NAA / Cr 1.2 1.3 1.2 1.2 1.3 1.3 NAA / Cr 1.3 1.4 1.5 1.5 1.5 1.5
Cho / Cr 0.2 0.2 0.2 0.2 0.2 0.2 Cho / Cr 0.2 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.6 0.6 mI / Cr 0.6 0.7 0.7 0.7 0.7 0.7
Glx / Cr 0.3 0.3 0.3 0.3 0.6 0.7 Glx / Cr 0.2 0.3 0.7 0.8 0.7 0.5
NAA 24.6 25.5 24.5 24.5 22.2 20.1 NAA 22.9 24.5 23.5 23.4 22.7 21.1
Cr 23.3 24.4 24.6 24.5 24.4 22.3 Cr 20.9 20.5 19.6 19.7 19.9 19.0
Cho 5.9 6.3 6.5 6.7 6.8 6.3 Cho 5.6 5.7 5.7 5.6 5.9 5.6
mI 12.6 14.2 14.2 14.6 11.6 13.3 mI 10.4 9.5 8.7 8.9 9.3 9.8
Glx 6.5 9.0 7.5 6.8 9.5 14.3 Glx 2.2 7.6 8.0 11.8 6.7 5.6
NAA / Cr 1.0 1.1 1.0 1.0 0.9 0.9 NAA / Cr 1.1 1.2 1.2 1.2 1.1 1.1
Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3 Cho / Cr 0.3 0.3 0.3 0.3 0.3 0.3
mI / Cr 0.6 0.6 0.6 0.6 0.5 0.7 mI / Cr 0.5 0.5 0.5 0.5 0.5 0.5






























































































































Table 9: Average SNR across all compartments. 
 
Compartment MINT 50x50x18 ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
All 25 15 13 13 11 10
Brain Stem 17 8 8 8 8 8
L. Central GM 25 17 14 14 10 9
L. Central WM 24 15 14 14 14 13
L. Cerebellum GM 35 15 15 15 15 14
L. Cerebellum WM 30 14 12 12 12 12
L. Cingulate GM 17 14 12 12 11 11
L. Cingulate WM 18 15 14 13 12 11
L. Fusiform GM 26 12 9 9 9 8
L. Fusiform WM 23 14 9 9 7 6
L. Inferior Parietal GM 27 21 18 17 15 14
L. Inferior Parietal WM 24 18 16 15 13 11
L. Inferior Temporal GM 32 15 14 13 11 10
L. Inferior Temporal WM 31 14 12 12 11 11
L. Insula GM 18 14 13 12 10 9
L. Insula WM 21 16 15 14 13 12
L. Lateral Occipital GM 32 19 18 18 14 12
L. Lateral Occipital WM 37 19 16 15 13 11
L. Lingual GM 28 17 14 13 12 10
L. Lingual WM 27 17 13 12 10 9
L. Orbito-Frontal GM 25 14 12 11 9 8
L. Orbito-Frontal WM 24 16 15 14 12 11
L. Pars GM 26 15 13 12 10 11
L. Pars WM 24 15 11 11 10 10
L. Post-Central GM 25 17 13 12 10 11
L. Post-Central WM 25 16 13 13 11 9
L. Pre-Cuneus GM 20 15 14 13 11 10
L. Pre-Cuneus WM 21 15 14 13 11 11
L. Rostral Middle Frontal GM 28 17 13 12 12 11
L. Rostral Middle Frontal WM 26 17 15 15 14 12
L. Striatum 24 12 11 10 7 7
L. Superior Frontal GM 24 13 11 11 9 7
L. Superior Frontal WM 23 15 15 14 12 12
L. Superior Parietal GM 25 15 12 11 8 7
L. Superior Parietal WM 23 16 16 15 12 11
L. Superior Temporal GM 29 13 11 11 10 9
L. Superior Temporal WM 24 13 11 10 8 7
L. Supra-Marginal GM 27 17 14 13 11 12
L. Supra-Marginal WM 24 15 13 12 12 12





Compartment MINT 50x50x18 ROIS 50x50x18 SLIM 50x50x12 SLIM 40x40x12 SLIM 20x20x12 SLIM 16x16x12
R. Central GM 23 17 16 15 11 10
R. Central WM 23 14 14 14 13 13
R. Cerebellum GM 36 13 13 13 12 13
R. Cerebellum WM 31 13 12 12 12 11
R. Cingulate GM 17 15 13 13 11 10
R. Cingulate WM 19 16 15 15 14 13
R. Fusiform GM 27 11 8 8 8 9
R. Fusiform WM 25 14 9 9 7 7
R. Inferior Parietal GM 24 18 15 14 12 11
R. Inferior Parietal WM 24 17 17 16 14 12
R. Inferior Temporal GM 29 12 10 10 9 8
R. Inferior Temporal WM 30 13 11 11 10 11
R. Insula GM 20 13 13 12 10 9
R. Insula WM 22 18 17 16 14 13
R. Lateral Occipital GM 31 18 15 15 11 10
R. Lateral Occipital WM 31 18 15 14 12 10
R. Lingual GM 27 16 13 13 11 10
R. Lingual WM 30 16 12 11 9 8
R. Orbito-Frontal GM 26 15 12 12 10 9
R. Orbito-Frontal WM 21 16 15 14 12 12
R. Pars GM 29 14 12 12 10 10
R. Pars WM 24 16 12 11 11 10
R. Post-Central GM 23 16 13 12 10 10
R. Post-Central WM 22 16 13 12 11 9
R. Pre-Cuneus GM 20 16 14 13 12 10
R. Pre-Cuneus WM 23 15 15 14 10 10
R. Rostral Middle Frontal GM 27 17 14 14 11 12
R. Rostral Middle Frontal WM 24 18 16 15 14 12
R. Striatum 25 12 11 10 8 8
R. Superior Frontal GM 23 15 13 12 9 9
R. Superior Frontal WM 21 16 15 15 12 11
R. Superior Parietal GM 27 16 14 13 11 9
R. Superior Parietal WM 24 16 15 14 12 11
R. Superior Temporal GM 30 13 11 10 10 10
R. Superior Temporal WM 24 13 10 10 8 7
R. Supra-Marginal GM 26 16 14 13 12 11
R. Supra-Marginal WM 21 16 14 14 13 12
R. Thalamus 16 10 8 8 8 7
Ventral Diencephalon 20 8 6 6 6 6
Ventricles 19 15 13 13 11 10
71 
 
Table 10: Average metabolite concentrations and standard deviations measured as a ratio of ROIS 50 x 50 x 12 over 






















NAA 0.97 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.03 ± 0.2 1.03 ± 0.2 NAA 0.79 ± 0.4 1.03 ± 0.1 1.02 ± 0.1 1.00 ± 0.1 1.03 ± 0.1
Cr 1.05 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.02 ± 0.2 1.03 ± 0.2 Cr 0.95 ± 0.4 1.03 ± 0.1 1.04 ± 0.1 1.07 ± 0.2 1.12 ± 0.3
Cho 0.98 ± 0.3 1.01 ± 0.1 1.01 ± 0.2 1.03 ± 0.2 1.04 ± 0.3 Cho 0.96 ± 0.5 1.05 ± 0.1 1.12 ± 0.3 1.19 ± 0.5 1.21 ± 0.6
mI 1.09 ± 1.3 1.04 ± 1.7 1.04 ± 1.7 1.06 ± 2.5 1.15 ± 5.1 mI 1.06 ± 0.3 1.08 ± 0.3 1.06 ± 0.3 0.99 ± 0.3 1.23 ± 0.5
Glx 3.38 ± 11.4 2.88 ± 13.9 2.77 ± 10.3 4.19 ± 16.4 5.93 ± 28.6 Glx 1.45 ± 1.8 2.54 ± 2.7 0.84 ± 0.9 2.00 ± 2.0 1.02 ± 0.9
NAA / Cr 0.93 ± 0.1 1.01 ± 0.1 1.01 ± 0.1 1.02 ± 0.1 1.03 ± 0.2 NAA / Cr 0.84 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 0.95 ± 0.1 0.95 ± 0.1
Cho / Cr 0.94 ± 0.2 1.01 ± 0.2 1.02 ± 0.2 1.03 ± 0.2 1.04 ± 0.2 Cho / Cr 1.08 ± 0.5 1.02 ± 0.1 1.12 ± 0.4 1.11 ± 0.4 1.09 ± 0.5
mI / Cr 1.05 ± 1.2 1.04 ± 1.6 1.03 ± 1.6 1.06 ± 2.8 1.11 ± 4.0 mI / Cr 1.28 ± 0.5 1.06 ± 0.3 1.06 ± 0.3 0.93 ± 0.2 1.09 ± 0.3
Glx / Cr 3.54 ± 13.1 2.86 ± 13.5 2.78 ± 10.6 4.14 ± 16.7 6.08 ± 28.4 Glx / Cr 1.72 ± 2.2 2.49 ± 2.7 0.83 ± 1.0 1.90 ± 1.9 1.03 ± 0.9
NAA 1.06 ± 0.1 0.95 ± 0.0 0.94 ± 0.1 0.85 ± 0.1 0.82 ± 0.1 NAA 0.95 ± 0.1 1.04 ± 0.0 1.05 ± 0.0 1.10 ± 0.1 1.13 ± 0.1
Cr 1.12 ± 0.1 0.97 ± 0.0 0.96 ± 0.1 0.85 ± 0.1 0.77 ± 0.1 Cr 0.98 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.05 ± 0.1 1.05 ± 0.1
Cho 1.09 ± 0.1 0.93 ± 0.1 0.90 ± 0.1 0.76 ± 0.1 0.79 ± 0.2 Cho 0.92 ± 0.1 1.07 ± 0.1 1.08 ± 0.0 1.15 ± 0.1 1.17 ± 0.1
mI 1.18 ± 0.3 0.90 ± 0.1 0.89 ± 0.2 0.81 ± 0.3 0.65 ± 0.2 mI 0.96 ± 0.3 1.08 ± 0.2 1.07 ± 0.2 1.14 ± 0.3 1.11 ± 0.4
Glx 4.83 ± 10.3 1.66 ± 2.8 1.03 ± 0.4 1.05 ± 1.0 3.05 ± 6.6 Glx 0.62 ± 0.6 1.15 ± 1.5 0.94 ± 1.3 1.85 ± 3.4 0.55 ± 0.1
NAA / Cr 0.95 ± 0.1 0.98 ± 0.1 0.98 ± 0.0 1.01 ± 0.1 1.08 ± 0.1 NAA / Cr 0.97 ± 0.1 1.02 ± 0.1 1.03 ± 0.0 1.05 ± 0.1 1.09 ± 0.1
Cho / Cr 0.98 ± 0.1 0.96 ± 0.1 0.93 ± 0.1 0.90 ± 0.2 1.04 ± 0.2 Cho / Cr 0.94 ± 0.1 1.05 ± 0.1 1.05 ± 0.1 1.10 ± 0.1 1.13 ± 0.2
mI / Cr 1.05 ± 0.2 0.92 ± 0.2 0.92 ± 0.2 0.95 ± 0.4 0.85 ± 0.3 mI / Cr 0.98 ± 0.3 1.04 ± 0.2 1.04 ± 0.2 1.06 ± 0.3 1.04 ± 0.3
Glx / Cr 4.48 ± 9.5 1.88 ± 3.2 1.02 ± 0.3 1.37 ± 1.6 4.09 ± 8.5 Glx / Cr 0.65 ± 0.7 1.15 ± 1.5 0.93 ± 1.3 1.75 ± 3.3 0.53 ± 0.1
NAA 0.85 ± 0.3 1.05 ± 0.1 1.07 ± 0.1 1.13 ± 0.1 1.11 ± 0.3 NAA 0.88 ± 0.2 1.07 ± 0.1 1.08 ± 0.1 1.10 ± 0.3 1.13 ± 0.2
Cr 0.80 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 1.02 ± 0.1 0.98 ± 0.2 Cr 0.89 ± 0.2 1.05 ± 0.1 1.07 ± 0.1 1.13 ± 0.3 1.19 ± 0.3
Cho 0.69 ± 0.2 0.96 ± 0.1 0.98 ± 0.1 0.98 ± 0.1 0.91 ± 0.2 Cho 0.76 ± 0.2 1.06 ± 0.2 1.10 ± 0.2 1.12 ± 0.2 1.17 ± 0.3
mI 0.95 ± 0.5 1.02 ± 0.2 0.98 ± 0.2 1.08 ± 0.2 0.97 ± 0.3 mI 0.81 ± 0.2 1.00 ± 0.2 0.96 ± 0.2 0.99 ± 0.2 1.00 ± 0.2
Glx 0.96 ± 0.9 1.01 ± 0.4 0.95 ± 0.4 1.27 ± 1.0 0.89 ± 0.5 Glx 1.67 ± 1.9 1.36 ± 1.2 1.29 ± 1.2 0.56 ± 0.3 1.24 ± 0.5
NAA / Cr 1.09 ± 0.3 1.05 ± 0.1 1.08 ± 0.1 1.11 ± 0.1 1.13 ± 0.1 NAA / Cr 1.01 ± 0.2 1.02 ± 0.1 1.02 ± 0.1 0.98 ± 0.1 0.96 ± 0.1
Cho / Cr 0.87 ± 0.2 0.97 ± 0.1 0.99 ± 0.1 0.97 ± 0.1 0.94 ± 0.1 Cho / Cr 0.86 ± 0.2 1.01 ± 0.1 1.03 ± 0.1 1.01 ± 0.2 1.00 ± 0.2
mI / Cr 1.20 ± 0.4 1.02 ± 0.2 0.99 ± 0.2 1.07 ± 0.2 1.01 ± 0.3 mI / Cr 0.93 ± 0.2 0.96 ± 0.2 0.91 ± 0.2 0.90 ± 0.2 0.87 ± 0.2
Glx / Cr 1.36 ± 1.1 1.01 ± 0.4 1.00 ± 0.5 1.23 ± 0.9 0.95 ± 0.4 Glx / Cr 1.80 ± 1.9 1.41 ± 1.3 1.31 ± 1.3 0.52 ± 0.2 1.08 ± 0.5
NAA 0.89 ± 0.2 1.02 ± 0.1 1.01 ± 0.1 1.08 ± 0.1 1.11 ± 0.1 NAA 0.81 ± 0.1 0.99 ± 0.1 0.98 ± 0.1 0.94 ± 0.1 0.90 ± 0.1
Cr 1.01 ± 0.2 1.09 ± 0.1 1.08 ± 0.1 1.15 ± 0.2 1.13 ± 0.2 Cr 0.97 ± 0.2 0.96 ± 0.1 0.95 ± 0.1 0.89 ± 0.1 0.84 ± 0.1
Cho 0.89 ± 0.2 1.01 ± 0.1 0.99 ± 0.1 1.05 ± 0.1 1.08 ± 0.2 Cho 0.95 ± 0.4 1.08 ± 0.3 1.09 ± 0.3 1.03 ± 0.2 0.97 ± 0.2
mI 0.90 ± 0.2 1.05 ± 0.2 1.04 ± 0.2 1.08 ± 0.3 1.08 ± 0.3 mI 0.88 ± 0.3 1.00 ± 0.2 1.00 ± 0.2 1.01 ± 0.3 0.88 ± 0.2
Glx 1.53 ± 1.5 4.15 ± 7.7 4.97 ± 7.6 13.25 ± 32.2 4.42 ± 6.0 Glx 0.24 ± 0.0 0.48 ± 0.3 0.70 ± 0.3 0.88 ± 0.6 1.00 ± 0.8
NAA / Cr 0.88 ± 0.1 0.94 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 1.00 ± 0.1 NAA / Cr 0.84 ± 0.1 1.03 ± 0.1 1.04 ± 0.1 1.07 ± 0.1 1.07 ± 0.1
Cho / Cr 0.87 ± 0.1 0.93 ± 0.1 0.92 ± 0.1 0.92 ± 0.1 0.96 ± 0.1 Cho / Cr 0.99 ± 0.3 1.14 ± 0.3 1.17 ± 0.5 1.17 ± 0.3 1.18 ± 0.3
mI / Cr 0.88 ± 0.2 0.96 ± 0.2 0.97 ± 0.2 0.95 ± 0.2 0.98 ± 0.3 mI / Cr 0.90 ± 0.2 1.04 ± 0.2 1.06 ± 0.2 1.15 ± 0.3 1.04 ± 0.3
Glx / Cr 1.66 ± 1.6 4.94 ± 9.8 5.67 ± 9.6 10.34 ± 24.0 4.96 ± 7.0 Glx / Cr 0.30 ± 0.1 0.51 ± 0.3 0.73 ± 0.3 1.01 ± 0.7 1.30 ± 1.1
NAA 0.82 ± 0.2 1.01 ± 0.1 0.99 ± 0.2 1.03 ± 0.2 0.97 ± 0.3 NAA 0.81 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 1.06 ± 0.3 1.32 ± 0.5
Cr 0.82 ± 0.2 1.00 ± 0.1 0.99 ± 0.1 1.08 ± 0.2 1.05 ± 0.3 Cr 0.85 ± 0.2 0.96 ± 0.2 0.94 ± 0.1 0.99 ± 0.4 1.32 ± 0.7
Cho 0.79 ± 0.2 1.03 ± 0.2 1.03 ± 0.1 1.11 ± 0.2 1.06 ± 0.2 Cho 0.84 ± 0.2 1.16 ± 0.2 1.15 ± 0.2 1.21 ± 0.4 1.61 ± 0.8
mI 1.03 ± 0.7 1.14 ± 0.8 1.14 ± 0.7 1.39 ± 1.4 1.23 ± 0.9 mI 1.02 ± 0.9 1.10 ± 0.7 1.06 ± 0.6 1.19 ± 1.1 1.63 ± 1.7
Glx 22.90 ± 50.1 1.32 ± 1.9 5.83 ± 14.0 38.93 ± 79.2 59.75 ± 97.0 Glx 2.34 ± 2.1 0.88 ± 1.2 1.03 ± 1.1 0.28 ± 0.0 N/A
NAA / Cr 1.02 ± 0.2 1.01 ± 0.1 1.00 ± 0.1 0.96 ± 0.1 0.92 ± 0.2 NAA / Cr 0.97 ± 0.2 1.03 ± 0.1 1.04 ± 0.1 1.13 ± 0.2 1.08 ± 0.2
Cho / Cr 1.00 ± 0.3 1.04 ± 0.2 1.06 ± 0.2 1.03 ± 0.2 1.00 ± 0.3 Cho / Cr 1.02 ± 0.3 1.22 ± 0.2 1.22 ± 0.2 1.26 ± 0.2 1.26 ± 0.3
mI / Cr 1.32 ± 1.1 1.17 ± 0.9 1.19 ± 0.9 1.47 ± 2.1 1.52 ± 1.8 mI / Cr 1.27 ± 1.4 1.15 ± 0.7 1.13 ± 0.6 1.11 ± 0.4 1.28 ± 0.7




































































































NAA 1.02 ± 0.2 0.92 ± 0.2 0.91 ± 0.2 0.95 ± 0.1 0.93 ± 0.1 NAA 0.90 ± 0.2 0.93 ± 0.1 0.94 ± 0.1 0.92 ± 0.1 0.96 ± 0.1
Cr 1.07 ± 0.2 0.98 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 Cr 1.03 ± 0.3 0.90 ± 0.1 0.89 ± 0.1 0.88 ± 0.1 0.93 ± 0.2
Cho 0.98 ± 0.2 0.97 ± 0.2 0.98 ± 0.2 0.95 ± 0.1 0.98 ± 0.1 Cho 1.08 ± 0.3 0.99 ± 0.1 1.01 ± 0.1 1.01 ± 0.1 1.05 ± 0.1
mI 1.14 ± 0.3 1.01 ± 0.3 1.00 ± 0.3 1.22 ± 0.6 0.97 ± 0.3 mI 0.89 ± 0.3 0.95 ± 0.1 1.00 ± 0.1 0.90 ± 0.2 1.02 ± 0.2
Glx 1.87 ± 2.6 2.06 ± 2.1 1.59 ± 1.4 2.98 ± 3.1 1.15 ± 1.0 Glx 0.85 ± 0.5 0.66 ± 0.5 1.10 ± 0.4 0.60 ± 0.8 1.23 ± 1.9
NAA / Cr 0.96 ± 0.1 0.94 ± 0.1 0.93 ± 0.1 0.95 ± 0.1 0.95 ± 0.1 NAA / Cr 0.89 ± 0.1 1.04 ± 0.1 1.06 ± 0.1 1.06 ± 0.1 1.05 ± 0.1
Cho / Cr 0.92 ± 0.2 0.99 ± 0.1 1.00 ± 0.2 0.95 ± 0.2 1.00 ± 0.2 Cho / Cr 1.05 ± 0.2 1.11 ± 0.1 1.13 ± 0.1 1.18 ± 0.2 1.15 ± 0.2
mI / Cr 1.07 ± 0.3 1.04 ± 0.3 1.02 ± 0.2 1.21 ± 0.5 0.99 ± 0.3 mI / Cr 0.85 ± 0.2 1.06 ± 0.1 1.12 ± 0.1 1.04 ± 0.2 1.10 ± 0.2
Glx / Cr 1.76 ± 2.5 2.22 ± 2.4 1.55 ± 1.5 2.85 ± 2.8 1.20 ± 1.1 Glx / Cr 0.66 ± 0.4 0.68 ± 0.5 1.18 ± 0.5 0.73 ± 0.9 1.31 ± 2.1
NAA 1.07 ± 0.1 0.97 ± 0.0 0.97 ± 0.1 0.97 ± 0.1 0.93 ± 0.1 NAA 1.04 ± 0.1 1.02 ± 0.0 1.03 ± 0.1 1.03 ± 0.1 1.03 ± 0.1
Cr 1.16 ± 0.1 0.96 ± 0.1 0.97 ± 0.1 0.92 ± 0.1 0.88 ± 0.1 Cr 1.11 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 0.98 ± 0.1 0.98 ± 0.1
Cho 1.21 ± 0.2 0.91 ± 0.1 0.87 ± 0.1 0.85 ± 0.3 0.81 ± 0.2 Cho 1.10 ± 0.1 1.03 ± 0.1 1.05 ± 0.1 1.08 ± 0.1 1.08 ± 0.1
mI 1.37 ± 0.5 1.00 ± 0.4 0.92 ± 0.2 0.80 ± 0.3 0.76 ± 0.3 mI 1.21 ± 0.5 0.99 ± 0.2 1.12 ± 0.3 1.27 ± 0.5 1.25 ± 0.6
Glx 12.01 ± 22.0 7.91 ± 10.0 9.27 ± 10.3 8.41 ± 10.4 6.50 ± 12.8 Glx 0.27 ± 0.3 1.28 ± 0.0 1.12 ± 0.2 18.18 ± 29.4 17.07 ± 24.1
NAA / Cr 0.93 ± 0.1 1.01 ± 0.1 1.00 ± 0.1 1.06 ± 0.1 1.07 ± 0.2 NAA / Cr 0.94 ± 0.1 1.02 ± 0.1 1.04 ± 0.1 1.06 ± 0.1 1.06 ± 0.1
Cho / Cr 1.04 ± 0.1 0.96 ± 0.1 0.90 ± 0.1 0.93 ± 0.3 0.92 ± 0.2 Cho / Cr 0.99 ± 0.1 1.03 ± 0.1 1.06 ± 0.1 1.10 ± 0.1 1.11 ± 0.1
mI / Cr 1.19 ± 0.4 1.06 ± 0.5 0.95 ± 0.2 0.89 ± 0.3 0.87 ± 0.3 mI / Cr 1.12 ± 0.5 0.99 ± 0.3 1.13 ± 0.3 1.33 ± 0.7 1.31 ± 0.7
Glx / Cr 13.95 ± 27.6 8.41 ± 10.6 9.91 ± 10.9 9.02 ± 10.5 8.46 ± 16.6 Glx / Cr 0.24 ± 0.2 1.52 ± 0.0 1.23 ± 0.4 22.40 ± 36.3 20.01 ± 28.3
NAA 1.16 ± 0.4 1.08 ± 0.1 1.08 ± 0.1 1.13 ± 0.1 1.12 ± 0.3 NAA 1.05 ± 0.2 0.99 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 1.04 ± 0.3
Cr 1.11 ± 0.3 1.00 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 0.97 ± 0.3 Cr 1.12 ± 0.3 1.07 ± 0.2 1.07 ± 0.2 1.17 ± 0.5 1.15 ± 0.3
Cho 1.06 ± 0.3 0.92 ± 0.1 0.91 ± 0.1 0.95 ± 0.2 0.90 ± 0.3 Cho 1.01 ± 0.3 1.11 ± 0.1 1.12 ± 0.1 1.10 ± 0.1 1.15 ± 0.2
mI 1.32 ± 0.6 1.04 ± 0.4 1.04 ± 0.4 1.01 ± 0.4 1.00 ± 0.6 mI 0.99 ± 0.2 1.05 ± 0.3 1.06 ± 0.3 1.09 ± 0.4 1.22 ± 0.7
Glx 7.52 ± 20.0 6.10 ± 12.5 3.89 ± 8.4 3.64 ± 10.0 1.16 ± 0.6 Glx 4.02 ± 9.4 1.08 ± 0.7 1.69 ± 1.8 1.80 ± 2.4 4.53 ± 9.2
NAA / Cr 1.04 ± 0.2 1.08 ± 0.1 1.08 ± 0.1 1.14 ± 0.1 1.17 ± 0.2 NAA / Cr 0.97 ± 0.2 0.94 ± 0.1 0.94 ± 0.1 0.91 ± 0.2 0.91 ± 0.1
Cho / Cr 0.95 ± 0.2 0.92 ± 0.1 0.92 ± 0.1 0.97 ± 0.2 0.95 ± 0.3 Cho / Cr 0.93 ± 0.2 1.05 ± 0.2 1.06 ± 0.2 1.05 ± 0.1 1.02 ± 0.2
mI / Cr 1.17 ± 0.4 1.05 ± 0.4 1.04 ± 0.4 1.02 ± 0.4 1.03 ± 0.6 mI / Cr 0.93 ± 0.3 0.99 ± 0.2 0.99 ± 0.2 0.96 ± 0.3 1.03 ± 0.4
Glx / Cr 6.83 ± 18.1 5.76 ± 11.6 3.80 ± 8.2 3.28 ± 8.4 1.54 ± 1.5 Glx / Cr 6.44 ± 18.1 1.07 ± 0.7 1.67 ± 1.8 1.70 ± 2.3 4.33 ± 8.9
NAA 0.96 ± 0.2 1.05 ± 0.1 1.05 ± 0.1 1.03 ± 0.1 1.05 ± 0.1 NAA 0.94 ± 0.2 0.99 ± 0.0 0.98 ± 0.0 0.96 ± 0.1 0.91 ± 0.2
Cr 1.15 ± 0.2 1.12 ± 0.1 1.12 ± 0.1 1.08 ± 0.2 1.09 ± 0.2 Cr 1.11 ± 0.2 0.96 ± 0.1 0.92 ± 0.1 0.91 ± 0.1 0.86 ± 0.2
Cho 0.96 ± 0.2 1.10 ± 0.1 1.11 ± 0.1 1.07 ± 0.2 1.12 ± 0.3 Cho 0.97 ± 0.2 1.03 ± 0.1 1.04 ± 0.1 1.00 ± 0.1 0.95 ± 0.2
mI 0.93 ± 0.2 1.08 ± 0.2 1.10 ± 0.3 1.06 ± 0.2 1.14 ± 0.4 mI 0.90 ± 0.2 0.95 ± 0.2 0.94 ± 0.1 0.93 ± 0.1 0.87 ± 0.2
Glx 0.15 ± 0.2 0.94 ± 1.1 1.19 ± 1.1 1.80 ± 1.8 2.29 ± 2.1 Glx 0.55 ± 0.6 0.81 ± 0.7 1.00 ± 0.6 1.02 ± 0.7 1.07 ± 0.7
NAA / Cr 0.85 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 0.97 ± 0.1 0.99 ± 0.1 NAA / Cr 0.85 ± 0.1 1.04 ± 0.1 1.07 ± 0.1 1.05 ± 0.1 1.07 ± 0.1
Cho / Cr 0.84 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 1.03 ± 0.2 Cho / Cr 0.89 ± 0.1 1.08 ± 0.1 1.14 ± 0.2 1.10 ± 0.1 1.10 ± 0.1
mI / Cr 0.80 ± 0.1 0.98 ± 0.2 0.99 ± 0.2 1.00 ± 0.3 1.09 ± 0.4 mI / Cr 0.81 ± 0.1 0.99 ± 0.2 1.03 ± 0.1 1.03 ± 0.2 1.05 ± 0.3
Glx / Cr 0.13 ± 0.1 0.88 ± 1.0 1.13 ± 1.1 2.32 ± 3.1 3.33 ± 3.6 Glx / Cr 0.43 ± 0.4 0.88 ± 0.8 1.14 ± 0.6 1.23 ± 0.8 1.95 ± 2.4
NAA 1.15 ± 0.2 1.03 ± 0.1 1.01 ± 0.1 1.06 ± 0.1 1.09 ± 0.2 NAA 1.06 ± 0.2 0.93 ± 0.1 0.93 ± 0.1 0.96 ± 0.2 1.08 ± 0.2
Cr 1.18 ± 0.3 1.00 ± 0.1 1.03 ± 0.1 1.15 ± 0.2 1.15 ± 0.2 Cr 1.08 ± 0.2 0.93 ± 0.1 0.93 ± 0.1 0.93 ± 0.2 1.10 ± 0.4
Cho 1.04 ± 0.2 1.01 ± 0.2 1.00 ± 0.2 1.09 ± 0.3 1.08 ± 0.3 Cho 1.13 ± 0.3 0.98 ± 0.1 1.02 ± 0.1 1.05 ± 0.1 1.24 ± 0.2
mI 1.30 ± 0.6 1.03 ± 0.3 1.03 ± 0.4 1.11 ± 0.4 1.43 ± 1.4 mI 1.12 ± 0.4 1.05 ± 0.3 1.06 ± 0.3 1.08 ± 0.4 1.41 ± 1.2
Glx 2.19 ± 1.6 1.45 ± 0.9 1.48 ± 1.4 1.29 ± 1.0 6.79 ± 13.5 Glx 3.39 ± 3.6 1.51 ± 1.3 1.21 ± 1.0 1.17 ± 1.4 1.80 ± 1.2
NAA / Cr 0.99 ± 0.1 1.03 ± 0.1 1.00 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 NAA / Cr 0.98 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 1.05 ± 0.2 1.03 ± 0.2
Cho / Cr 0.90 ± 0.2 1.02 ± 0.2 0.99 ± 0.2 0.98 ± 0.2 0.96 ± 0.3 Cho / Cr 1.06 ± 0.2 1.06 ± 0.2 1.10 ± 0.1 1.15 ± 0.2 1.26 ± 0.2
mI / Cr 1.12 ± 0.4 1.05 ± 0.3 1.02 ± 0.4 0.98 ± 0.3 1.38 ± 1.7 mI / Cr 1.05 ± 0.3 1.14 ± 0.3 1.15 ± 0.4 1.21 ± 0.5 1.40 ± 1.1

















































































































NAA 0.96 ± 0.2 1.01 ± 0.0 1.02 ± 0.1 1.07 ± 0.1 1.05 ± 0.1 NAA 0.90 ± 0.2 1.01 ± 0.0 1.00 ± 0.0 1.00 ± 0.1 1.01 ± 0.1
Cr 1.07 ± 0.2 1.06 ± 0.1 1.08 ± 0.1 1.17 ± 0.2 1.16 ± 0.1 Cr 1.08 ± 0.2 1.01 ± 0.1 1.00 ± 0.1 0.94 ± 0.1 0.94 ± 0.1
Cho 0.98 ± 0.3 1.00 ± 0.1 1.01 ± 0.1 1.00 ± 0.1 0.96 ± 0.1 Cho 0.89 ± 0.2 1.02 ± 0.1 1.03 ± 0.1 1.10 ± 0.1 1.17 ± 0.1
mI 0.86 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 1.05 ± 0.1 1.04 ± 0.2 mI 0.88 ± 0.2 0.97 ± 0.1 0.95 ± 0.1 0.87 ± 0.1 0.82 ± 0.2
Glx 13.11 ± 15.6 4.56 ± 6.6 4.89 ± 6.5 3.72 ± 6.1 5.10 ± 9.1 Glx 2.84 ± 2.1 0.49 ± 0.5 1.25 ± 0.0 0.88 ± 0.0 N/A
NAA / Cr 0.90 ± 0.1 0.95 ± 0.1 0.95 ± 0.1 0.93 ± 0.1 0.92 ± 0.1 NAA / Cr 0.83 ± 0.1 1.01 ± 0.0 1.01 ± 0.0 1.06 ± 0.1 1.08 ± 0.1
Cho / Cr 0.92 ± 0.2 0.95 ± 0.1 0.94 ± 0.1 0.87 ± 0.2 0.84 ± 0.2 Cho / Cr 0.83 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.17 ± 0.1 1.26 ± 0.2
mI / Cr 0.81 ± 0.1 0.94 ± 0.1 0.92 ± 0.1 0.91 ± 0.2 0.91 ± 0.2 mI / Cr 0.82 ± 0.1 0.96 ± 0.1 0.95 ± 0.1 0.93 ± 0.1 0.87 ± 0.2
Glx / Cr 11.49 ± 14.4 4.06 ± 5.8 4.39 ± 5.8 3.59 ± 6.7 5.03 ± 10.0 Glx / Cr 2.36 ± 1.8 0.52 ± 0.5 1.12 ± 0.0 0.95 ± 0.0 N/A
NAA 0.94 ± 0.2 1.08 ± 0.1 1.08 ± 0.1 1.08 ± 0.1 1.03 ± 0.1 NAA 0.91 ± 0.2 0.98 ± 0.1 0.98 ± 0.0 1.03 ± 0.1 1.04 ± 0.1
Cr 1.04 ± 0.2 1.11 ± 0.1 1.11 ± 0.1 1.11 ± 0.1 1.08 ± 0.2 Cr 1.05 ± 0.2 0.97 ± 0.1 0.97 ± 0.1 1.01 ± 0.1 1.03 ± 0.1
Cho 0.90 ± 0.2 1.04 ± 0.2 1.03 ± 0.2 1.02 ± 0.2 1.01 ± 0.2 Cho 0.83 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.07 ± 0.1 1.03 ± 0.1
mI 1.15 ± 0.5 1.07 ± 0.4 1.08 ± 0.5 0.95 ± 0.3 0.89 ± 0.2 mI 1.07 ± 0.5 1.00 ± 0.2 1.02 ± 0.2 1.15 ± 0.4 0.98 ± 0.3
Glx 1.39 ± 0.8 1.81 ± 1.4 1.72 ± 1.4 1.57 ± 1.6 1.00 ± 0.6 Glx 4.21 ± 7.3 1.01 ± 0.3 0.83 ± 0.2 2.39 ± 3.2 N/A
NAA / Cr 0.90 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 NAA / Cr 0.87 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.01 ± 0.1
Cho / Cr 0.87 ± 0.1 0.95 ± 0.2 0.93 ± 0.2 0.92 ± 0.2 0.95 ± 0.2 Cho / Cr 0.79 ± 0.1 1.06 ± 0.1 1.06 ± 0.1 1.07 ± 0.1 1.00 ± 0.1
mI / Cr 1.10 ± 0.4 0.97 ± 0.4 0.98 ± 0.4 0.87 ± 0.3 0.85 ± 0.3 mI / Cr 0.99 ± 0.3 1.03 ± 0.1 1.05 ± 0.2 1.15 ± 0.5 0.96 ± 0.3
Glx / Cr 1.37 ± 0.8 1.74 ± 1.6 1.66 ± 1.6 1.53 ± 1.8 0.86 ± 0.5 Glx / Cr 3.64 ± 5.8 1.03 ± 0.4 0.85 ± 0.2 2.64 ± 3.6 N/A
NAA 0.90 ± 0.2 1.02 ± 0.1 1.03 ± 0.0 1.08 ± 0.1 1.15 ± 0.1 NAA 0.86 ± 0.2 1.01 ± 0.0 1.00 ± 0.0 1.05 ± 0.1 1.09 ± 0.1
Cr 0.98 ± 0.2 1.03 ± 0.0 1.05 ± 0.0 1.13 ± 0.1 1.21 ± 0.1 Cr 0.99 ± 0.2 0.98 ± 0.1 0.96 ± 0.1 0.94 ± 0.1 0.96 ± 0.1
Cho 0.98 ± 0.3 1.03 ± 0.1 1.04 ± 0.1 1.16 ± 0.1 1.25 ± 0.2 Cho 0.95 ± 0.3 1.03 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.05 ± 0.1
mI 0.95 ± 0.3 1.01 ± 0.1 1.03 ± 0.1 1.07 ± 0.2 1.11 ± 0.2 mI 0.93 ± 0.3 1.00 ± 0.2 0.97 ± 0.2 0.93 ± 0.1 0.95 ± 0.1
Glx 0.37 ± 0.1 13.44 ± 24.8 5.39 ± 8.5 2.60 ± 2.3 199.54 ± 281.2 Glx 0.92 ± 0.0 1.37 ± 0.8 0.92 ± 0.8 0.19 ± 0.2 0.10 ± 0.0
NAA / Cr 0.91 ± 0.2 0.99 ± 0.1 0.99 ± 0.0 0.96 ± 0.1 0.96 ± 0.1 NAA / Cr 0.89 ± 0.1 1.03 ± 0.1 1.05 ± 0.1 1.12 ± 0.1 1.15 ± 0.1
Cho / Cr 1.03 ± 0.3 1.00 ± 0.1 1.00 ± 0.1 1.03 ± 0.2 1.04 ± 0.2 Cho / Cr 0.96 ± 0.1 1.06 ± 0.1 1.07 ± 0.1 1.10 ± 0.1 1.11 ± 0.1
mI / Cr 0.98 ± 0.2 0.98 ± 0.1 0.98 ± 0.1 0.95 ± 0.2 0.92 ± 0.2 mI / Cr 0.97 ± 0.2 1.02 ± 0.1 1.01 ± 0.1 0.99 ± 0.1 1.00 ± 0.1
Glx / Cr 0.36 ± 0.1 12.58 ± 23.2 4.98 ± 7.8 2.27 ± 2.0 187.52 ± 264.5 Glx / Cr 0.88 ± 0.1 1.45 ± 1.0 0.98 ± 1.0 0.19 ± 0.2 0.11 ± 0.0
NAA 0.81 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.06 ± 0.2 1.12 ± 0.3 NAA 0.81 ± 0.2 1.06 ± 0.1 1.06 ± 0.1 1.17 ± 0.1 1.18 ± 0.1
Cr 0.84 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 1.04 ± 0.2 Cr 0.87 ± 0.2 1.01 ± 0.1 1.02 ± 0.1 1.09 ± 0.1 1.07 ± 0.2
Cho 0.76 ± 0.2 0.97 ± 0.2 0.98 ± 0.2 0.98 ± 0.2 1.03 ± 0.3 Cho 0.72 ± 0.2 1.04 ± 0.1 1.02 ± 0.1 1.05 ± 0.1 0.99 ± 0.3
mI 0.97 ± 0.4 0.94 ± 0.2 0.94 ± 0.2 0.96 ± 0.2 0.97 ± 0.2 mI 0.83 ± 0.2 0.99 ± 0.2 0.99 ± 0.2 1.01 ± 0.3 0.89 ± 0.2
Glx 0.85 ± 0.6 0.88 ± 0.7 0.92 ± 0.8 1.48 ± 1.4 1.63 ± 1.3 Glx 1.06 ± 0.6 1.01 ± 0.7 1.11 ± 0.4 0.82 ± 0.2 0.50 ± 0.7
NAA / Cr 0.97 ± 0.2 1.01 ± 0.1 1.02 ± 0.1 1.05 ± 0.2 1.08 ± 0.2 NAA / Cr 0.95 ± 0.1 1.05 ± 0.1 1.05 ± 0.1 1.08 ± 0.1 1.12 ± 0.2
Cho / Cr 0.92 ± 0.2 0.97 ± 0.2 0.99 ± 0.2 0.98 ± 0.2 1.02 ± 0.3 Cho / Cr 0.84 ± 0.1 1.03 ± 0.1 1.01 ± 0.1 0.98 ± 0.2 0.94 ± 0.3
mI / Cr 1.17 ± 0.5 0.94 ± 0.2 0.96 ± 0.2 0.96 ± 0.2 0.96 ± 0.3 mI / Cr 0.96 ± 0.2 0.98 ± 0.2 0.98 ± 0.2 0.93 ± 0.2 0.84 ± 0.2
Glx / Cr 0.99 ± 0.7 0.89 ± 0.8 0.94 ± 0.7 1.48 ± 1.4 1.57 ± 1.2 Glx / Cr 1.30 ± 0.7 1.01 ± 0.7 1.14 ± 0.4 0.75 ± 0.2 0.45 ± 0.6
NAA 0.83 ± 0.2 0.97 ± 0.1 0.96 ± 0.1 0.96 ± 0.1 0.90 ± 0.2 NAA 0.80 ± 0.1 1.08 ± 0.1 1.09 ± 0.1 1.14 ± 0.2 1.06 ± 0.2
Cr 0.82 ± 0.2 0.96 ± 0.1 0.96 ± 0.1 1.00 ± 0.1 0.96 ± 0.1 Cr 0.86 ± 0.2 0.98 ± 0.1 1.00 ± 0.1 1.01 ± 0.2 0.97 ± 0.2
Cho 0.80 ± 0.1 0.93 ± 0.1 0.92 ± 0.1 0.87 ± 0.2 0.94 ± 0.5 Cho 0.82 ± 0.1 1.09 ± 0.1 1.11 ± 0.1 1.22 ± 0.1 1.30 ± 0.3
mI 0.79 ± 0.2 0.91 ± 0.1 0.90 ± 0.2 0.80 ± 0.2 0.81 ± 0.2 mI 0.85 ± 0.2 1.06 ± 0.4 1.00 ± 0.3 1.15 ± 0.8 0.96 ± 0.3
Glx 0.65 ± 0.2 1.33 ± 1.0 0.61 ± 0.3 0.74 ± 0.5 0.47 ± 0.2 Glx 0.67 ± 0.7 4.22 ± 7.6 4.79 ± 8.6 10.41 ± 17.7 0.19 ± 0.2
NAA / Cr 1.01 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 0.97 ± 0.1 1.00 ± 0.1 NAA / Cr 0.94 ± 0.1 1.10 ± 0.1 1.09 ± 0.1 1.14 ± 0.1 1.12 ± 0.2
Cho / Cr 0.99 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 0.88 ± 0.2 0.86 ± 0.2 Cho / Cr 0.97 ± 0.1 1.13 ± 0.2 1.13 ± 0.2 1.23 ± 0.2 1.39 ± 0.4
mI / Cr 0.99 ± 0.3 0.96 ± 0.1 0.95 ± 0.2 0.82 ± 0.3 0.86 ± 0.3 mI / Cr 1.01 ± 0.3 1.10 ± 0.5 1.00 ± 0.2 1.11 ± 0.5 1.06 ± 0.5




























































































































NAA 1.01 ± 0.2 1.01 ± 0.1 0.99 ± 0.3 1.11 ± 0.1 1.00 ± 0.4 NAA 1.04 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.00 ± 0.1 1.02 ± 0.1
Cr 1.09 ± 0.2 1.09 ± 0.1 1.10 ± 0.1 1.13 ± 0.1 1.14 ± 0.1 Cr 1.19 ± 0.2 1.03 ± 0.1 1.01 ± 0.1 0.98 ± 0.1 1.01 ± 0.1
Cho 1.03 ± 0.4 1.06 ± 0.3 1.00 ± 0.1 0.95 ± 0.2 0.96 ± 0.2 Cho 0.95 ± 0.2 1.02 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.07 ± 0.1
mI 1.02 ± 0.3 0.95 ± 0.1 0.92 ± 0.3 0.92 ± 0.2 0.92 ± 0.5 mI 0.98 ± 0.3 1.03 ± 0.1 1.02 ± 0.1 0.99 ± 0.1 0.97 ± 0.2
Glx 5.48 ± 7.7 0.73 ± 0.5 0.99 ± 0.9 3.83 ± 2.4 3.36 ± 1.9 Glx 0.92 ± 0.6 3.08 ± 5.1 5.19 ± 6.0 8.99 ± 13.8 12.37 ± 11.9
NAA / Cr 0.92 ± 0.1 0.95 ± 0.1 0.96 ± 0.1 0.99 ± 0.2 0.99 ± 0.1 NAA / Cr 0.87 ± 0.1 0.99 ± 0.1 1.01 ± 0.1 1.02 ± 0.0 1.01 ± 0.1
Cho / Cr 0.95 ± 0.3 0.91 ± 0.1 0.91 ± 0.1 0.85 ± 0.2 0.84 ± 0.1 Cho / Cr 0.80 ± 0.1 0.99 ± 0.1 1.02 ± 0.1 1.05 ± 0.1 1.07 ± 0.1
mI / Cr 0.94 ± 0.2 0.88 ± 0.1 0.89 ± 0.1 0.83 ± 0.3 0.79 ± 0.2 mI / Cr 0.82 ± 0.1 1.01 ± 0.1 1.01 ± 0.1 1.02 ± 0.2 0.97 ± 0.2
Glx / Cr 4.14 ± 5.5 0.63 ± 0.4 0.90 ± 0.8 3.36 ± 2.3 2.85 ± 1.7 Glx / Cr 0.68 ± 0.4 3.16 ± 5.2 5.34 ± 6.3 9.83 ± 15.0 12.58 ± 11.7
NAA 1.08 ± 0.2 1.02 ± 0.1 1.00 ± 0.1 1.02 ± 0.2 1.02 ± 0.2 NAA 1.14 ± 0.2 0.99 ± 0.1 0.99 ± 0.1 1.01 ± 0.1 1.05 ± 0.1
Cr 1.13 ± 0.2 1.02 ± 0.2 1.05 ± 0.2 1.07 ± 0.2 1.07 ± 0.2 Cr 1.20 ± 0.3 1.01 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 1.04 ± 0.2
Cho 1.02 ± 0.1 0.91 ± 0.2 0.88 ± 0.2 0.90 ± 0.2 0.93 ± 0.3 Cho 1.03 ± 0.2 0.99 ± 0.2 0.99 ± 0.2 0.99 ± 0.2 1.02 ± 0.2
mI 1.30 ± 0.4 0.86 ± 0.3 0.90 ± 0.3 1.02 ± 0.3 1.07 ± 0.8 mI 1.18 ± 0.4 0.99 ± 0.2 1.00 ± 0.2 1.01 ± 0.3 0.90 ± 0.3
Glx 1.68 ± 1.1 1.41 ± 1.2 1.39 ± 1.1 1.34 ± 1.2 1.10 ± 1.0 Glx 1.78 ± 1.5 3.68 ± 10.8 0.72 ± 0.7 1.75 ± 3.6 1.03 ± 0.9
NAA / Cr 0.97 ± 0.1 1.00 ± 0.1 0.95 ± 0.1 1.01 ± 0.2 0.96 ± 0.1 NAA / Cr 0.97 ± 0.1 0.98 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 1.02 ± 0.1
Cho / Cr 0.92 ± 0.2 0.92 ± 0.3 0.86 ± 0.2 0.87 ± 0.3 0.87 ± 0.2 Cho / Cr 0.87 ± 0.1 0.98 ± 0.2 0.99 ± 0.2 0.99 ± 0.2 1.01 ± 0.3
mI / Cr 1.16 ± 0.3 0.87 ± 0.3 0.88 ± 0.3 1.00 ± 0.4 1.06 ± 0.9 mI / Cr 1.01 ± 0.3 0.99 ± 0.2 1.00 ± 0.2 1.00 ± 0.2 0.87 ± 0.3
Glx / Cr 1.47 ± 0.9 1.40 ± 1.3 1.34 ± 1.2 1.06 ± 0.9 0.91 ± 0.8 Glx / Cr 1.61 ± 1.6 3.74 ± 11.1 0.71 ± 0.6 1.69 ± 3.4 0.94 ± 0.9
NAA 0.99 ± 0.3 1.01 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.06 ± 0.1 NAA 0.96 ± 0.3 1.01 ± 0.0 1.01 ± 0.1 1.05 ± 0.1 1.07 ± 0.1
Cr 1.03 ± 0.3 1.06 ± 0.1 1.08 ± 0.1 1.16 ± 0.1 1.14 ± 0.1 Cr 1.06 ± 0.3 1.00 ± 0.1 0.99 ± 0.1 0.94 ± 0.1 0.95 ± 0.1
Cho 1.05 ± 0.2 1.00 ± 0.2 1.04 ± 0.2 1.12 ± 0.2 1.22 ± 0.2 Cho 1.00 ± 0.3 1.04 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.02 ± 0.1
mI 1.01 ± 0.5 1.02 ± 0.4 1.03 ± 0.4 1.08 ± 0.3 1.30 ± 1.0 mI 0.81 ± 0.3 0.97 ± 0.1 0.97 ± 0.1 0.93 ± 0.1 0.86 ± 0.2
Glx 0.55 ± 0.0 1.58 ± 1.2 1.15 ± 1.3 1.15 ± 0.9 3.47 ± 5.3 Glx 0.99 ± 0.9 0.87 ± 0.3 0.72 ± 0.4 0.54 ± 0.7 0.07 ± 0.0
NAA / Cr 0.95 ± 0.2 0.95 ± 0.1 0.95 ± 0.1 0.89 ± 0.1 0.93 ± 0.1 NAA / Cr 0.91 ± 0.1 1.01 ± 0.1 1.02 ± 0.1 1.12 ± 0.1 1.13 ± 0.1
Cho / Cr 1.04 ± 0.2 0.96 ± 0.2 0.98 ± 0.2 0.98 ± 0.2 1.08 ± 0.2 Cho / Cr 0.97 ± 0.1 1.04 ± 0.1 1.03 ± 0.1 1.10 ± 0.1 1.08 ± 0.1
mI / Cr 1.01 ± 0.4 0.96 ± 0.3 0.96 ± 0.3 0.93 ± 0.2 1.15 ± 0.9 mI / Cr 0.78 ± 0.1 0.97 ± 0.1 0.97 ± 0.1 0.99 ± 0.1 0.91 ± 0.2
Glx / Cr 0.47 ± 0.0 1.43 ± 1.0 1.00 ± 1.1 1.02 ± 0.9 3.14 ± 4.7 Glx / Cr 0.93 ± 0.8 0.85 ± 0.3 0.73 ± 0.4 0.68 ± 0.9 0.07 ± 0.0
NAA 0.94 ± 0.4 0.97 ± 0.1 0.95 ± 0.1 0.93 ± 0.1 0.93 ± 0.2 NAA 1.00 ± 0.3 1.05 ± 0.1 1.03 ± 0.2 1.13 ± 0.2 1.18 ± 0.2
Cr 1.02 ± 0.3 0.98 ± 0.1 0.96 ± 0.1 0.89 ± 0.2 0.87 ± 0.2 Cr 1.02 ± 0.2 1.03 ± 0.1 1.03 ± 0.1 1.13 ± 0.2 1.20 ± 0.3
Cho 1.01 ± 0.3 0.90 ± 0.2 0.89 ± 0.2 1.03 ± 0.3 0.90 ± 0.3 Cho 0.99 ± 0.3 1.05 ± 0.2 1.03 ± 0.2 1.04 ± 0.1 0.99 ± 0.2
mI 1.06 ± 0.5 0.90 ± 0.2 0.91 ± 0.2 1.01 ± 0.4 0.80 ± 0.6 mI 1.10 ± 0.3 0.97 ± 0.2 0.96 ± 0.1 1.03 ± 0.3 1.04 ± 0.8
Glx 5.23 ± 8.2 1.34 ± 1.0 0.79 ± 0.6 2.55 ± 4.8 1.50 ± 1.2 Glx 1.51 ± 1.1 1.38 ± 2.5 1.95 ± 3.0 1.97 ± 3.0 1.59 ± 2.3
NAA / Cr 0.98 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 1.06 ± 0.2 1.08 ± 0.2 NAA / Cr 0.99 ± 0.2 1.03 ± 0.1 1.01 ± 0.2 1.01 ± 0.1 1.00 ± 0.2
Cho / Cr 1.03 ± 0.3 0.94 ± 0.3 0.94 ± 0.2 1.17 ± 0.4 1.04 ± 0.2 Cho / Cr 1.00 ± 0.2 1.03 ± 0.2 1.01 ± 0.2 0.95 ± 0.2 0.85 ± 0.2
mI / Cr 1.10 ± 0.3 0.93 ± 0.2 0.96 ± 0.2 1.20 ± 0.5 0.92 ± 0.6 mI / Cr 1.11 ± 0.4 0.95 ± 0.2 0.93 ± 0.2 0.91 ± 0.2 0.82 ± 0.5
Glx / Cr 4.51 ± 5.8 1.35 ± 1.0 0.89 ± 0.8 2.64 ± 4.7 2.51 ± 3.0 Glx / Cr 1.64 ± 1.1 1.40 ± 2.6 1.97 ± 3.0 1.88 ± 3.1 1.49 ± 2.3
NAA 1.11 ± 0.2 0.98 ± 0.1 0.98 ± 0.1 0.98 ± 0.1 0.99 ± 0.1 NAA 1.05 ± 0.2 1.03 ± 0.1 1.02 ± 0.1 1.10 ± 0.1 1.17 ± 0.2
Cr 1.15 ± 0.2 1.01 ± 0.1 1.00 ± 0.1 1.03 ± 0.1 1.04 ± 0.1 Cr 1.14 ± 0.2 0.96 ± 0.1 0.95 ± 0.1 0.98 ± 0.2 1.02 ± 0.2
Cho 0.98 ± 0.1 0.92 ± 0.1 0.92 ± 0.1 0.91 ± 0.1 0.96 ± 0.2 Cho 0.98 ± 0.2 1.07 ± 0.2 1.06 ± 0.2 1.16 ± 0.2 1.19 ± 0.2
mI 1.01 ± 0.3 0.90 ± 0.1 0.88 ± 0.2 0.92 ± 0.1 0.85 ± 0.2 mI 0.97 ± 0.2 1.03 ± 0.2 1.01 ± 0.2 0.90 ± 0.4 1.09 ± 0.7
Glx 2.26 ± 1.2 1.54 ± 2.0 1.62 ± 2.0 1.20 ± 0.7 1.62 ± 1.7 Glx 1.33 ± 1.5 0.39 ± 0.2 0.27 ± 0.1 0.04 ± 0.0 1.65 ± 0.0
NAA / Cr 0.97 ± 0.1 0.97 ± 0.0 0.98 ± 0.1 0.96 ± 0.1 0.96 ± 0.1 NAA / Cr 0.94 ± 0.1 1.08 ± 0.1 1.09 ± 0.1 1.13 ± 0.1 1.15 ± 0.1
Cho / Cr 0.87 ± 0.1 0.92 ± 0.1 0.92 ± 0.1 0.90 ± 0.2 0.93 ± 0.2 Cho / Cr 0.87 ± 0.1 1.13 ± 0.2 1.14 ± 0.3 1.22 ± 0.3 1.22 ± 0.4
mI / Cr 0.88 ± 0.2 0.89 ± 0.1 0.88 ± 0.1 0.90 ± 0.1 0.83 ± 0.2 mI / Cr 0.87 ± 0.2 1.09 ± 0.2 1.08 ± 0.3 0.95 ± 0.4 1.09 ± 0.6


































































































































NAA 0.99 ± 0.2 1.04 ± 0.1 1.05 ± 0.1 1.16 ± 0.2 1.20 ± 0.3 NAA 0.91 ± 0.2 0.97 ± 0.1 0.98 ± 0.1 0.98 ± 0.1 0.99 ± 0.1
Cr 1.09 ± 0.3 1.01 ± 0.1 1.02 ± 0.1 1.13 ± 0.2 1.15 ± 0.4 Cr 0.97 ± 0.2 0.96 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 0.94 ± 0.1
Cho 1.00 ± 0.3 0.96 ± 0.1 0.95 ± 0.1 0.91 ± 0.2 0.88 ± 0.4 Cho 0.95 ± 0.2 1.05 ± 0.1 1.08 ± 0.1 1.10 ± 0.1 1.11 ± 0.1
mI 1.38 ± 1.0 1.02 ± 0.4 0.97 ± 0.5 1.11 ± 0.7 1.25 ± 1.1 mI 0.95 ± 0.4 0.97 ± 0.3 0.97 ± 0.4 0.96 ± 0.4 1.03 ± 0.6
Glx 1.22 ± 1.7 2.27 ± 1.8 2.44 ± 1.8 2.08 ± 2.7 2.65 ± 2.9 Glx 1.17 ± 1.2 0.97 ± 0.8 0.86 ± 1.0 0.96 ± 1.1 0.41 ± 0.5
NAA / Cr 0.92 ± 0.1 1.03 ± 0.1 1.03 ± 0.1 1.05 ± 0.2 1.09 ± 0.3 NAA / Cr 0.94 ± 0.1 1.01 ± 0.1 1.04 ± 0.1 1.04 ± 0.1 1.06 ± 0.1
Cho / Cr 0.92 ± 0.2 0.95 ± 0.2 0.94 ± 0.2 0.82 ± 0.2 0.82 ± 0.5 Cho / Cr 1.00 ± 0.2 1.10 ± 0.1 1.15 ± 0.1 1.16 ± 0.1 1.19 ± 0.2
mI / Cr 1.24 ± 0.7 1.00 ± 0.4 0.95 ± 0.5 1.04 ± 0.6 1.23 ± 1.2 mI / Cr 1.00 ± 0.5 1.01 ± 0.3 1.02 ± 0.4 1.02 ± 0.4 1.10 ± 0.6
Glx / Cr 1.02 ± 1.3 2.41 ± 2.0 2.55 ± 2.1 1.83 ± 2.1 2.40 ± 2.5 Glx / Cr 1.10 ± 1.1 1.01 ± 0.8 0.96 ± 1.2 1.03 ± 1.1 0.42 ± 0.5
NAA 0.94 ± 0.2 1.04 ± 0.1 1.04 ± 0.1 1.05 ± 0.1 1.08 ± 0.2 NAA 0.92 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 0.96 ± 0.1 1.00 ± 0.1
Cr 1.03 ± 0.2 1.07 ± 0.1 1.11 ± 0.1 1.16 ± 0.2 1.15 ± 0.2 Cr 1.05 ± 0.2 1.02 ± 0.1 1.01 ± 0.1 0.94 ± 0.2 1.02 ± 0.2
Cho 0.92 ± 0.3 1.04 ± 0.2 1.03 ± 0.1 1.11 ± 0.2 1.03 ± 0.3 Cho 0.91 ± 0.2 1.02 ± 0.1 1.04 ± 0.1 0.97 ± 0.2 1.06 ± 0.2
mI 1.04 ± 0.4 1.13 ± 0.7 1.12 ± 0.4 1.15 ± 0.4 1.02 ± 0.3 mI 0.98 ± 0.3 0.87 ± 0.2 0.85 ± 0.2 0.81 ± 0.2 0.89 ± 0.5
Glx 1.27 ± 1.0 0.57 ± 0.3 1.47 ± 1.4 0.47 ± 0.1 2.02 ± 2.1 Glx 1.78 ± 1.6 0.44 ± 0.5 0.76 ± 0.5 2.84 ± 3.7 0.90 ± 0.0
NAA / Cr 0.90 ± 0.1 0.98 ± 0.1 0.94 ± 0.1 0.91 ± 0.1 0.94 ± 0.1 NAA / Cr 0.88 ± 0.1 0.99 ± 0.1 1.01 ± 0.1 1.05 ± 0.2 1.01 ± 0.1
Cho / Cr 0.90 ± 0.3 0.99 ± 0.2 0.94 ± 0.1 0.96 ± 0.1 0.89 ± 0.2 Cho / Cr 0.88 ± 0.1 1.02 ± 0.1 1.05 ± 0.2 1.07 ± 0.2 1.07 ± 0.2
mI / Cr 1.01 ± 0.3 1.09 ± 0.8 1.02 ± 0.3 1.01 ± 0.3 0.89 ± 0.2 mI / Cr 0.93 ± 0.2 0.88 ± 0.2 0.85 ± 0.2 0.96 ± 0.6 0.86 ± 0.3
Glx / Cr 1.30 ± 1.0 0.55 ± 0.3 1.25 ± 1.1 0.43 ± 0.1 2.00 ± 2.1 Glx / Cr 1.71 ± 1.7 0.44 ± 0.4 0.73 ± 0.4 2.80 ± 3.6 1.00 ± 0.0
NAA 1.09 ± 0.2 0.94 ± 0.1 0.92 ± 0.1 0.83 ± 0.1 0.91 ± 0.1 NAA 0.98 ± 0.1 1.09 ± 0.1 1.14 ± 0.1 1.31 ± 0.2 1.37 ± 0.4
Cr 1.14 ± 0.2 0.94 ± 0.1 0.92 ± 0.1 0.85 ± 0.1 0.96 ± 0.2 Cr 1.04 ± 0.1 1.03 ± 0.1 1.04 ± 0.1 1.12 ± 0.2 1.12 ± 0.3
Cho 1.11 ± 0.1 0.97 ± 0.1 0.96 ± 0.1 0.91 ± 0.2 1.01 ± 0.2 Cho 0.97 ± 0.1 1.13 ± 0.1 1.19 ± 0.1 1.39 ± 0.2 1.42 ± 0.3
mI 1.25 ± 0.3 0.98 ± 0.3 0.92 ± 0.2 0.82 ± 0.3 0.90 ± 0.5 mI 1.12 ± 0.4 1.05 ± 0.2 1.11 ± 0.3 1.11 ± 0.4 1.06 ± 0.5
Glx 3.71 ± 5.6 3.36 ± 4.3 4.03 ± 5.1 3.81 ± 4.6 2.49 ± 3.1 Glx 1.15 ± 1.0 0.53 ± 0.6 0.29 ± 0.0 2.89 ± 2.9 0.37 ± 0.4
NAA / Cr 0.95 ± 0.1 1.01 ± 0.1 1.00 ± 0.1 1.01 ± 0.2 0.96 ± 0.1 NAA / Cr 0.95 ± 0.1 1.07 ± 0.1 1.10 ± 0.1 1.17 ± 0.1 1.23 ± 0.1
Cho / Cr 0.98 ± 0.1 1.04 ± 0.2 1.05 ± 0.2 1.09 ± 0.2 1.11 ± 0.2 Cho / Cr 0.94 ± 0.1 1.10 ± 0.1 1.14 ± 0.1 1.25 ± 0.1 1.29 ± 0.2
mI / Cr 1.10 ± 0.3 1.05 ± 0.3 1.00 ± 0.3 1.00 ± 0.4 0.97 ± 0.5 mI / Cr 1.08 ± 0.3 1.02 ± 0.2 1.06 ± 0.3 1.02 ± 0.4 0.97 ± 0.5
Glx / Cr 4.27 ± 6.9 3.51 ± 4.3 4.41 ± 5.2 4.86 ± 5.2 2.60 ± 3.3 Glx / Cr 1.22 ± 1.0 0.54 ± 0.7 0.25 ± 0.0 2.48 ± 2.4 0.35 ± 0.4
NAA 0.92 ± 0.1 1.02 ± 0.1 1.01 ± 0.0 1.03 ± 0.1 1.03 ± 0.1 NAA 0.86 ± 0.1 1.00 ± 0.0 1.00 ± 0.0 0.99 ± 0.1 0.96 ± 0.1
Cr 0.99 ± 0.1 1.03 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.01 ± 0.1 Cr 1.00 ± 0.1 0.98 ± 0.0 0.97 ± 0.0 0.95 ± 0.1 0.90 ± 0.1
Cho 0.91 ± 0.1 0.93 ± 0.1 0.90 ± 0.1 0.83 ± 0.2 0.81 ± 0.2 Cho 0.85 ± 0.1 1.02 ± 0.0 1.03 ± 0.0 1.07 ± 0.1 1.01 ± 0.1
mI 0.91 ± 0.2 0.99 ± 0.2 0.93 ± 0.2 0.91 ± 0.1 0.92 ± 0.2 mI 0.85 ± 0.2 0.94 ± 0.1 0.92 ± 0.1 0.90 ± 0.2 0.89 ± 0.2
Glx 6.01 ± 5.2 1.62 ± 2.2 1.99 ± 3.0 0.98 ± 0.2 23.00 ± 57.4 Glx N/A 0.69 ± 0.2 0.59 ± 0.1 0.08 ± 0.0 N/A
NAA / Cr 0.93 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 1.01 ± 0.1 1.03 ± 0.1 NAA / Cr 0.86 ± 0.1 1.03 ± 0.0 1.03 ± 0.0 1.05 ± 0.0 1.07 ± 0.1
Cho / Cr 0.93 ± 0.1 0.91 ± 0.1 0.88 ± 0.1 0.81 ± 0.1 0.80 ± 0.1 Cho / Cr 0.86 ± 0.1 1.04 ± 0.0 1.06 ± 0.0 1.13 ± 0.1 1.13 ± 0.1
mI / Cr 0.92 ± 0.2 0.96 ± 0.2 0.91 ± 0.2 0.88 ± 0.1 0.91 ± 0.2 mI / Cr 0.85 ± 0.2 0.96 ± 0.1 0.95 ± 0.1 0.96 ± 0.2 0.98 ± 0.2
Glx / Cr 5.95 ± 5.1 1.60 ± 2.1 1.94 ± 2.9 0.95 ± 0.2 22.89 ± 57.0 Glx / Cr N/A 0.72 ± 0.2 0.63 ± 0.1 0.08 ± 0.0 N/A
NAA 1.01 ± 0.2 1.01 ± 0.1 1.03 ± 0.1 0.98 ± 0.3 1.06 ± 0.1 NAA 0.94 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 1.02 ± 0.1 0.98 ± 0.1
Cr 1.07 ± 0.2 1.04 ± 0.1 1.04 ± 0.1 1.09 ± 0.1 1.06 ± 0.2 Cr 1.03 ± 0.2 0.98 ± 0.1 0.98 ± 0.1 1.02 ± 0.1 0.98 ± 0.1
Cho 0.99 ± 0.2 0.92 ± 0.1 0.92 ± 0.1 0.78 ± 0.2 0.84 ± 0.1 Cho 0.89 ± 0.2 1.05 ± 0.1 1.06 ± 0.1 1.11 ± 0.1 1.15 ± 0.1
mI 1.03 ± 0.3 1.04 ± 0.3 1.00 ± 0.3 1.00 ± 0.3 0.98 ± 0.4 mI 0.93 ± 0.2 1.00 ± 0.1 0.99 ± 0.2 0.96 ± 0.2 0.89 ± 0.3
Glx 1.51 ± 1.5 3.44 ± 7.7 0.59 ± 0.8 6.78 ± 12.9 0.76 ± 0.9 Glx 0.70 ± 0.4 1.35 ± 0.7 1.23 ± 0.7 1.51 ± 1.0 0.80 ± 0.7
NAA / Cr 0.94 ± 0.1 0.97 ± 0.1 1.00 ± 0.1 0.96 ± 0.1 1.01 ± 0.1 NAA / Cr 0.92 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.01 ± 0.1 1.00 ± 0.1
Cho / Cr 0.92 ± 0.1 0.89 ± 0.1 0.90 ± 0.2 0.77 ± 0.2 0.80 ± 0.1 Cho / Cr 0.87 ± 0.1 1.07 ± 0.1 1.09 ± 0.1 1.10 ± 0.1 1.19 ± 0.2
mI / Cr 0.96 ± 0.3 1.00 ± 0.2 0.97 ± 0.2 0.93 ± 0.3 0.93 ± 0.4 mI / Cr 0.90 ± 0.1 1.02 ± 0.1 1.02 ± 0.2 0.94 ± 0.2 0.91 ± 0.3




































































































































NAA 0.97 ± 0.2 1.07 ± 0.1 1.11 ± 0.2 1.10 ± 0.2 1.13 ± 0.4 NAA 0.89 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.02 ± 0.1 1.00 ± 0.1
Cr 1.02 ± 0.3 1.10 ± 0.2 1.14 ± 0.3 1.36 ± 0.7 1.51 ± 0.9 Cr 0.98 ± 0.3 0.99 ± 0.1 1.00 ± 0.1 0.98 ± 0.1 0.95 ± 0.2
Cho 1.19 ± 0.5 1.03 ± 0.2 1.07 ± 0.4 0.93 ± 0.2 1.01 ± 0.3 Cho 0.95 ± 0.2 1.03 ± 0.1 1.04 ± 0.1 1.07 ± 0.1 1.06 ± 0.2
mI 1.34 ± 0.7 1.07 ± 0.5 1.12 ± 0.4 1.04 ± 0.5 1.92 ± 3.0 mI 0.88 ± 0.2 1.01 ± 0.2 1.01 ± 0.3 1.04 ± 0.4 1.07 ± 0.5
Glx 1.27 ± 1.6 1.28 ± 0.6 1.64 ± 1.2 2.98 ± 3.7 1.89 ± 1.2 Glx 6.63 ± 0.0 0.92 ± 0.3 0.98 ± 0.7 0.47 ± 0.5 0.77 ± 0.6
NAA / Cr 0.96 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 0.93 ± 0.3 0.88 ± 0.3 NAA / Cr 0.92 ± 0.1 1.03 ± 0.1 1.02 ± 0.1 1.04 ± 0.1 1.08 ± 0.1
Cho / Cr 1.20 ± 0.8 1.00 ± 0.3 1.03 ± 0.4 0.86 ± 0.2 0.90 ± 0.2 Cho / Cr 0.98 ± 0.1 1.05 ± 0.2 1.05 ± 0.1 1.09 ± 0.2 1.14 ± 0.2
mI / Cr 1.29 ± 0.5 1.00 ± 0.2 1.01 ± 0.2 0.90 ± 0.4 1.05 ± 0.7 mI / Cr 0.91 ± 0.2 1.02 ± 0.2 1.01 ± 0.3 1.05 ± 0.3 1.10 ± 0.4
Glx / Cr 1.10 ± 1.3 1.33 ± 0.7 1.74 ± 1.4 3.87 ± 6.0 1.54 ± 0.8 Glx / Cr 7.77 ± 0.0 0.95 ± 0.3 1.02 ± 0.9 0.50 ± 0.5 0.87 ± 0.8
NAA 1.05 ± 0.3 1.04 ± 0.1 1.02 ± 0.3 1.10 ± 0.2 1.11 ± 0.2 NAA 1.02 ± 0.2 1.03 ± 0.1 0.98 ± 0.1 1.00 ± 0.1 1.01 ± 0.1
Cr 1.08 ± 0.3 1.07 ± 0.1 1.08 ± 0.3 1.11 ± 0.2 1.19 ± 0.3 Cr 1.09 ± 0.2 1.02 ± 0.2 0.95 ± 0.3 0.97 ± 0.2 0.95 ± 0.1
Cho 1.03 ± 0.3 1.03 ± 0.2 1.00 ± 0.3 1.08 ± 0.3 1.04 ± 0.3 Cho 1.04 ± 0.2 1.13 ± 0.1 1.04 ± 0.2 1.14 ± 0.2 1.13 ± 0.1
mI 1.06 ± 0.4 1.10 ± 0.7 1.11 ± 0.8 0.95 ± 0.4 0.94 ± 0.3 mI 0.96 ± 0.3 1.05 ± 0.4 0.96 ± 0.3 1.04 ± 0.4 0.92 ± 0.3
Glx 1.82 ± 1.2 0.88 ± 0.5 1.05 ± 0.9 2.37 ± 2.1 1.34 ± 1.0 Glx 0.71 ± 0.3 0.28 ± 0.2 0.14 ± 0.1 0.36 ± 0.3 0.60 ± 0.7
NAA / Cr 0.98 ± 0.1 0.98 ± 0.1 0.95 ± 0.1 1.00 ± 0.2 0.96 ± 0.1 NAA / Cr 0.92 ± 0.1 1.04 ± 0.1 1.20 ± 0.8 1.06 ± 0.2 1.07 ± 0.1
Cho / Cr 0.97 ± 0.2 0.96 ± 0.2 0.88 ± 0.2 0.99 ± 0.2 0.93 ± 0.2 Cho / Cr 0.95 ± 0.1 1.14 ± 0.2 1.31 ± 0.9 1.21 ± 0.2 1.21 ± 0.2
mI / Cr 1.01 ± 0.4 1.03 ± 0.6 1.00 ± 0.7 0.88 ± 0.4 0.79 ± 0.3 mI / Cr 0.87 ± 0.2 1.06 ± 0.2 1.18 ± 0.8 1.07 ± 0.3 0.98 ± 0.3
Glx / Cr 1.75 ± 1.1 0.80 ± 0.4 0.80 ± 0.5 2.19 ± 1.8 1.14 ± 0.9 Glx / Cr 0.58 ± 0.2 0.32 ± 0.2 0.14 ± 0.1 0.36 ± 0.3 0.57 ± 0.6
NAA 1.10 ± 0.2 0.97 ± 0.1 0.94 ± 0.1 0.86 ± 0.1 0.90 ± 0.1 NAA 1.02 ± 0.1 1.08 ± 0.1 1.12 ± 0.1 1.19 ± 0.1 1.17 ± 0.2
Cr 1.17 ± 0.2 0.95 ± 0.1 0.92 ± 0.1 0.86 ± 0.1 0.90 ± 0.1 Cr 1.10 ± 0.2 1.02 ± 0.1 1.04 ± 0.1 1.07 ± 0.1 1.06 ± 0.2
Cho 1.20 ± 0.2 0.96 ± 0.1 0.94 ± 0.2 0.87 ± 0.2 1.01 ± 0.2 Cho 1.10 ± 0.2 1.14 ± 0.1 1.15 ± 0.2 1.22 ± 0.2 1.28 ± 0.3
mI 1.55 ± 0.5 0.92 ± 0.3 0.84 ± 0.4 0.72 ± 0.3 0.74 ± 0.4 mI 1.12 ± 0.2 0.97 ± 0.2 1.04 ± 0.3 1.19 ± 0.4 1.02 ± 0.3
Glx 3.23 ± 4.5 66.35 ± 125.8 3.51 ± 2.3 15.67 ± 28.7 1.71 ± 2.1 Glx 9.93 ± 22.6 1.41 ± 2.2 7.29 ± 9.4 9.19 ± 12.2 0.33 ± 0.3
NAA / Cr 0.93 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 NAA / Cr 0.93 ± 0.1 1.06 ± 0.1 1.08 ± 0.1 1.12 ± 0.1 1.12 ± 0.1
Cho / Cr 1.03 ± 0.2 1.02 ± 0.1 1.03 ± 0.2 1.00 ± 0.2 1.13 ± 0.3 Cho / Cr 1.01 ± 0.1 1.12 ± 0.1 1.11 ± 0.2 1.14 ± 0.2 1.20 ± 0.2
mI / Cr 1.37 ± 0.7 0.96 ± 0.4 0.90 ± 0.4 0.86 ± 0.4 0.81 ± 0.4 mI / Cr 1.03 ± 0.2 0.95 ± 0.2 1.00 ± 0.2 1.12 ± 0.4 0.97 ± 0.3
Glx / Cr 3.95 ± 5.9 63.89 ± 120.2 3.61 ± 2.2 18.95 ± 34.8 1.79 ± 2.1 Glx / Cr 13.16 ± 30.4 1.34 ± 2.0 6.80 ± 8.6 8.13 ± 10.4 0.31 ± 0.3
NAA 1.06 ± 0.2 1.01 ± 0.0 1.01 ± 0.0 1.04 ± 0.0 1.11 ± 0.1 NAA 1.08 ± 0.3 0.98 ± 0.0 0.98 ± 0.0 0.91 ± 0.1 0.89 ± 0.1
Cr 1.17 ± 0.2 1.03 ± 0.1 1.04 ± 0.1 1.07 ± 0.1 1.09 ± 0.1 Cr 1.24 ± 0.2 0.97 ± 0.0 0.95 ± 0.1 0.84 ± 0.1 0.81 ± 0.1
Cho 1.03 ± 0.2 0.94 ± 0.1 0.91 ± 0.1 0.86 ± 0.1 0.86 ± 0.2 Cho 0.97 ± 0.2 1.01 ± 0.0 1.02 ± 0.0 1.06 ± 0.1 1.01 ± 0.1
mI 1.04 ± 0.2 0.98 ± 0.2 0.96 ± 0.2 0.87 ± 0.2 0.88 ± 0.3 mI 1.00 ± 0.2 1.02 ± 0.1 1.02 ± 0.1 0.96 ± 0.2 0.94 ± 0.2
Glx 0.99 ± 1.3 1.57 ± 1.6 1.04 ± 0.6 0.49 ± 0.2 6.32 ± 12.3 Glx 3.56 ± 0.0 1.05 ± 0.6 1.25 ± 0.5 N/A N/A
NAA / Cr 0.90 ± 0.1 0.99 ± 0.1 0.97 ± 0.1 0.97 ± 0.1 1.03 ± 0.1 NAA / Cr 0.87 ± 0.1 1.02 ± 0.0 1.03 ± 0.1 1.09 ± 0.1 1.11 ± 0.1
Cho / Cr 0.87 ± 0.1 0.91 ± 0.1 0.87 ± 0.1 0.80 ± 0.1 0.79 ± 0.2 Cho / Cr 0.78 ± 0.1 1.05 ± 0.1 1.07 ± 0.1 1.27 ± 0.2 1.26 ± 0.2
mI / Cr 0.89 ± 0.1 0.95 ± 0.2 0.92 ± 0.2 0.81 ± 0.2 0.81 ± 0.3 mI / Cr 0.81 ± 0.1 1.06 ± 0.1 1.07 ± 0.1 1.15 ± 0.2 1.16 ± 0.2
Glx / Cr 0.92 ± 1.2 1.61 ± 1.7 1.01 ± 0.6 0.47 ± 0.2 6.10 ± 11.9 Glx / Cr 2.92 ± 0.0 1.15 ± 0.7 1.39 ± 0.6 N/A N/A
NAA 1.02 ± 0.2 1.01 ± 0.1 1.02 ± 0.1 1.07 ± 0.1 1.08 ± 0.1 NAA 0.98 ± 0.2 1.01 ± 0.1 0.99 ± 0.1 1.01 ± 0.1 0.99 ± 0.1
Cr 1.04 ± 0.2 1.02 ± 0.1 1.03 ± 0.1 1.10 ± 0.2 1.11 ± 0.2 Cr 1.03 ± 0.2 1.00 ± 0.1 0.99 ± 0.2 1.01 ± 0.1 1.01 ± 0.2
Cho 1.01 ± 0.2 1.01 ± 0.1 0.97 ± 0.1 0.98 ± 0.2 0.90 ± 0.2 Cho 0.97 ± 0.2 1.05 ± 0.1 1.04 ± 0.2 1.09 ± 0.2 1.11 ± 0.2
mI 1.07 ± 0.5 1.00 ± 0.2 0.95 ± 0.2 0.93 ± 0.4 0.86 ± 0.3 mI 0.94 ± 0.4 1.06 ± 0.3 1.10 ± 0.5 1.15 ± 0.7 1.18 ± 0.7
Glx 0.85 ± 0.9 0.93 ± 0.5 1.40 ± 0.9 1.09 ± 0.7 1.01 ± 0.8 Glx 0.26 ± 0.0 0.87 ± 0.5 1.05 ± 0.2 0.44 ± 0.2 0.52 ± 0.3
NAA / Cr 0.98 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 0.98 ± 0.1 0.99 ± 0.1 NAA / Cr 0.94 ± 0.1 1.01 ± 0.1 1.02 ± 0.1 1.01 ± 0.1 0.99 ± 0.1
Cho / Cr 0.97 ± 0.1 1.01 ± 0.2 0.96 ± 0.2 0.90 ± 0.1 0.82 ± 0.1 Cho / Cr 0.94 ± 0.2 1.04 ± 0.1 1.06 ± 0.1 1.08 ± 0.1 1.10 ± 0.2
mI / Cr 1.04 ± 0.5 0.98 ± 0.2 0.92 ± 0.2 0.84 ± 0.3 0.77 ± 0.3 mI / Cr 0.89 ± 0.3 1.06 ± 0.3 1.12 ± 0.4 1.11 ± 0.4 1.13 ± 0.5




































































































































NAA 1.04 ± 0.1 0.99 ± 0.1 0.95 ± 0.2 0.95 ± 0.2 0.92 ± 0.2 NAA 0.94 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.08 ± 0.1 1.13 ± 0.1
Cr 1.12 ± 0.1 0.97 ± 0.1 0.95 ± 0.2 0.89 ± 0.2 0.99 ± 0.3 Cr 0.98 ± 0.1 1.05 ± 0.1 1.05 ± 0.1 1.10 ± 0.2 1.14 ± 0.3
Cho 1.11 ± 0.1 0.96 ± 0.1 0.92 ± 0.2 0.93 ± 0.2 0.92 ± 0.3 Cho 0.98 ± 0.1 1.03 ± 0.1 1.04 ± 0.1 1.12 ± 0.2 1.13 ± 0.3
mI 1.35 ± 0.9 0.97 ± 0.4 0.96 ± 0.5 1.06 ± 0.7 2.03 ± 2.0 mI 1.07 ± 0.4 1.11 ± 0.2 1.15 ± 0.3 1.09 ± 0.5 1.34 ± 0.5
Glx 2.02 ± 2.6 1.83 ± 1.6 1.90 ± 1.6 2.00 ± 1.7 15.07 ± 19.9 Glx 1.29 ± 1.1 1.14 ± 0.8 2.06 ± 3.3 0.31 ± 0.2 0.87 ± 1.0
NAA / Cr 0.94 ± 0.1 1.04 ± 0.1 1.01 ± 0.1 1.09 ± 0.2 0.99 ± 0.2 NAA / Cr 0.97 ± 0.1 0.97 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 1.04 ± 0.2
Cho / Cr 1.00 ± 0.1 1.00 ± 0.1 0.98 ± 0.1 1.06 ± 0.2 1.00 ± 0.4 Cho / Cr 1.01 ± 0.1 0.98 ± 0.1 1.00 ± 0.1 1.04 ± 0.2 1.01 ± 0.2
mI / Cr 1.20 ± 0.7 1.01 ± 0.4 1.00 ± 0.6 1.16 ± 0.7 1.83 ± 1.2 mI / Cr 1.09 ± 0.4 1.05 ± 0.2 1.13 ± 0.4 1.02 ± 0.5 1.20 ± 0.4
Glx / Cr 1.91 ± 2.4 1.91 ± 1.6 1.92 ± 1.6 1.98 ± 1.4 10.83 ± 12.9 Glx / Cr 1.48 ± 1.5 1.10 ± 0.7 2.18 ± 3.7 0.32 ± 0.2 0.98 ± 1.2
NAA 0.91 ± 0.1 0.93 ± 0.1 0.90 ± 0.1 0.80 ± 0.3 0.79 ± 0.2 NAA 0.87 ± 0.1 1.06 ± 0.0 1.07 ± 0.0 1.17 ± 0.1 1.25 ± 0.1
Cr 0.98 ± 0.2 0.96 ± 0.1 0.91 ± 0.2 0.80 ± 0.2 0.69 ± 0.2 Cr 0.97 ± 0.1 1.06 ± 0.1 1.07 ± 0.1 1.18 ± 0.1 1.28 ± 0.1
Cho 0.89 ± 0.2 0.78 ± 0.1 0.77 ± 0.2 0.73 ± 0.2 0.66 ± 0.2 Cho 0.80 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.11 ± 0.1 1.14 ± 0.1
mI 0.91 ± 0.2 0.76 ± 0.2 0.77 ± 0.2 0.56 ± 0.3 0.47 ± 0.3 mI 0.84 ± 0.2 1.10 ± 0.3 1.10 ± 0.3 1.10 ± 0.3 1.10 ± 0.3
Glx 1.51 ± 2.0 0.98 ± 0.8 1.00 ± 0.7 2.14 ± 2.0 2.43 ± 3.1 Glx 1.65 ± 1.1 1.98 ± 1.8 3.40 ± 2.7 1.87 ± 2.4 2.33 ± 2.8
NAA / Cr 0.94 ± 0.1 0.98 ± 0.1 1.00 ± 0.1 1.07 ± 0.1 1.17 ± 0.2 NAA / Cr 0.90 ± 0.1 1.01 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 0.98 ± 0.1
Cho / Cr 0.92 ± 0.1 0.82 ± 0.2 0.86 ± 0.2 0.92 ± 0.3 0.95 ± 0.2 Cho / Cr 0.84 ± 0.1 0.97 ± 0.1 0.97 ± 0.1 0.94 ± 0.1 0.89 ± 0.1
mI / Cr 0.94 ± 0.2 0.80 ± 0.2 0.85 ± 0.2 0.70 ± 0.4 0.68 ± 0.4 mI / Cr 0.87 ± 0.2 1.05 ± 0.3 1.04 ± 0.3 0.94 ± 0.3 0.87 ± 0.2
Glx / Cr 1.47 ± 2.0 1.00 ± 0.9 1.08 ± 0.7 2.61 ± 2.2 3.74 ± 4.9 Glx / Cr 1.83 ± 1.1 1.92 ± 1.8 3.37 ± 2.8 1.72 ± 2.4 1.96 ± 2.5
NAA 0.99 ± 0.2 1.01 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 0.98 ± 0.1 NAA 0.92 ± 0.2 1.07 ± 0.1 1.04 ± 0.2 1.03 ± 0.2 1.13 ± 0.3
Cr 1.05 ± 0.2 1.10 ± 0.2 1.08 ± 0.2 1.09 ± 0.2 1.01 ± 0.1 Cr 1.07 ± 0.3 1.04 ± 0.1 1.01 ± 0.2 0.98 ± 0.2 1.13 ± 0.4
Cho 0.98 ± 0.2 1.05 ± 0.1 1.05 ± 0.1 1.09 ± 0.1 1.05 ± 0.2 Cho 0.89 ± 0.2 0.98 ± 0.1 1.00 ± 0.1 1.01 ± 0.2 1.05 ± 0.3
mI 1.15 ± 0.3 1.01 ± 0.2 0.96 ± 0.2 0.93 ± 0.3 0.88 ± 0.3 mI 0.99 ± 0.3 0.94 ± 0.2 0.89 ± 0.2 0.88 ± 0.3 0.88 ± 0.3
Glx 4.87 ± 5.6 2.37 ± 2.3 2.83 ± 4.0 45.54 ± 76.2 21.55 ± 49.2 Glx 1.70 ± 1.4 1.90 ± 2.4 0.40 ± 0.3 0.08 ± 0.0 N/A
NAA / Cr 0.94 ± 0.1 0.95 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 0.97 ± 0.1 NAA / Cr 0.86 ± 0.1 1.03 ± 0.1 1.04 ± 0.1 1.06 ± 0.1 1.03 ± 0.2
Cho / Cr 0.95 ± 0.2 0.99 ± 0.2 1.00 ± 0.2 1.05 ± 0.1 1.04 ± 0.2 Cho / Cr 0.84 ± 0.1 0.96 ± 0.2 1.00 ± 0.1 1.05 ± 0.2 0.99 ± 0.3
mI / Cr 1.12 ± 0.3 0.95 ± 0.2 0.91 ± 0.2 0.87 ± 0.3 0.88 ± 0.3 mI / Cr 0.93 ± 0.1 0.90 ± 0.1 0.91 ± 0.4 0.92 ± 0.3 0.85 ± 0.3
Glx / Cr 5.93 ± 8.7 1.89 ± 1.7 2.71 ± 3.9 39.72 ± 66.6 19.19 ± 43.9 Glx / Cr 1.48 ± 1.2 1.50 ± 1.8 0.40 ± 0.3 0.13 ± 0.1 N/A
NAA 1.02 ± 0.2 1.00 ± 0.0 0.99 ± 0.1 1.01 ± 0.1 1.05 ± 0.1 NAA 0.90 ± 0.1 1.00 ± 0.0 1.01 ± 0.0 1.00 ± 0.0 0.97 ± 0.1
Cr 1.14 ± 0.2 1.00 ± 0.1 1.00 ± 0.1 1.02 ± 0.1 1.08 ± 0.1 Cr 1.08 ± 0.2 0.96 ± 0.1 0.96 ± 0.1 0.92 ± 0.1 0.89 ± 0.1
Cho 1.11 ± 0.3 0.96 ± 0.1 0.95 ± 0.1 0.93 ± 0.1 0.90 ± 0.1 Cho 0.91 ± 0.1 1.05 ± 0.1 1.05 ± 0.1 1.09 ± 0.1 1.07 ± 0.1
mI 1.08 ± 0.3 0.98 ± 0.1 0.96 ± 0.2 0.97 ± 0.1 1.01 ± 0.2 mI 0.96 ± 0.2 0.93 ± 0.1 0.92 ± 0.1 0.94 ± 0.2 0.86 ± 0.1
Glx 28.44 ± 35.1 2.31 ± 2.8 12.45 ± 26.2 3.08 ± 5.0 12.48 ± 26.6 Glx N/A 0.62 ± 0.4 0.30 ± 0.0 3.52 ± 4.6 0.79 ± 0.6
NAA / Cr 0.90 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 0.98 ± 0.1 NAA / Cr 0.84 ± 0.1 1.04 ± 0.1 1.05 ± 0.1 1.09 ± 0.1 1.09 ± 0.1
Cho / Cr 0.97 ± 0.2 0.97 ± 0.1 0.96 ± 0.1 0.91 ± 0.1 0.84 ± 0.1 Cho / Cr 0.86 ± 0.1 1.10 ± 0.1 1.10 ± 0.2 1.19 ± 0.1 1.21 ± 0.1
mI / Cr 0.94 ± 0.2 0.98 ± 0.1 0.96 ± 0.1 0.95 ± 0.1 0.93 ± 0.1 mI / Cr 0.89 ± 0.1 0.97 ± 0.1 0.96 ± 0.1 1.02 ± 0.2 0.97 ± 0.1
Glx / Cr 24.31 ± 30.8 2.50 ± 3.1 11.63 ± 23.9 3.29 ± 5.5 9.52 ± 20.0 Glx / Cr N/A 0.62 ± 0.3 0.34 ± 0.0 3.66 ± 4.8 0.88 ± 0.7
NAA 1.05 ± 0.7 0.96 ± 0.1 0.96 ± 0.1 0.84 ± 0.1 0.83 ± 0.1 NAA 0.86 ± 0.2 0.99 ± 0.0 0.98 ± 0.0 0.97 ± 0.1 0.92 ± 0.1
Cr 1.10 ± 0.5 1.03 ± 0.1 1.04 ± 0.1 1.04 ± 0.1 1.01 ± 0.2 Cr 0.98 ± 0.3 1.02 ± 0.1 1.01 ± 0.1 1.04 ± 0.1 0.98 ± 0.1
Cho 1.18 ± 1.2 1.08 ± 0.1 1.09 ± 0.1 1.03 ± 0.1 1.05 ± 0.2 Cho 0.81 ± 0.2 1.00 ± 0.1 0.98 ± 0.1 1.00 ± 0.1 0.94 ± 0.1
mI 1.21 ± 0.4 1.07 ± 0.3 1.12 ± 0.3 0.97 ± 0.5 1.04 ± 0.5 mI 1.64 ± 2.7 0.92 ± 0.1 0.93 ± 0.2 0.94 ± 0.2 1.13 ± 0.8
Glx 0.87 ± 0.7 0.97 ± 0.7 0.88 ± 0.8 1.10 ± 0.5 1.06 ± 0.7 Glx 1.19 ± 1.1 0.75 ± 0.4 3.06 ± 5.2 4.23 ± 5.9 2.48 ± 4.5
NAA / Cr 0.92 ± 0.1 0.94 ± 0.1 0.93 ± 0.1 0.81 ± 0.1 0.83 ± 0.1 NAA / Cr 0.87 ± 0.1 0.98 ± 0.0 0.98 ± 0.0 0.94 ± 0.1 0.94 ± 0.1
Cho / Cr 0.99 ± 0.3 1.05 ± 0.1 1.06 ± 0.1 1.00 ± 0.2 1.06 ± 0.2 Cho / Cr 0.84 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 0.97 ± 0.1 0.97 ± 0.1
mI / Cr 1.17 ± 0.4 1.04 ± 0.3 1.09 ± 0.3 0.94 ± 0.5 1.07 ± 0.5 mI / Cr 1.49 ± 1.9 0.91 ± 0.2 0.93 ± 0.2 0.92 ± 0.3 1.17 ± 0.8













































































































































NAA 1.00 ± 0.1 0.99 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 0.90 ± 0.1 NAA 0.91 ± 0.1 1.02 ± 0.0 1.02 ± 0.0 1.06 ± 0.1 1.09 ± 0.1
Cr 1.09 ± 0.1 0.97 ± 0.1 0.96 ± 0.1 0.93 ± 0.1 0.84 ± 0.2 Cr 0.98 ± 0.1 1.00 ± 0.1 1.00 ± 0.1 1.03 ± 0.1 1.05 ± 0.2
Cho 1.07 ± 0.2 0.98 ± 0.1 0.96 ± 0.1 0.89 ± 0.2 1.02 ± 0.2 Cho 1.02 ± 0.1 1.04 ± 0.1 1.04 ± 0.1 1.06 ± 0.2 1.08 ± 0.2
mI 3.62 ± 10.4 4.38 ± 14.8 4.46 ± 15.3 6.43 ± 22.5 15.53 ± 52.3 mI 1.04 ± 0.5 1.05 ± 0.2 1.01 ± 0.3 1.04 ± 0.6 0.84 ± 0.4
Glx 3.62 ± 4.2 1.46 ± 1.1 1.85 ± 1.4 2.60 ± 2.7 11.87 ± 32.4 Glx 1.05 ± 0.4 0.96 ± 0.6 0.72 ± 0.6 0.66 ± 0.8 1.27 ± 0.6
NAA / Cr 0.92 ± 0.1 1.04 ± 0.1 1.04 ± 0.1 1.09 ± 0.1 1.10 ± 0.2 NAA / Cr 0.93 ± 0.1 1.02 ± 0.1 1.02 ± 0.1 1.04 ± 0.1 1.04 ± 0.1
Cho / Cr 0.99 ± 0.2 1.02 ± 0.2 1.01 ± 0.2 0.97 ± 0.3 1.21 ± 0.2 Cho / Cr 1.05 ± 0.1 1.04 ± 0.1 1.04 ± 0.1 1.04 ± 0.2 1.03 ± 0.2
mI / Cr 3.45 ± 10.1 4.17 ± 13.7 4.22 ± 14.0 7.22 ± 25.4 12.69 ± 41.1 mI / Cr 1.06 ± 0.5 1.05 ± 0.2 1.00 ± 0.3 1.03 ± 0.7 0.78 ± 0.4
Glx / Cr 3.38 ± 4.2 1.56 ± 1.2 2.07 ± 1.7 2.81 ± 2.9 14.38 ± 38.7 Glx / Cr 1.18 ± 0.6 1.00 ± 0.6 0.73 ± 0.6 0.68 ± 0.8 2.00 ± 1.6
NAA 1.01 ± 0.2 0.97 ± 0.1 0.96 ± 0.1 0.98 ± 0.1 0.83 ± 0.3 NAA 0.99 ± 0.2 1.05 ± 0.0 1.06 ± 0.0 1.10 ± 0.1 1.15 ± 0.1
Cr 1.09 ± 0.2 0.96 ± 0.1 0.94 ± 0.1 0.93 ± 0.1 0.87 ± 0.1 Cr 1.07 ± 0.1 1.05 ± 0.1 1.06 ± 0.1 1.08 ± 0.1 1.13 ± 0.1
Cho 1.13 ± 0.3 0.87 ± 0.2 0.80 ± 0.2 0.88 ± 0.3 0.74 ± 0.2 Cho 1.01 ± 0.2 1.05 ± 0.1 1.06 ± 0.1 1.09 ± 0.2 1.13 ± 0.2
mI 1.37 ± 1.0 0.72 ± 0.2 0.65 ± 0.3 0.54 ± 0.3 0.48 ± 0.6 mI 1.10 ± 0.7 1.01 ± 0.2 0.99 ± 0.2 1.00 ± 0.2 1.11 ± 0.4
Glx 5.85 ± 6.1 26.99 ± 37.5 33.51 ± 55.5 15.61 ± 19.5 48.26 ± 83.4 Glx 1.73 ± 1.3 5.99 ± 9.0 5.78 ± 8.8 8.28 ± 13.9 10.04 ± 12.8
NAA / Cr 0.93 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.05 ± 0.1 1.11 ± 0.1 NAA / Cr 0.92 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 1.03 ± 0.1 1.02 ± 0.1
Cho / Cr 1.04 ± 0.2 0.91 ± 0.2 0.84 ± 0.2 0.93 ± 0.2 0.85 ± 0.2 Cho / Cr 0.95 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.01 ± 0.2 1.00 ± 0.2
mI / Cr 1.19 ± 0.6 0.75 ± 0.2 0.70 ± 0.3 0.58 ± 0.3 0.57 ± 0.6 mI / Cr 1.00 ± 0.5 0.95 ± 0.1 0.94 ± 0.2 0.93 ± 0.2 0.98 ± 0.3
Glx / Cr 5.01 ± 5.9 28.20 ± 40.2 35.65 ± 60.5 14.97 ± 18.5 63.75 ± 93.1 Glx / Cr 1.59 ± 1.3 5.62 ± 8.6 5.61 ± 8.4 7.89 ± 12.9 9.46 ± 11.5
NAA 1.08 ± 0.1 1.06 ± 0.1 1.03 ± 0.1 1.08 ± 0.1 1.07 ± 0.1 NAA 1.03 ± 0.1 1.01 ± 0.1 1.01 ± 0.1 0.96 ± 0.1 0.87 ± 0.2
Cr 1.11 ± 0.1 1.07 ± 0.1 1.06 ± 0.1 1.05 ± 0.1 1.04 ± 0.1 Cr 1.07 ± 0.1 0.98 ± 0.1 0.97 ± 0.1 0.91 ± 0.1 0.85 ± 0.2
Cho 1.12 ± 0.2 1.07 ± 0.2 1.03 ± 0.2 1.10 ± 0.2 1.03 ± 0.2 Cho 1.06 ± 0.2 1.05 ± 0.2 1.07 ± 0.2 1.03 ± 0.3 0.92 ± 0.3
mI 1.35 ± 0.5 1.22 ± 0.7 1.15 ± 0.7 1.08 ± 0.5 1.05 ± 0.5 mI 1.09 ± 0.2 1.06 ± 0.3 1.00 ± 0.3 0.87 ± 0.2 0.94 ± 0.5
Glx 2.89 ± 5.2 1.82 ± 2.2 0.99 ± 0.7 2.45 ± 3.8 0.69 ± 0.5 Glx 0.60 ± 0.4 0.87 ± 0.8 2.22 ± 3.9 0.73 ± 0.2 1.99 ± 1.9
NAA / Cr 0.98 ± 0.1 1.00 ± 0.1 0.98 ± 0.1 1.03 ± 0.1 1.03 ± 0.1 NAA / Cr 0.96 ± 0.1 1.04 ± 0.1 1.05 ± 0.1 1.07 ± 0.2 1.06 ± 0.2
Cho / Cr 1.01 ± 0.2 1.01 ± 0.2 0.98 ± 0.2 1.05 ± 0.2 1.00 ± 0.2 Cho / Cr 1.00 ± 0.2 1.09 ± 0.2 1.11 ± 0.3 1.13 ± 0.2 1.09 ± 0.3
mI / Cr 1.23 ± 0.5 1.12 ± 0.5 1.07 ± 0.5 1.03 ± 0.5 1.02 ± 0.5 mI / Cr 1.02 ± 0.2 1.09 ± 0.4 1.04 ± 0.4 0.95 ± 0.2 1.23 ± 0.9
Glx / Cr 2.73 ± 5.0 1.75 ± 2.1 0.97 ± 0.7 2.39 ± 3.6 0.71 ± 0.6 Glx / Cr 0.63 ± 0.4 0.98 ± 1.0 2.83 ± 5.3 0.79 ± 0.4 2.71 ± 2.3
NAA 1.11 ± 0.2 1.06 ± 0.1 1.06 ± 0.1 1.12 ± 0.1 1.12 ± 0.1 NAA 1.07 ± 0.1 1.00 ± 0.0 0.99 ± 0.0 0.98 ± 0.0 0.97 ± 0.1
Cr 1.16 ± 0.2 1.09 ± 0.1 1.08 ± 0.1 1.12 ± 0.1 1.12 ± 0.1 Cr 1.22 ± 0.1 0.97 ± 0.1 0.97 ± 0.1 0.96 ± 0.1 0.93 ± 0.1
Cho 1.09 ± 0.2 0.94 ± 0.1 0.94 ± 0.1 0.95 ± 0.1 0.99 ± 0.2 Cho 0.99 ± 0.1 1.02 ± 0.1 1.03 ± 0.1 1.03 ± 0.1 1.02 ± 0.1
mI 1.10 ± 0.2 1.01 ± 0.2 1.03 ± 0.2 1.06 ± 0.3 1.10 ± 0.3 mI 1.06 ± 0.2 1.03 ± 0.2 0.99 ± 0.2 1.02 ± 0.2 0.95 ± 0.2
Glx 0.67 ± 0.3 1.57 ± 1.1 1.83 ± 1.8 4.94 ± 7.1 4.51 ± 6.8 Glx 0.89 ± 0.0 31.87 ± 61.5 43.11 ± 68.1 42.84 ± 73.4 0.30 ± 0.0
NAA / Cr 0.96 ± 0.1 0.98 ± 0.1 0.99 ± 0.1 1.00 ± 0.1 1.01 ± 0.1 NAA / Cr 0.88 ± 0.1 1.03 ± 0.1 1.03 ± 0.1 1.03 ± 0.1 1.04 ± 0.1
Cho / Cr 0.95 ± 0.2 0.87 ± 0.1 0.88 ± 0.1 0.85 ± 0.1 0.89 ± 0.1 Cho / Cr 0.82 ± 0.1 1.06 ± 0.1 1.07 ± 0.1 1.08 ± 0.1 1.10 ± 0.1
mI / Cr 0.95 ± 0.1 0.94 ± 0.2 0.96 ± 0.2 0.95 ± 0.2 0.97 ± 0.3 mI / Cr 0.87 ± 0.1 1.07 ± 0.2 1.03 ± 0.1 1.07 ± 0.2 1.03 ± 0.2
Glx / Cr 0.62 ± 0.2 1.47 ± 1.1 1.73 ± 1.8 4.73 ± 7.2 4.32 ± 6.9 Glx / Cr 0.75 ± 0.0 30.25 ± 58.3 41.62 ± 65.6 41.14 ± 70.5 0.27 ± 0.0
NAA 0.98 ± 0.2 0.96 ± 0.1 0.96 ± 0.1 0.90 ± 0.0 0.79 ± 0.2 NAA 0.97 ± 0.2 0.96 ± 0.1 0.95 ± 0.1 0.92 ± 0.1 0.86 ± 0.1
Cr 0.97 ± 0.2 1.01 ± 0.1 1.01 ± 0.1 1.03 ± 0.1 0.94 ± 0.3 Cr 1.07 ± 0.3 0.96 ± 0.1 0.97 ± 0.1 0.98 ± 0.1 0.93 ± 0.1
Cho 0.95 ± 0.2 1.03 ± 0.1 1.07 ± 0.2 1.11 ± 0.1 0.96 ± 0.3 Cho 1.01 ± 0.3 0.99 ± 0.1 0.98 ± 0.1 1.03 ± 0.1 0.98 ± 0.1
mI 0.93 ± 0.3 1.02 ± 0.2 1.01 ± 0.3 0.88 ± 0.4 0.97 ± 0.5 mI 1.23 ± 0.6 0.92 ± 0.4 0.95 ± 0.4 0.97 ± 0.2 1.02 ± 0.5
Glx 1.25 ± 1.0 1.04 ± 0.7 0.70 ± 0.5 1.80 ± 1.3 2.69 ± 2.5 Glx N/A 0.86 ± 0.0 0.86 ± 0.0 0.62 ± 0.2 N/A
NAA / Cr 1.00 ± 0.2 0.96 ± 0.1 0.96 ± 0.1 0.88 ± 0.1 0.87 ± 0.1 NAA / Cr 0.92 ± 0.1 1.00 ± 0.1 0.99 ± 0.1 0.95 ± 0.1 0.93 ± 0.1
Cho / Cr 0.99 ± 0.1 1.03 ± 0.1 1.07 ± 0.2 1.08 ± 0.1 1.02 ± 0.2 Cho / Cr 0.98 ± 0.2 1.03 ± 0.1 1.02 ± 0.1 1.06 ± 0.1 1.06 ± 0.1
mI / Cr 0.96 ± 0.2 1.01 ± 0.2 1.01 ± 0.3 0.85 ± 0.3 1.09 ± 0.5 mI / Cr 1.15 ± 0.4 0.97 ± 0.4 0.99 ± 0.4 1.01 ± 0.2 1.13 ± 0.7






























































































































Table 11: Average FWHM across all compartments
 
Compartment MINT 50x50x18 ROIS 50x50x18 SLIM 16x16x12 SLIM 20x20x12 SLIM 40x40x12 SLIM 50x50x12
All 0.06 0.06 0.06 0.06 0.06 0.06
Brain Stem 0.07 0.07 0.07 0.07 0.07 0.07
L. Central GM 0.06 0.05 0.06 0.06 0.05 0.05
L. Central WM 0.05 0.05 0.04 0.05 0.05 0.05
L. Cerebellum GM 0.07 0.07 0.07 0.07 0.07 0.07
L. Cerebellum WM 0.07 0.06 0.06 0.06 0.06 0.06
L. Cingulate GM 0.05 0.05 0.05 0.05 0.05 0.05
L. Cingulate WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Fusiform GM 0.06 0.06 0.07 0.07 0.06 0.07
L. Fusiform WM 0.06 0.06 0.06 0.06 0.06 0.06
L. Inferior Parietal GM 0.06 0.05 0.06 0.06 0.06 0.06
L. Inferior Parietal WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Inferior Temporal GM 0.06 0.06 0.07 0.07 0.07 0.07
L. Inferior Temporal WM 0.06 0.06 0.06 0.06 0.06 0.06
L. Insula GM 0.05 0.06 0.06 0.06 0.06 0.06
L. Insula WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Lateral Occipital GM 0.06 0.06 0.07 0.07 0.07 0.07
L. Lateral Occipital WM 0.06 0.06 0.05 0.06 0.06 0.06
L. Lingual GM 0.06 0.06 0.06 0.06 0.06 0.06
L. Lingual WM 0.06 0.06 0.06 0.06 0.06 0.06
L. Orbito-Frontal GM 0.06 0.06 0.06 0.06 0.06 0.06
L. Orbito-Frontal WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Pars GM 0.06 0.06 0.06 0.06 0.06 0.06
L. Pars WM 0.06 0.06 0.06 0.05 0.05 0.05
L. Post-Central GM 0.06 0.05 0.05 0.06 0.05 0.05
L. Post-Central WM 0.06 0.05 0.06 0.05 0.05 0.05
L. Pre-Cuneus GM 0.05 0.05 0.05 0.05 0.05 0.05
L. Pre-Cuneus WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Rostral Middle Frontal GM 0.06 0.06 0.06 0.06 0.06 0.06
L. Rostral Middle Frontal WM 0.06 0.06 0.06 0.06 0.06 0.06
L. Striatum 0.06 0.06 0.08 0.07 0.07 0.07
L. Superior Frontal GM 0.06 0.06 0.07 0.06 0.06 0.06
L. Superior Frontal WM 0.06 0.06 0.05 0.05 0.05 0.05
L. Superior Parietal GM 0.05 0.06 0.07 0.07 0.06 0.06
L. Superior Parietal WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Superior Temporal GM 0.06 0.06 0.07 0.06 0.06 0.06
L. Superior Temporal WM 0.05 0.05 0.05 0.05 0.05 0.05
L. Supra-Marginal GM 0.06 0.05 0.06 0.06 0.06 0.06
L. Supra-Marginal WM 0.05 0.05 0.05 0.05 0.05 0.05




Compartment MINT 50x50x18 ROIS 50x50x18 SLIM 16x16x12 SLIM 20x20x12 SLIM 40x40x12 SLIM 50x50x12
R. Central GM 0.06 0.06 0.06 0.06 0.06 0.06
R. Central WM 0.05 0.05 0.04 0.05 0.05 0.05
R. Cerebellum GM 0.07 0.07 0.07 0.07 0.07 0.07
R. Cerebellum WM 0.07 0.06 0.06 0.06 0.07 0.06
R. Cingulate GM 0.05 0.05 0.05 0.05 0.05 0.05
R. Cingulate WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Fusiform GM 0.06 0.07 0.07 0.07 0.07 0.07
R. Fusiform WM 0.06 0.06 0.06 0.06 0.06 0.06
R. Inferior Parietal GM 0.06 0.06 0.07 0.07 0.06 0.06
R. Inferior Parietal WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Inferior Temporal GM 0.07 0.07 0.08 0.08 0.08 0.08
R. Inferior Temporal WM 0.06 0.06 0.06 0.06 0.06 0.06
R. Insula GM 0.06 0.06 0.06 0.06 0.06 0.06
R. Insula WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Lateral Occipital GM 0.07 0.07 0.07 0.07 0.07 0.07
R. Lateral Occipital WM 0.06 0.07 0.07 0.07 0.07 0.07
R. Lingual GM 0.06 0.06 0.06 0.06 0.06 0.06
R. Lingual WM 0.06 0.06 0.06 0.06 0.05 0.05
R. Orbito-Frontal GM 0.06 0.06 0.07 0.07 0.07 0.06
R. Orbito-Frontal WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Pars GM 0.06 0.07 0.07 0.07 0.07 0.07
R. Pars WM 0.06 0.06 0.06 0.06 0.06 0.06
R. Post-Central GM 0.06 0.06 0.06 0.06 0.06 0.06
R. Post-Central WM 0.05 0.05 0.06 0.05 0.05 0.05
R. Pre-Cuneus GM 0.05 0.05 0.05 0.05 0.05 0.05
R. Pre-Cuneus WM 0.05 0.05 0.04 0.04 0.05 0.05
R. Rostral Middle Frontal GM 0.06 0.06 0.06 0.06 0.06 0.06
R. Rostral Middle Frontal WM 0.06 0.06 0.06 0.06 0.06 0.06
R. Striatum 0.06 0.06 0.07 0.07 0.07 0.06
R. Superior Frontal GM 0.06 0.06 0.07 0.07 0.06 0.06
R. Superior Frontal WM 0.06 0.05 0.05 0.05 0.05 0.05
R. Superior Parietal GM 0.06 0.06 0.07 0.07 0.06 0.06
R. Superior Parietal WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Superior Temporal GM 0.06 0.06 0.06 0.06 0.06 0.07
R. Superior Temporal WM 0.06 0.06 0.06 0.06 0.06 0.06
R. Supra-Marginal GM 0.05 0.06 0.06 0.06 0.06 0.06
R. Supra-Marginal WM 0.05 0.05 0.05 0.05 0.05 0.05
R. Thalamus 0.06 0.06 0.06 0.06 0.06 0.06
Ventral Diencephalon 0.07 0.07 0.07 0.07 0.07 0.07
Ventricles 0.05 0.05 0.05 0.05 0.05 0.05
81 
 























NAA 0.64 0.93 0.90 0.83 0.73 NAA -0.34 0.93 0.93 0.94 0.81
Cr 0.58 0.88 0.85 0.75 0.67 Cr -0.59 0.89 0.89 0.80 0.70
Cho 0.56 0.86 0.85 0.78 0.69 Cho -0.10 0.93 0.73 0.76 0.48
mI 0.42 0.71 0.71 0.60 0.42 mI 0.50 0.46 0.52 0.72 0.14
Glx 0.07 0.24 0.22 0.12 0.10 Glx 0.58 0.26 0.20 -0.64 -0.05
NAA / Cr 0.71 0.87 0.78 0.79 0.76 NAA / Cr -0.03 0.74 0.60 0.53 0.55
Cho / Cr 0.66 0.80 0.74 0.74 0.68 Cho / Cr 0.08 0.87 0.57 0.84 0.70
mI / Cr 0.37 0.66 0.66 0.54 0.37 mI / Cr -0.17 0.39 0.36 0.70 0.35
Glx / Cr 0.08 0.20 0.21 0.10 0.02 Glx / Cr 0.47 0.29 -0.14 -0.43 -0.10
NAA 0.77 0.94 0.92 0.71 0.69 NAA 0.81 0.97 0.96 0.94 0.92
Cr 0.87 0.94 0.93 0.80 0.72 Cr 0.78 0.91 0.94 0.87 0.80
Cho 0.81 0.86 0.86 0.71 0.83 Cho 0.80 0.93 0.97 0.90 0.85
mI 0.67 0.81 0.81 0.54 0.71 mI 0.26 0.76 0.78 0.67 0.60
Glx -0.23 -1.00 0.99 0.96 0.50 Glx -1.00 0.03 0.09 -0.35 0.99
NAA / Cr 0.43 0.88 0.87 0.63 0.49 NAA / Cr 0.53 0.73 0.85 0.49 0.36
Cho / Cr 0.33 0.36 0.57 0.13 0.34 Cho / Cr 0.38 0.57 0.79 0.33 0.11
mI / Cr 0.49 0.71 0.76 0.34 0.54 mI / Cr 0.29 0.76 0.73 0.65 0.62
Glx / Cr -0.16 -0.92 1.00 0.95 0.50 Glx / Cr -1.00 0.23 0.30 -0.30 0.98
NAA 0.34 0.70 0.84 0.86 0.24 NAA 0.41 0.86 0.83 0.75 0.64
Cr 0.42 0.87 0.86 0.84 0.82 Cr 0.46 0.78 0.79 0.66 0.60
Cho 0.31 0.90 0.92 0.75 0.57 Cho 0.42 0.69 0.68 0.62 0.21
mI -0.13 0.77 0.85 0.84 0.75 mI 0.31 0.69 0.58 0.31 -0.02
Glx 0.44 0.42 0.87 0.53 0.33 Glx -0.30 -0.05 -0.34 0.96 0.02
NAA / Cr 0.10 0.88 0.96 0.88 0.83 NAA / Cr 0.58 0.88 0.89 0.84 0.78
Cho / Cr 0.35 0.78 0.79 0.61 0.66 Cho / Cr 0.31 0.87 0.82 0.56 0.45
mI / Cr -0.34 0.78 0.82 0.75 0.62 mI / Cr -0.06 0.31 0.28 0.63 0.47
Glx / Cr 0.35 0.54 0.92 0.67 0.87 Glx / Cr -0.48 -0.29 -0.33 1.00 0.00
NAA 0.54 0.93 0.94 0.91 0.85 NAA 0.66 0.93 0.89 0.90 0.71
Cr 0.54 0.79 0.77 0.71 0.71 Cr 0.48 0.80 0.78 0.73 0.56
Cho 0.62 0.85 0.77 0.83 0.83 Cho 0.30 0.70 0.64 0.85 0.76
mI 0.47 0.71 0.75 0.65 0.52 mI 0.43 0.57 0.62 0.47 0.57
Glx 0.50 -0.02 0.06 -0.39 -0.13 Glx 1.00 0.84 0.15 0.77 0.12
NAA / Cr 0.52 0.68 0.68 0.53 0.54 NAA / Cr 0.81 0.83 0.87 0.87 0.76
Cho / Cr 0.47 0.67 0.59 0.60 0.68 Cho / Cr 0.11 0.42 0.05 0.76 0.43
mI / Cr 0.46 0.58 0.62 0.47 -0.07 mI / Cr 0.41 0.57 0.59 0.36 0.55
Glx / Cr 0.36 -0.15 -0.07 -0.45 -0.29 Glx / Cr 1.00 0.76 0.29 0.83 0.39
NAA 0.41 0.74 0.71 0.51 0.48 NAA 0.65 0.73 0.72 0.17 0.43
Cr 0.47 0.88 0.82 0.49 0.40 Cr 0.58 0.83 0.89 -0.17 0.51
Cho 0.46 0.72 0.78 0.26 0.63 Cho 0.69 0.59 0.39 -0.02 0.01
mI 0.23 0.50 0.51 0.19 0.21 mI 0.10 0.60 0.73 -0.24 -0.22
Glx -0.12 -0.67 -0.04 0.23 -0.30 Glx 0.66 0.22 0.09 1.00 NaN
NAA / Cr 0.46 0.68 0.70 0.72 0.46 NAA / Cr 0.27 0.62 0.57 0.35 0.42
Cho / Cr -0.08 0.46 0.57 0.77 0.61 Cho / Cr 0.31 0.61 0.64 0.49 0.25
mI / Cr 0.38 0.52 0.47 0.08 0.14 mI / Cr 0.54 0.78 0.77 0.15 0.21
































































































NAA 0.53 0.68 0.68 0.74 0.81 NAA 0.56 0.95 0.96 0.84 0.84
Cr -0.03 0.70 0.64 0.84 0.77 Cr 0.60 0.91 0.92 0.76 0.73
Cho 0.35 0.38 0.37 0.47 0.79 Cho 0.46 0.90 0.90 0.82 0.76
mI 0.26 0.70 0.72 0.19 0.68 mI 0.48 0.90 0.88 0.83 0.71
Glx 0.18 -0.21 -0.32 -0.29 -0.03 Glx -1.00 0.74 0.72 0.18 -0.13
NAA / Cr 0.63 0.69 0.68 0.67 0.66 NAA / Cr 0.65 0.78 0.87 0.65 0.71
Cho / Cr 0.36 0.42 0.20 0.24 0.50 Cho / Cr 0.38 0.68 0.75 0.65 0.66
mI / Cr 0.42 0.60 0.76 0.35 0.65 mI / Cr 0.45 0.85 0.86 0.72 0.50
Glx / Cr 0.41 -0.18 -0.21 -0.25 -0.02 Glx / Cr -1.00 0.57 0.59 -0.15 -0.22
NAA 0.76 0.96 0.92 0.79 0.82 NAA 0.79 0.95 0.93 0.87 0.81
Cr 0.79 0.97 0.95 0.87 0.87 Cr 0.81 0.96 0.95 0.85 0.84
Cho 0.74 0.88 0.85 0.65 0.53 Cho 0.83 0.93 0.89 0.85 0.88
mI 0.66 0.79 0.76 0.54 0.63 mI 0.27 0.77 0.71 0.48 -0.07
Glx 0.41 0.39 0.31 0.48 0.53 Glx 1.00 1.00 1.00 0.77 -1.00
NAA / Cr 0.56 0.85 0.84 0.80 0.80 NAA / Cr 0.63 0.85 0.85 0.83 0.70
Cho / Cr 0.35 0.32 0.39 0.12 -0.37 Cho / Cr 0.31 0.84 0.85 0.74 0.64
mI / Cr 0.29 0.32 0.53 0.22 0.36 mI / Cr -0.21 0.76 0.71 0.31 -0.28
Glx / Cr 0.46 0.29 0.04 0.77 0.67 Glx / Cr 1.00 1.00 -1.00 0.30 -1.00
NAA 0.35 0.88 0.91 0.87 0.52 NAA 0.66 0.83 0.84 0.96 0.65
Cr 0.50 0.88 0.91 0.85 0.50 Cr 0.53 0.69 0.69 0.44 0.51
Cho 0.38 0.93 0.93 0.77 0.65 Cho 0.47 0.85 0.87 0.91 0.69
mI 0.33 0.76 0.72 0.63 0.61 mI 0.60 0.48 0.48 0.43 0.00
Glx -0.18 0.07 0.30 -0.24 0.76 Glx 0.33 0.08 -0.23 -0.10 -0.28
NAA / Cr 0.31 0.84 0.86 0.74 0.57 NAA / Cr 0.22 0.68 0.66 0.38 0.59
Cho / Cr 0.52 0.78 0.81 0.27 0.38 Cho / Cr 0.09 0.66 0.71 0.76 0.58
mI / Cr 0.42 0.71 0.70 0.61 0.45 mI / Cr 0.33 0.71 0.69 0.58 0.28
Glx / Cr 0.08 0.22 0.42 0.11 0.46 Glx / Cr 0.17 0.36 0.28 0.23 0.28
NAA 0.62 0.94 0.93 0.80 0.75 NAA 0.52 0.97 0.97 0.94 0.70
Cr 0.37 0.83 0.77 0.59 0.47 Cr 0.39 0.88 0.81 0.70 0.55
Cho 0.51 0.77 0.78 0.53 0.31 Cho 0.60 0.89 0.87 0.86 0.45
mI 0.45 0.58 0.53 0.56 0.39 mI 0.51 0.74 0.83 0.70 0.69
Glx 0.96 0.03 -0.16 -0.39 -0.16 Glx 0.09 0.66 0.43 0.12 0.65
NAA / Cr 0.38 0.77 0.69 0.43 0.47 NAA / Cr 0.74 0.78 0.73 0.77 0.82
Cho / Cr 0.19 0.64 0.50 0.47 0.31 Cho / Cr 0.10 0.54 0.41 0.50 0.35
mI / Cr 0.43 0.33 0.29 0.23 -0.17 mI / Cr 0.48 0.75 0.83 0.65 0.54
Glx / Cr 0.99 0.00 -0.08 -0.45 -0.34 Glx / Cr 0.37 0.66 0.27 -0.21 0.40
NAA 0.65 0.93 0.94 0.76 0.74 NAA 0.48 0.88 0.84 0.56 0.49
Cr 0.57 0.85 0.83 0.71 0.37 Cr 0.67 0.92 0.90 0.70 0.52
Cho 0.56 0.69 0.61 0.19 -0.09 Cho 0.40 0.81 0.82 0.46 0.50
mI 0.17 0.65 0.52 0.57 0.02 mI 0.34 0.30 0.24 0.04 0.08
Glx 0.09 0.34 0.09 -0.07 -0.37 Glx -0.50 0.87 0.85 -1.00 -1.00
NAA / Cr 0.64 0.53 0.55 0.07 0.08 NAA / Cr 0.66 0.78 0.76 0.64 0.41
Cho / Cr 0.40 0.35 0.34 0.31 0.02 Cho / Cr 0.35 0.75 0.80 0.66 0.62
mI / Cr 0.15 0.64 0.55 0.66 -0.19 mI / Cr 0.11 0.53 0.49 0.19 -0.16











































































































NAA 0.43 0.97 0.92 0.84 0.89 NAA 0.38 0.95 0.94 0.92 0.82
Cr 0.53 0.85 0.74 0.38 0.46 Cr 0.43 0.91 0.89 0.88 0.82
Cho 0.46 0.85 0.78 0.80 0.78 Cho 0.39 0.90 0.84 0.83 0.66
mI 0.43 0.95 0.86 0.88 0.88 mI 0.30 0.92 0.83 0.69 0.36
Glx -0.75 0.10 0.26 0.89 0.82 Glx 0.34 -1.00 1.00 1.00 NaN
NAA / Cr 0.30 0.80 0.77 0.22 0.55 NAA / Cr 0.47 0.95 0.90 0.87 0.81
Cho / Cr 0.18 0.39 0.34 0.18 0.18 Cho / Cr 0.52 0.89 0.81 0.67 0.61
mI / Cr 0.53 0.91 0.81 0.56 0.64 mI / Cr 0.55 0.85 0.80 0.77 0.61
Glx / Cr -0.71 0.11 0.17 0.83 0.76 Glx / Cr 0.32 -1.00 1.00 1.00 NaN
NAA 0.53 0.87 0.84 0.78 0.82 NAA 0.50 0.94 0.97 0.92 0.86
Cr 0.61 0.80 0.86 0.89 0.79 Cr 0.50 0.85 0.88 0.81 0.81
Cho 0.42 0.41 0.44 0.60 0.66 Cho 0.57 0.89 0.90 0.81 0.67
mI 0.08 0.54 0.42 0.59 0.65 mI 0.11 0.84 0.78 0.54 0.74
Glx 0.42 0.24 0.45 -0.41 0.15 Glx -0.02 0.99 0.94 -0.24 NaN
NAA / Cr 0.65 0.73 0.68 0.57 0.58 NAA / Cr 0.50 0.72 0.77 0.76 0.64
Cho / Cr 0.49 0.10 0.16 0.35 0.60 Cho / Cr 0.34 0.59 0.59 0.59 0.70
mI / Cr 0.17 0.48 0.34 0.50 0.69 mI / Cr 0.26 0.84 0.80 0.14 0.57
Glx / Cr 0.17 -0.07 0.11 -0.34 0.34 Glx / Cr -0.07 0.98 0.94 -0.29 NaN
NAA 0.57 0.95 0.96 0.93 0.89 NAA 0.67 0.97 0.96 0.91 0.93
Cr 0.64 0.98 0.98 0.90 0.87 Cr 0.54 0.93 0.89 0.83 0.79
Cho 0.32 0.91 0.93 0.75 0.69 Cho 0.43 0.88 0.84 0.79 0.74
mI 0.44 0.89 0.83 0.67 0.69 mI 0.41 0.74 0.76 0.84 0.76
Glx 1.00 0.80 0.95 0.24 -1.00 Glx 1.00 -1.00 -0.75 -0.28 1.00
NAA / Cr -0.08 0.91 0.91 0.85 0.67 NAA / Cr 0.42 0.81 0.80 0.77 0.74
Cho / Cr 0.07 0.96 0.96 0.74 0.73 Cho / Cr 0.36 0.61 0.58 0.58 0.54
mI / Cr 0.24 0.75 0.70 0.49 0.38 mI / Cr 0.43 0.76 0.78 0.86 0.85
Glx / Cr 1.00 0.75 0.98 0.20 -1.00 Glx / Cr 1.00 -1.00 -0.96 -0.34 1.00
NAA 0.43 0.79 0.70 0.56 0.39 NAA 0.53 0.90 0.89 0.77 0.68
Cr 0.31 0.85 0.74 0.85 0.38 Cr 0.22 0.89 0.87 0.74 0.74
Cho 0.19 0.59 0.66 0.53 0.15 Cho 0.51 0.76 0.84 0.68 0.14
mI 0.11 0.56 0.79 0.52 0.46 mI 0.12 0.48 0.55 0.40 0.73
Glx 0.18 -0.16 -0.10 -0.16 -0.42 Glx 0.39 0.14 0.57 -1.00 -1.00
NAA / Cr 0.09 0.64 0.58 0.34 0.08 NAA / Cr 0.65 0.82 0.79 0.73 0.60
Cho / Cr 0.16 0.58 0.34 0.30 -0.41 Cho / Cr 0.38 0.66 0.62 0.49 0.03
mI / Cr 0.26 0.31 0.77 0.54 0.26 mI / Cr 0.26 0.49 0.50 0.51 0.73
Glx / Cr 0.00 -0.36 -0.21 -0.17 -0.43 Glx / Cr 0.42 0.22 0.61 -1.00 1.00
NAA 0.43 0.93 0.88 0.89 0.38 NAA 0.67 0.67 0.62 0.18 0.68
Cr 0.63 0.90 0.89 0.85 0.79 Cr 0.63 0.75 0.75 0.54 0.44
Cho 0.73 0.80 0.80 0.59 0.05 Cho 0.76 0.88 0.91 0.78 0.43
mI 0.31 0.87 0.80 0.64 0.64 mI 0.35 0.02 0.32 -0.19 0.16
Glx 0.90 0.85 0.84 0.49 0.94 Glx -0.77 -0.71 -0.76 -0.90 -0.30
NAA / Cr 0.30 0.88 0.86 0.76 0.69 NAA / Cr 0.58 0.68 0.75 0.62 0.39
Cho / Cr 0.68 0.81 0.78 0.25 0.34 Cho / Cr 0.73 0.74 0.72 0.64 0.09
mI / Cr 0.31 0.83 0.60 0.25 0.30 mI / Cr 0.17 -0.09 0.43 0.06 -0.20




























































































































NAA 0.30 0.91 0.80 0.83 0.37 NAA 0.47 0.95 0.95 0.91 0.88
Cr 0.48 0.91 0.92 0.76 0.83 Cr 0.45 0.86 0.81 0.85 0.78
Cho 0.38 0.30 0.73 0.59 0.67 Cho 0.58 0.90 0.88 0.86 0.84
mI 0.22 0.79 0.22 0.67 0.25 mI 0.44 0.92 0.91 0.86 0.78
Glx 0.77 -0.04 0.30 0.54 0.53 Glx 0.73 0.82 -0.43 -0.21 -0.43
NAA / Cr 0.61 0.86 0.85 0.42 0.65 NAA / Cr 0.62 0.85 0.82 0.92 0.87
Cho / Cr 0.37 0.68 0.56 0.19 0.62 Cho / Cr 0.33 0.68 0.63 0.63 0.53
mI / Cr 0.43 0.71 0.63 0.52 0.47 mI / Cr 0.60 0.87 0.85 0.74 0.67
Glx / Cr 0.79 0.02 0.26 0.37 0.57 Glx / Cr 0.85 0.81 -0.39 -0.35 -0.41
NAA 0.57 0.86 0.86 0.82 0.68 NAA 0.54 0.90 0.90 0.91 0.84
Cr 0.71 0.85 0.85 0.81 0.78 Cr 0.45 0.93 0.93 0.88 0.64
Cho 0.64 -0.02 0.04 0.22 0.77 Cho 0.15 0.62 0.61 0.53 0.51
mI 0.28 0.72 0.63 0.49 -0.21 mI 0.12 0.85 0.83 0.64 0.39
Glx 0.09 -0.05 0.17 0.48 0.38 Glx -0.10 0.16 -0.05 0.60 0.40
NAA / Cr 0.11 -0.05 0.15 0.05 0.23 NAA / Cr 0.41 0.76 0.65 0.78 0.47
Cho / Cr 0.28 0.09 0.17 0.32 0.62 Cho / Cr 0.30 0.38 0.32 0.31 -0.36
mI / Cr 0.30 0.71 0.60 0.50 -0.02 mI / Cr 0.23 0.79 0.72 0.59 0.54
Glx / Cr 0.05 -0.23 0.01 0.42 0.41 Glx / Cr -0.21 0.00 0.01 0.68 0.48
NAA 0.51 0.96 0.95 0.89 0.82 NAA 0.35 0.98 0.96 0.96 0.95
Cr 0.54 0.91 0.91 0.91 0.91 Cr 0.36 0.94 0.95 0.87 0.86
Cho 0.41 0.27 0.22 0.25 0.43 Cho 0.27 0.90 0.89 0.85 0.75
mI 0.15 0.18 0.20 0.60 -0.05 mI 0.30 0.93 0.93 0.82 0.63
Glx 1.00 -0.25 -0.26 0.38 -0.68 Glx -0.31 0.66 0.76 -0.88 1.00
NAA / Cr 0.25 0.84 0.81 0.85 0.63 NAA / Cr 0.38 0.73 0.75 0.65 0.58
Cho / Cr 0.29 0.35 0.34 0.48 0.38 Cho / Cr 0.36 0.74 0.75 0.58 0.51
mI / Cr -0.10 0.65 0.68 0.71 0.06 mI / Cr 0.72 0.86 0.85 0.88 0.74
Glx / Cr 1.00 0.34 0.10 -0.47 -0.42 Glx / Cr -0.70 0.76 0.80 -0.83 1.00
NAA 0.27 0.91 0.85 0.74 0.49 NAA 0.29 0.95 0.92 0.79 0.67
Cr 0.08 0.86 0.74 0.50 0.03 Cr 0.27 0.82 0.84 0.60 0.21
Cho 0.40 0.75 0.78 0.49 0.63 Cho 0.28 0.70 0.73 0.84 0.76
mI -0.20 0.86 0.71 0.37 0.08 mI -0.16 0.69 0.79 0.44 0.13
Glx 0.30 0.36 0.45 0.44 -0.43 Glx -0.27 0.38 0.60 -0.67 -0.64
NAA / Cr 0.66 0.61 0.75 0.47 0.49 NAA / Cr 0.44 0.85 0.80 0.69 0.47
Cho / Cr 0.31 0.45 0.48 -0.23 0.60 Cho / Cr 0.17 0.35 0.45 0.36 0.44
mI / Cr 0.42 0.61 0.38 -0.43 -0.02 mI / Cr 0.26 0.75 0.86 0.76 0.42
Glx / Cr 0.31 0.64 0.62 0.34 -0.75 Glx / Cr -0.17 0.30 0.62 -0.79 -0.69
NAA 0.50 0.96 0.95 0.89 0.84 NAA 0.53 0.95 0.95 0.63 0.43
Cr 0.67 0.93 0.89 0.90 0.82 Cr 0.52 0.90 0.84 0.65 0.39
Cho 0.63 0.83 0.81 0.75 0.54 Cho 0.48 0.93 0.88 0.30 0.34
mI 0.34 0.89 0.85 0.80 0.77 mI 0.49 0.84 0.59 0.52 0.07
Glx 0.25 0.61 -0.03 0.28 -0.03 Glx -0.75 0.87 -1.00 1.00 1.00
NAA / Cr 0.53 0.93 0.89 0.79 0.69 NAA / Cr 0.56 0.81 0.70 0.78 0.64
Cho / Cr 0.73 0.81 0.78 0.77 0.56 Cho / Cr 0.71 0.67 0.52 0.20 0.11
mI / Cr 0.33 0.86 0.77 0.83 0.54 mI / Cr 0.44 0.68 0.42 0.38 -0.01


































































































































NAA 0.68 0.94 0.94 0.72 0.59 NAA 0.66 0.94 0.92 0.84 0.78
Cr 0.48 0.95 0.94 0.86 0.70 Cr 0.64 0.82 0.79 0.75 0.60
Cho 0.26 0.86 0.85 0.77 0.65 Cho 0.56 0.95 0.95 0.91 0.76
mI 0.24 0.62 0.65 0.56 0.38 mI 0.42 0.69 0.59 0.65 0.45
Glx -0.59 0.51 0.45 -0.03 -0.09 Glx 0.17 0.86 0.67 -0.52 -0.41
NAA / Cr 0.64 0.79 0.74 0.70 0.58 NAA / Cr 0.48 0.86 0.81 0.70 0.66
Cho / Cr 0.42 0.57 0.54 0.59 0.62 Cho / Cr 0.02 0.66 0.69 0.67 0.57
mI / Cr 0.13 0.51 0.57 0.52 0.31 mI / Cr 0.37 0.68 0.59 0.49 0.38
Glx / Cr -0.57 0.38 0.27 0.08 -0.02 Glx / Cr 0.15 0.87 0.64 -0.55 -0.49
NAA 0.52 0.74 0.79 0.78 0.71 NAA 0.47 0.90 0.92 0.55 0.70
Cr 0.43 0.78 0.76 0.66 0.73 Cr 0.38 0.62 0.62 -0.01 0.71
Cho 0.35 0.69 0.84 0.76 0.70 Cho 0.61 0.80 0.75 0.27 0.54
mI 0.35 0.57 0.64 0.49 0.40 mI 0.39 0.74 0.82 0.85 0.72
Glx -0.57 0.27 -0.51 -1.00 -0.28 Glx -1.00 0.59 0.85 0.64 1.00
NAA / Cr 0.78 0.51 0.72 0.48 0.45 NAA / Cr 0.62 0.58 0.59 0.29 0.57
Cho / Cr 0.01 0.44 0.57 0.58 0.37 Cho / Cr 0.15 0.47 0.44 0.11 0.45
mI / Cr 0.08 0.62 0.69 0.33 0.51 mI / Cr 0.34 0.61 0.70 0.40 0.63
Glx / Cr -0.59 0.65 -0.23 1.00 -0.21 Glx / Cr -1.00 0.67 0.88 0.67 1.00
NAA 0.61 0.91 0.87 0.82 0.70 NAA 0.71 0.90 0.88 0.65 0.47
Cr 0.65 0.91 0.87 0.80 0.70 Cr 0.65 0.90 0.88 0.73 0.71
Cho 0.71 0.87 0.82 0.73 0.71 Cho 0.76 0.89 0.90 0.76 0.71
mI 0.74 0.80 0.79 0.50 0.33 mI 0.51 0.71 0.68 0.81 0.65
Glx -0.27 -0.24 -0.26 -0.31 0.21 Glx -0.10 -0.70 1.00 1.00 1.00
NAA / Cr 0.21 0.75 0.68 0.38 0.59 NAA / Cr 0.08 0.66 0.59 0.56 0.53
Cho / Cr 0.20 0.63 0.53 0.50 0.48 Cho / Cr 0.00 0.73 0.70 0.66 0.29
mI / Cr 0.50 0.72 0.76 0.38 0.33 mI / Cr 0.38 0.71 0.53 0.67 0.49
Glx / Cr -0.71 -0.13 -0.05 0.21 0.35 Glx / Cr 0.20 -0.49 1.00 1.00 1.00
NAA 0.79 0.94 0.97 0.93 0.86 NAA 0.71 0.99 0.99 0.95 0.79
Cr 0.67 0.89 0.91 0.91 0.84 Cr 0.64 0.98 0.97 0.89 0.68
Cho 0.80 0.92 0.93 0.89 0.82 Cho 0.69 0.97 0.96 0.89 0.66
mI 0.66 0.74 0.84 0.60 0.74 mI 0.59 0.92 0.91 0.77 0.50
Glx 1.00 0.15 0.05 1.00 0.70 Glx NaN 1.00 1.00 1.00 NaN
NAA / Cr 0.46 0.73 0.76 0.76 0.68 NAA / Cr 0.68 0.93 0.93 0.89 0.81
Cho / Cr 0.42 0.67 0.66 0.62 0.46 Cho / Cr 0.50 0.92 0.90 0.80 0.84
mI / Cr 0.46 0.59 0.76 0.60 0.62 mI / Cr 0.67 0.92 0.92 0.68 0.71
Glx / Cr 1.00 0.06 -0.03 1.00 0.74 Glx / Cr NaN -1.00 -1.00 1.00 NaN
NAA 0.60 0.91 0.89 0.72 0.81 NAA 0.32 0.91 0.91 0.81 0.88
Cr 0.53 0.78 0.69 0.58 0.73 Cr 0.18 0.89 0.85 0.79 0.79
Cho 0.29 0.80 0.73 0.74 0.78 Cho 0.53 0.74 0.72 0.52 0.67
mI 0.44 0.58 0.53 0.33 0.46 mI 0.35 0.78 0.78 0.57 0.43
Glx 0.38 0.23 0.55 -0.62 -0.16 Glx 0.88 0.64 0.71 0.64 -0.61
NAA / Cr 0.51 0.70 0.62 0.67 0.58 NAA / Cr 0.57 0.80 0.77 0.80 0.82
Cho / Cr 0.19 0.25 0.11 0.19 0.15 Cho / Cr 0.47 0.45 0.34 0.35 0.23
mI / Cr 0.05 0.53 0.54 0.43 0.49 mI / Cr 0.43 0.73 0.65 0.65 0.47
































































































































NAA 0.56 0.81 0.76 0.80 0.72 NAA 0.54 0.95 0.94 0.90 0.82
Cr 0.38 0.79 0.74 0.52 0.45 Cr 0.34 0.72 0.75 0.72 0.41
Cho -0.24 0.48 0.25 0.56 0.52 Cho 0.36 0.89 0.91 0.74 0.55
mI 0.38 0.81 0.76 0.69 -0.16 mI 0.44 0.54 0.54 0.30 0.03
Glx -0.20 0.72 0.83 0.16 0.54 Glx 1.00 0.76 -0.03 -0.55 0.02
NAA / Cr 0.61 0.77 0.76 0.45 0.46 NAA / Cr 0.53 0.71 0.74 0.63 0.64
Cho / Cr -0.10 0.41 0.22 0.74 0.79 Cho / Cr 0.41 0.43 0.56 0.46 0.43
mI / Cr 0.29 0.85 0.76 0.66 0.25 mI / Cr 0.40 0.41 0.22 0.08 -0.04
Glx / Cr 0.16 0.67 0.75 -0.10 0.71 Glx / Cr 1.00 0.67 -0.07 -0.37 -0.50
NAA 0.38 0.92 0.42 0.80 0.65 NAA 0.51 0.87 0.65 0.90 0.81
Cr 0.21 0.85 0.57 0.62 0.47 Cr 0.51 0.56 0.38 0.57 0.54
Cho 0.25 0.63 0.75 0.71 0.77 Cho 0.10 0.74 0.65 0.68 0.74
mI -0.26 -0.14 -0.20 0.24 0.58 mI 0.33 0.08 0.23 0.10 0.49
Glx -0.28 0.52 0.04 -0.44 0.17 Glx 1.00 1.00 1.00 -1.00 -0.32
NAA / Cr 0.46 0.13 0.46 0.22 0.21 NAA / Cr 0.48 0.52 0.26 0.54 0.53
Cho / Cr 0.40 0.15 0.61 0.34 0.46 Cho / Cr 0.63 0.40 -0.15 0.41 0.38
mI / Cr -0.43 -0.26 -0.11 0.03 0.57 mI / Cr 0.52 0.44 0.14 0.34 0.63
Glx / Cr -0.26 0.61 0.39 -0.42 0.36 Glx / Cr 1.00 1.00 1.00 -1.00 -0.32
NAA 0.63 0.85 0.90 0.66 0.81 NAA 0.63 0.93 0.94 0.82 0.62
Cr 0.74 0.94 0.90 0.64 0.86 Cr 0.66 0.93 0.91 0.89 0.52
Cho 0.68 0.75 0.62 0.34 0.53 Cho 0.68 0.88 0.72 0.75 0.53
mI 0.84 0.55 0.43 0.32 0.22 mI 0.67 0.83 0.78 0.39 0.45
Glx -0.32 -0.59 1.00 0.69 0.77 Glx -0.42 -0.05 -0.07 -0.13 0.36
NAA / Cr 0.37 0.53 0.70 0.44 0.31 NAA / Cr 0.60 0.71 0.75 0.69 0.51
Cho / Cr 0.05 0.16 0.07 0.21 -0.14 Cho / Cr 0.41 0.57 0.18 0.71 0.26
mI / Cr 0.19 0.39 0.26 0.15 -0.09 mI / Cr 0.26 0.48 0.46 0.31 0.56
Glx / Cr -0.31 -0.56 1.00 0.51 0.59 Glx / Cr -0.49 0.02 0.06 -0.17 0.22
NAA 0.59 0.98 0.97 0.96 0.93 NAA 0.41 0.99 0.99 0.95 0.74
Cr 0.59 0.94 0.91 0.90 0.85 Cr 0.62 0.95 0.91 0.74 0.46
Cho 0.49 0.88 0.86 0.78 0.77 Cho 0.52 0.98 0.96 0.80 0.77
mI 0.65 0.72 0.60 0.49 -0.01 mI 0.71 0.91 0.86 0.69 0.57
Glx 1.00 0.33 -1.00 0.80 -0.91 Glx 1.00 0.82 0.44 NaN NaN
NAA / Cr 0.34 0.71 0.62 0.50 0.48 NAA / Cr 0.08 0.87 0.82 0.71 0.69
Cho / Cr -0.07 0.43 0.40 0.36 0.18 Cho / Cr -0.23 0.89 0.87 0.36 0.37
mI / Cr 0.67 0.62 0.57 0.29 -0.10 mI / Cr 0.72 0.88 0.87 0.81 0.79
Glx / Cr 1.00 0.25 -1.00 0.76 -0.85 Glx / Cr 1.00 0.70 0.27 NaN NaN
NAA 0.39 0.94 0.94 0.85 0.85 NAA 0.12 0.88 0.76 0.83 0.69
Cr 0.40 0.73 0.79 0.71 0.70 Cr 0.20 0.73 0.74 0.49 0.46
Cho 0.33 0.83 0.89 0.87 0.88 Cho 0.32 0.75 0.50 0.66 0.44
mI 0.17 0.79 0.73 0.66 0.70 mI 0.02 0.57 0.37 0.31 0.20
Glx -0.47 0.46 0.02 0.54 0.17 Glx 1.00 0.05 0.68 -0.01 0.00
NAA / Cr 0.57 0.70 0.74 0.52 0.45 NAA / Cr 0.25 0.68 0.82 0.74 0.77
Cho / Cr 0.43 0.27 0.37 0.61 0.61 Cho / Cr 0.47 0.71 0.88 0.74 0.73
mI / Cr 0.02 0.79 0.72 0.64 0.71 mI / Cr 0.18 0.61 0.45 0.47 0.38
































































































































NAA 0.79 0.79 0.29 0.41 0.49 NAA 0.81 0.88 0.92 0.82 0.79
Cr 0.80 0.67 -0.04 0.31 0.30 Cr 0.77 0.88 0.81 0.62 0.58
Cho 0.86 0.77 0.49 0.64 0.57 Cho 0.89 0.85 0.87 0.71 0.61
mI 0.56 0.73 0.36 0.52 0.09 mI 0.63 0.72 0.90 0.52 0.63
Glx -0.21 -0.48 -0.33 0.04 0.93 Glx 0.12 0.47 0.40 0.79 0.12
NAA / Cr 0.54 0.85 0.72 0.40 0.03 NAA / Cr 0.22 0.77 0.71 0.59 0.67
Cho / Cr 0.77 0.80 0.82 0.65 0.24 Cho / Cr 0.40 0.83 0.77 0.51 0.36
mI / Cr 0.33 0.75 0.48 0.69 0.47 mI / Cr 0.29 0.62 0.38 0.30 0.44
Glx / Cr -0.17 -0.45 -0.46 0.13 0.98 Glx / Cr -0.16 0.18 0.02 0.69 0.00
NAA 0.77 0.91 0.81 0.82 0.45 NAA 0.58 0.97 0.96 0.91 0.84
Cr 0.75 0.89 0.82 0.61 0.70 Cr 0.60 0.93 0.91 0.87 0.86
Cho 0.80 0.92 0.91 0.85 0.50 Cho 0.73 0.95 0.95 0.92 0.86
mI 0.47 0.73 0.79 0.69 0.31 mI 0.47 0.76 0.63 0.53 0.66
Glx -0.80 0.00 0.17 -0.23 -0.79 Glx 0.91 0.75 -0.46 0.04 0.78
NAA / Cr 0.43 0.89 0.89 0.62 0.68 NAA / Cr 0.48 0.82 0.66 0.84 0.79
Cho / Cr 0.44 0.68 0.71 0.66 0.25 Cho / Cr 0.68 0.71 0.71 0.80 0.83
mI / Cr 0.60 0.62 0.66 0.60 -0.16 mI / Cr 0.26 0.49 0.11 0.33 0.56
Glx / Cr -0.80 -0.06 0.19 -0.09 -0.70 Glx / Cr 0.86 0.72 -0.66 0.05 0.79
NAA 0.40 0.92 0.92 0.88 0.76 NAA 0.42 0.84 0.80 0.65 0.45
Cr 0.38 0.53 0.66 0.61 0.80 Cr 0.42 0.73 0.75 0.64 0.29
Cho 0.14 0.74 0.76 0.69 0.49 Cho 0.18 0.84 0.84 0.71 0.13
mI 0.41 0.72 0.79 0.75 0.53 mI 0.44 0.61 0.61 0.47 0.57
Glx 0.11 0.90 0.77 0.59 0.49 Glx -0.07 0.01 0.80 1.00 NaN
NAA / Cr 0.45 0.54 0.59 0.63 0.66 NAA / Cr 0.49 0.75 0.64 0.69 0.33
Cho / Cr 0.31 0.53 0.48 0.47 0.12 Cho / Cr 0.28 -0.04 0.23 0.44 -0.05
mI / Cr 0.08 0.23 0.42 0.49 0.32 mI / Cr 0.52 0.78 0.52 0.62 0.47
Glx / Cr 0.19 0.81 0.81 0.53 0.55 Glx / Cr -0.48 0.17 0.96 1.00 NaN
NAA 0.55 0.95 0.90 0.83 0.84 NAA 0.67 0.97 0.97 0.94 0.93
Cr 0.55 0.86 0.82 0.83 0.77 Cr 0.40 0.92 0.88 0.90 0.92
Cho 0.38 0.87 0.88 0.87 0.87 Cho 0.57 0.74 0.69 0.70 0.62
mI 0.44 0.92 0.90 0.89 0.83 mI 0.51 0.82 0.87 0.74 0.87
Glx -0.66 0.33 -0.71 -0.99 -0.39 Glx NaN -1.00 1.00 -0.03 -0.81
NAA / Cr 0.29 0.90 0.84 0.79 0.83 NAA / Cr 0.57 0.87 0.84 0.86 0.88
Cho / Cr -0.03 0.54 0.63 0.80 0.70 Cho / Cr 0.27 0.56 0.45 0.62 0.58
mI / Cr 0.34 0.91 0.91 0.92 0.83 mI / Cr 0.63 0.84 0.91 0.68 0.88
Glx / Cr -0.77 0.33 -0.68 -0.97 0.05 Glx / Cr NaN -1.00 1.00 -0.35 -0.45
NAA 0.43 0.90 0.87 0.92 0.65 NAA 0.64 0.98 0.92 0.89 0.63
Cr 0.49 0.84 0.83 0.81 0.36 Cr 0.66 0.91 0.85 0.66 0.38
Cho 0.34 0.93 0.91 0.84 0.58 Cho 0.67 0.82 0.59 0.74 0.53
mI 0.12 0.62 0.67 0.47 0.36 mI 0.00 0.92 0.85 0.87 0.68
Glx 0.51 0.09 0.12 0.30 -0.02 Glx -0.55 0.82 -0.12 -0.55 -0.10
NAA / Cr 0.35 0.73 0.77 0.61 0.28 NAA / Cr 0.48 0.91 0.89 0.72 0.76
Cho / Cr 0.39 0.79 0.74 0.61 0.14 Cho / Cr 0.51 0.66 0.72 0.55 0.48
mI / Cr 0.18 0.43 0.51 0.29 0.15 mI / Cr 0.10 0.88 0.81 0.81 0.65














































































































































NAA 0.77 0.91 0.87 0.86 0.49 NAA 0.88 0.95 0.94 0.87 0.74
Cr 0.84 0.78 0.79 0.79 -0.04 Cr 0.74 0.92 0.89 0.79 0.69
Cho 0.54 0.91 0.91 0.84 0.57 Cho 0.83 0.95 0.95 0.85 0.76
mI 0.60 0.66 0.66 0.28 -0.22 mI 0.76 0.85 0.78 0.67 0.52
Glx 0.31 0.23 -0.15 -0.21 -0.04 Glx 0.73 0.65 0.47 1.00 -1.00
NAA / Cr 0.66 0.57 0.65 0.65 -0.08 NAA / Cr 0.48 0.84 0.90 0.70 0.71
Cho / Cr -0.01 0.69 0.76 0.60 0.81 Cho / Cr 0.33 0.79 0.79 0.51 0.55
mI / Cr 0.50 0.50 0.51 0.08 -0.24 mI / Cr 0.38 0.85 0.77 0.53 0.54
Glx / Cr 0.38 0.10 -0.23 -0.15 -0.06 Glx / Cr 0.59 0.59 0.30 1.00 -1.00
NAA 0.49 0.81 0.84 0.65 0.39 NAA 0.54 0.98 0.96 0.87 0.88
Cr 0.60 0.92 0.94 0.85 0.82 Cr 0.75 0.89 0.93 0.87 0.89
Cho 0.54 0.72 0.83 0.55 0.51 Cho 0.53 0.93 0.91 0.67 0.67
mI 0.41 0.76 0.75 0.47 0.02 mI 0.76 0.76 0.81 0.76 0.44
Glx 0.39 -0.04 0.32 -0.50 -0.39 Glx 0.28 -0.62 -0.28 -0.68 -0.42
NAA / Cr 0.40 0.75 0.80 0.67 0.72 NAA / Cr 0.30 0.70 0.72 0.66 0.69
Cho / Cr 0.35 0.33 0.35 0.20 0.01 Cho / Cr -0.01 0.59 0.66 0.31 0.20
mI / Cr 0.31 0.73 0.63 0.37 -0.08 mI / Cr 0.46 0.81 0.84 0.74 0.47
Glx / Cr -0.17 0.04 0.10 -0.48 -0.49 Glx / Cr 0.48 -0.69 -0.19 -0.57 -0.39
NAA 0.71 0.89 0.94 0.84 0.87 NAA 0.73 0.87 0.90 0.76 0.77
Cr 0.68 0.89 0.91 0.85 0.84 Cr 0.80 0.84 0.85 0.36 0.67
Cho 0.48 0.28 0.35 0.36 0.54 Cho 0.42 0.49 0.42 -0.04 0.15
mI 0.34 0.28 0.26 0.37 0.49 mI 0.66 0.33 0.38 0.44 0.32
Glx 0.33 0.78 0.77 0.17 0.80 Glx 0.04 0.34 0.11 0.94 0.36
NAA / Cr 0.41 0.71 0.74 0.81 0.71 NAA / Cr 0.67 0.53 0.65 0.35 0.25
Cho / Cr 0.44 0.23 0.34 0.32 0.38 Cho / Cr 0.37 0.44 0.25 0.34 -0.11
mI / Cr 0.02 0.33 0.34 0.12 0.29 mI / Cr 0.50 0.14 0.13 0.39 0.06
Glx / Cr 0.45 0.81 0.78 0.31 0.83 Glx / Cr 0.63 0.39 0.07 0.48 0.51
NAA 0.46 0.95 0.95 0.89 0.89 NAA 0.77 0.96 0.97 0.97 0.96
Cr 0.56 0.80 0.83 0.78 0.78 Cr 0.83 0.88 0.89 0.84 0.86
Cho 0.54 0.85 0.88 0.88 0.77 Cho 0.75 0.92 0.91 0.85 0.79
mI 0.63 0.80 0.77 0.72 0.57 mI 0.71 0.66 0.76 0.74 0.76
Glx 0.91 -0.12 -0.32 0.23 0.25 Glx 1.00 -0.97 -0.22 -0.10 1.00
NAA / Cr 0.25 0.64 0.70 0.71 0.71 NAA / Cr 0.63 0.80 0.83 0.64 0.80
Cho / Cr 0.16 0.40 0.60 0.80 0.65 Cho / Cr 0.38 0.79 0.75 0.42 0.63
mI / Cr 0.54 0.59 0.61 0.65 0.53 mI / Cr 0.62 0.63 0.79 0.65 0.72
Glx / Cr 0.93 -0.14 -0.33 0.30 0.33 Glx / Cr 1.00 -0.97 -0.19 -0.08 1.00
NAA 0.61 0.95 0.90 0.98 0.61 NAA 0.30 0.83 0.88 0.89 0.84
Cr 0.64 0.95 0.94 0.98 0.41 Cr 0.23 0.65 0.73 0.70 0.51
Cho 0.59 0.89 0.82 0.88 0.84 Cho 0.44 0.82 0.85 0.91 0.63
mI 0.16 0.65 0.83 0.38 -0.02 mI 0.25 0.57 0.59 0.86 0.66
Glx -0.30 0.48 0.40 0.00 -0.31 Glx NaN 1.00 1.00 1.00 NaN
NAA / Cr 0.24 0.76 0.39 0.85 0.33 NAA / Cr 0.46 0.86 0.86 0.78 0.65
Cho / Cr 0.53 0.56 0.34 0.72 0.67 Cho / Cr -0.22 0.90 0.84 0.85 0.55
mI / Cr 0.10 0.60 0.73 0.51 0.60 mI / Cr 0.34 0.58 0.59 0.72 0.35
























































































































Table 13: Percentage of non-zero data obtained after processing in LCModel and passing post-filtration parameters 
 
L. Central GM 85% R. Central GM 85% L. Central WM 85% R. Central WM 85%
L. Cerebellum GM 96% R. Cerebellum GM 90% L. Cerebellum WM 86% R. Cerebellum WM 90%
L. Cingulate GM 89% R. Cingulate GM 89% L. Cingulate WM 85% R. Cingulate WM 88%
L. Fusiform GM 89% R. Fusiform GM 89% L. Fusiform WM 78% R. Fusiform WM 79%
L. Inferior Parietal GM 88% R. Inferior Parietal GM 79% L. Inferior Parietal WM 81% R. Inferior Parietal WM 85%
L. Inferior Temporal GM 90% R. Inferior Temporal GM 77% L. Inferior Temporal WM 86% R. Inferior Temporal WM 91%
L. Insula GM 85% R. Insula GM 86% L. Insula WM 84% R. Insula WM 86%
L. Lateral Occipital GM 87% R. Lateral Occipital GM 73% L. Lateral Occipital WM 80% R. Lateral Occipital WM 87%
L. Lingual GM 86% R. Lingual GM 88% L. Lingual WM 82% R. Lingual WM 81%
L. Orbito-Frontal GM 80% R. Orbito-Frontal GM 71% L. Orbito-Frontal WM 86% R. Orbito-Frontal WM 86%
L. Pars GM 80% R. Pars GM 82% L. Pars WM 81% R. Pars WM 83%
L. Post-Central GM 84% R. Post-Central GM 78% L. Post-Central WM 85% R. Post-Central WM 86%
L. Pre-Cuneus GM 89% R. Pre-Cuneus GM 85% L. Pre-Cuneus WM 80% R. Pre-Cuneus WM 82%
L. Rostral Middle Frontal GM 84% R. Rostral Middle Frontal GM 81% L. Rostral Middle Frontal WM 83% R. Rostral Middle Frontal WM 82%
L. Superior Frontal GM 79% R. Superior Frontal GM 82% L. Superior Frontal WM 89% R. Superior Frontal WM 86%
L. Superior Parietal GM 76% R. Superior Parietal GM 73% L. Superior Parietal WM 87% R. Superior Parietal WM 86%
L. Superior Temporal GM 83% R. Superior Temporal GM 85% L. Superior Temporal WM 81% R. Superior Temporal WM 85%
L. Supra-Marginal GM 88% R. Supra-Marginal GM 91% L. Supra-Marginal WM 82% R. Supra-Marginal WM 84%
L. Striatum 90% R. Striatum 89% L. Thalamus 84% R. Thalamus 81%
Brain Stem 83% Ventral Diencephalon 73% Ventricles 85% All 84%
NAA 95% NAA / Cr 95% Cho 95% Cho / Cr 95%
mI 94% mI / Cr 94% Glx 46% Glx / Cr 45%
Cr 95%
SLIM 16x16x12 79% SLIM 20x20x12 82% SLIM 40x40x12 85% SLIM 50x50x12 85%
MINT 50x50x18 86% ROIS 50x50x18 88%
Subject 008 88% Subject 009 82% Subject 010 85% Subject 012 84%
Subject 013 77% Subject 014 88% Subject 015 82% Subject 016 85%
Subject 017 80% Subject 018 87% Subject 019 85% Subject 020 78%
Subject 021 86% Subject 022 89% Subject 023 86% Subject 024 85%
Subject 025 86% Subject 026 85% Subject 027 85% Subject 028 78%
% data obtained by compartment
% data obtained by metabolite
% data obtained by localization type
% data obtained by subject
